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Abstract 
Sigma-70 is the subunit of E. coil RNA polymerase which confers 
specificity for initiation of transcription at most promoters in 
actively growing cells. The protein shares four conserved regions 
with major and many alternative sigmas of all studied prokaryotes. 
However, a stretch of 245 amino acids, lying between conserved 
regions 1 and 2, is absent from all minor sigmas and even from the 
similar and functionally homologous sigma-43 of Bacillus subtilis. 
Deletion of these 245 residues from sigma-70 generates a protein 
which retains significant function in vitro and partial in vivo 
function. The three natural cysteine residues of sigma-70 are 
confined to the deleted region. Plasmids allowing overproduction of 
the internally deleted protein and of a number of single-cysteine 
substituted mutant derivatives were constructed, and these were 
tested for function in vivo using a chimaeric sigma/promoter 
system. The overproduced proteins were isolated employing a novel 
purification method, and their activities analysed in vitro at XPR  and 
T7A 1 promoters. An extraordinary tendency towards reversible 
aggregation and hydrophobicity was observed. A possible role of the 
245 amino acid domain is discussed. 
The scrP gene encoding sigma cross-reacting protein was originally 
identified during a search for alternative sigma factors, but later 
shown not to be a sigma protein. As part of the effort to elucidate 
its possible function, the regulation of expression of scrP gene was 
studied. Transcriptional fusions of lacZ to scrP, and to arcB and 
mtgA, the genes adjacent to it, were produced, transferred to the E. 
coil chromosome and utilised to analyse the expression of scrP. The 
results indicate that scrP belongs to the same operon as arcB and 
mtgA, and is transcribed both from its own promoter and from the 
promoter upstream from arcB. Further analysis was used to 




aa Amino acid residues 
Amp Ampicillin 
ATP Adenosine 5'-triphosphate disodium salt 
Awv Absorbance at wavelength <Wv> nm 
bp Base pair 
CAT Chloramphenicol acetyltransferase 
BSA Bovine serum albumin 
Cm Chioramphenicol 
CTP Cytidine 5'-triphosphate sodium salt 
dATP Deoxy ATP 
DNA Deoxyribonucleic acid 
dNTP Deoxyribonucleoside 5-triphosphate 
dsDNA Double-stranded DNA 
E DNA-dependent RNA polymerase, core enzyme 
DNA-dependent RNA polymerase, holoenzyme 
EDTA Ethylenediaminetetraacetic acid tetrasodium salt 
GTP Guanosine 5'-triphosphate sodium salt 





MOPS 3-N-Morpholinopropanesulphonic acid 
nt Nucleotide 
NTP Nucleoside 5'-triphosphate 
ORF Open reading frame 
PAGE Polyacrylamide gel electrophoresis 
PCR Polymerase chain reaction 
P1 5'-phosphorylated 
PIPES Piperazine N,Ntbis (2-ethane suiphonic acid) 
PMSF Phenylmethylsulphonyl fluoride 
rbs Ribosome binding site 
RNA Ribonucleic acid 
RNAP RNA polymerase 
rpm Revolutions per minute 
xi 
SDS Sodium dodecyl sulphate 
Spc Spectinomycin 
ssDNA Single-stranded DNA 
Str Streptomycin 
TEMED N, N, N', N', -tetramethylethylethylenediamine 
Tet Tetracycline 
Tris Tris(hydroxymethyl)aminomethane 
ts Temperature sensitive 
UTP Uridine 5'-triphosphate trisodium salt 
X-gal 5-Bromo-4-chloro3-indolyl-13-gaiactosjde 
X' Resistance to antibiotic X 
Xs Sensitive to antibiotic X 
The numbering of amino acids in ArcB is according to luchi et al. 





1. 1. subunit of RNA polymerase. 
1.1.1. Transcription initiation by bacterial RNA polymerase. 
In eubacteria transcription is carried out by DNA dependent RNA 
polymerase (RNAP). The activities of this enzyme can be described 
in terms of two functional forms, one of which is the core enzyme 
involved in RNA polymerisation and the other the holoenzyme 
responsible for recognition and binding of specific promoter 
sequences and for initiation of transcription. The core RNAP 
interacts with a a subunit, and together these constitute the RNA 
polymerase holoenzyme in which the a subunit determines its 
transcriptional specificity [Burgess et al., 1969; Gross et al., 19921. 
The core enzyme (E) involved in RNA synthesis is zinc containing 
protein which has a minimal composition of four subunits OVX2. 
The individual subunits do not show biological activity, but can 
self-assemble in a defined order, as was shown in vitro and in vivo by 
Yura and Ishihama [1979]. The core enzyme is unable to initiate 
transcription specifically, but is capable of ribonucleotide 
polymerisation and termination at some sites. A functional sigma 
subunit is absolutely required to allow specific transcription 
initiation by RNA polymerase [Burgess et al., 1969]. The initiating 
RNA polymerase holoenzyme (Eu) of Escherichia coli has a molecular 
weight of about 4.5 x 10 5 and contains five subunits: 
a+a —> a2 —> a213 > a21I3' —> a213I3cY 
E 	Ea 
The four subunits of the core enzyme have molecular sizes 
36.5 kDa (a), 150.6 kDa (3) and 155.2 kDa (n'), and are encoded by 
rpoA (a), rpoB (13) and rpoC (13') genes [rev, by Smillie, 1994]. 
The c subunit is bound relatively weakly to the rest of the enzyme 
(the core polymerase); it is responsible for specific promoter 
recognition by RNA polymerase, but is released during the 
initiation process. The core polymerase then continues to catalyse 
2 
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phosphodiester bond formation between the growing RNA chain and 
the next NTP, the identity of which is specified by the sequence of 
the template strand. After chain termination and dissociation of 
the ternary complex of the core RNA polymerase, RNA, and DNA, 
the released core can again bind a a subunit and start a new cycle 
of RNA synthesis. 
The Escherichia coli genome encodes seven a factors, of which a 70 
(named for its molecular weight of 70,000) is the most abundant 
during exponential cell growth (alternative names are given in 
brackets): 
070 (RpoD) [Helmann and Chamberlin, 1988] 
a32 (RpoH) ibid 
aF (a28 ) ibid 
aE (RpoE) ibid 
a38 (RpoS) ibid 
aF'eCI [Lonetto et al., 19921 
aN (a54 ) [Merrick et al., 1993] 
The a subunit is an important determinant of the sequence-specific 
recognition of promoter DNA. Through the use of different a factors, 
RNA polymerase can be targeted to promoters with distinct 
sequences. In response to various environmental stimuli different 
a factors can preferentially bind to core RNA polymerase to initiate 
transcription of separate sets of genes which are under their 
control. 
Prokaryotic sigma factors can be classified into two families 
according to their sequence similarities. Members of the first family 
are similar to the E. coli a 7 ° factor and have four regions of 
homology which will be described later; they specifically recognise 
-35 and -10 regions of their cognate promoters. Members of the 
other family are similar to the E. coli a54 factor, have very little 
similarity to a 70 family, and recognise -24 and -12 regions of 
promoters mostly involved in nitrogen regulation of bacteria 
[Merrick et al., 19931. Mechanisms of transcription initiation are 
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different between these two families. Here only &0  family will be 
discussed. 
The cr70 family of transcription factors can be further subdivided into 
several groups. Bacteria usually have one primary sigma factor 
which is required for transcription initiation at the majority of 
promoters in exponentially grown cells. Alternative sigma factors 
direct transcriptional responses to changing environmental 
conditions. Although all members of 070 family have significant 
sequence similarities in four conserved regions, they recognise 
different sequences at the two promoter elements localised -10 and 
-35 base pairs upstream of the transcription start sites and thus 
contribute to the control of initiation of transcription [Helmann and 
Chamberlin, 1988]. 
Four important promoter elements can be distinguished: two 
hexamers centred at or near positions 10 and 35 upstream from the 
transcription start site (designated by their locations as the -10 
and -35 regions), the spacer DNA separating them, and a region 
between -40 and -60 (the UP element). Various compilations of 
promoter sequences recognised by E& 0 have established the 
importance of the 35 and 10 regions. The consensus sequences of 
these two regions as read on the nontemplate strand are, 
respectively, TTGACA and IATAAL Generally the greater the 
similarity of the 10 and 35 regions to their consensus sequence, 
the better the promoter functions in vitro, as well as in vivo; in this 
regard, well-conserved base pairs (underlined above) may be of 
greater importance than the less-conserved ones [Helmann and 
Chamberlin, 1988]. The ability of RNA polymerase to discriminate 
between promoters with different sequences at the -10 and -35 
regions has allowed the basal rate of transcription of various genes 
to be set at different levels. A consensus length of 17 bp has been 
established for the spacer between the 10 and 35 regions. 
Promoters with such a spacer length have been found to be more 
active in vitro, as well as in vivo, than those with shorter or longer 
spacers [Helmann and Chamberlin, 1988; Dombroski et al., 1996]. 
An A+T-rich region between positions 40 and 60 (the UP element) is 
rd 
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recognised in some promoters as an additional important 
determinant of promoter activity. This region is contacted by the a 
subunit [Igarashi and Ishihama 1991]. 
Transcription initiation by RNAP can be described in several steps: 
E + 




EPabortive  —* abortive transcripts 
where P is promoter DNA, E(Y-P c closed complex, Ecy-Pi intermediate 
complexes, Ea-P O open complex, EaPt initiation complex, EP eiong 
elongation complex, EYP abort non-productive complex [Gross et al., 
1998]. 
Initially core enzyme binds to the a subunit, bringing 
conformational changes both to the core enzyme and to the a 
subunit [Dombroski, 1997; Wilson and Dombroski, 1997; Schaubach 
and Dombroski, 1999; Callaci et al., 1998; Callaci and Heyduk, 1998; 
Buckle et al., 1999; Craig et al., 1998; deHaseth et al., 1998; Nagai 
and Shimamoto, 1997; Polyakov et al., 1995]. It has been now 
established that a makes contacts with the core enzyme in many 
regions along its length, notably 1. 1, 2.1, 2.2, 2.4, 3.1, 4. 1, and 4.2, 
according to protein footprinting and genetic studies [Gross et al., 
1998; Jo0 et al., 1997; Joo et al., 1998; Nagai and Shimamoto, 1997]. 
The holoenzyme, but not the core enzyme or a alone, is able to 
specifically recognise and bind promoter sequences within the 
DNA. The holoenzyme bound to promoter DNA forms a closed 
complex (E(yP) in which DNA is double-stranded. Then EaP 
undergoes several isomerisation steps (EaP 1), during which 
promoter DNA melts at the -10 element, the melting spreads to the 
transcriptional start at +1 and beyond, establishing the open 
complex EaP 0 . a subunit is also needed to precisely locate 
transcription start site. After addition of NTPs and formation of the 
first phosphodiester bonds (EaP 1 t) RNA polymerase leaves the 
promoter, soon after a dissociates from the transcriptional 
complex, and the elongating complex EP e i ong continues to 
synthesise RNA [rev, by Gross et al., 1998]. 
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1.1.2. Conservation among members of a 70 family. 
Each bacterium has several different sigma subunits responsible 
for the recognition of different sets of promoters. From extensive 
studies it has been revealed that all a subunits fall into two major 
families, with little similarities between them [Lonetto et al., 1992]. 
The first, and the largest, a family has a significant degree of 
similarity to a 70, the primary a subunit of Escherichia coli, which is 
responsible for the recognition of the majority of promoters in 
actively growing cells. The other family of sigmas has similarity to 
aN, or a54 , of E. coli, and is responsible for transcription initiation of 
genes involved in nitrogen regulation [Gross et at., 19921. 
The a 70 family can be further subdivided into primary and 
alternative a factors [Gross et at., 19921. The sequences of many of 
these are known, and four conserved regions have been identified 
(Fig. 1.1.1.) [rev, by Helmann and Chamberlin, 19881. 
Series of studies have shown that region 2.4 interacts directly with 
-10 elements, and region 4.2 with -35 elements of promoters 
[reviewed by Gross et al., 1998]. Region 2.5, between 2.4 and 3.1, 
was proposed as the site of recognition of the "extended -10" motif 
of the promoter [Barne et al., 1997; Dombroski, 1997; Bown et at., 
1999], which can drive factor-independent transcription at some 
promoters lacking consensus within -35 element [Kumar et al., 
1993]. 
Free a 70 alone or core enzyme does not bind promoter DNA 
specifically [Wellman and Meares, 19911. It has been shown that it 
is region 1.1 of a 70 that prevents the polypeptide from binding to 
DNA in the absence of the core enzyme [Dombroski et at., 1992; 
Dombroski et at., 1993], negatively affecting binding of region 4 to 
the -35 element of the promoter [Bowers and Dombroski, 1999]. 
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However, &0 itself has the ability to recognise and bind the DNA 
fork between positions -12 and -7 of the transcriptional bubble (a 
heteroduplex DNA). The identity of the unpaired nucleotide of the 
nontemplate strand at position -11 is crucial for the recognition 
[Dombroski, 1997; Guo and Gralla, 1998]. In heteroduplex promoter 
DNA base recognition by a 70 is directed to the nontemplate strand, 
and G at position -12 or -11 of a consensus promoter was the only 
base significantly disfavoured by a [Roberts and Roberts, 1996]. 
In the holoenzyme-lacUV5 promoter complex sigma cross-links to 
nucleotides -7 to -2 of exclusively nontemplate strand of the 
promoter [Simpson, 1979; Siebenlist et at., 1980; Chenchik et at., 
1982; Buckle et al., 1999]. Buckle et at. observed open complex 
formation using time-resolved UV irradiation and controlled 
proteolysis. First distortions at -35 region of the lacUV5 promoter 
occurred, due to intimate contact of U70  with this site, followed by 
its direct contacts at positions -8, -5 and -3 of the promoter. These 
contacts occur prior to DNA strand separation. After the fast 
melting step, and when RNA polymerase already synthesises full-
length transcripts, reformation of close contacts of a 70 with the -10 
region begins, thus reversing the order of a 70-promoter contact 
events leading to open complex formation [Buckle et al., 1999]. 
Using UV laser footprinting it was shown that RNA polymerase 
contacts -35 element of the malTi promoter first, and then it 
spreads the contact in the closed complex to -10, in presence or 
absence of activator CRP [Eichenberger et at., 1997]. The length of 
the spacer DNA (17 bp for a 70) between -35 and -10 elements is an 
important determinant of promoter strength [e.g. Kumar et at., 
1995a; Dombroski et al., 1996]. 
1.1.3. Amino acids in a subunits involved in promoter 
recognition and opening. 
We were interested in investigating the mechanism of promoter 
opening. The conserved region 2.3 is known to be involved in DNA 
melting is [Helmann and Chamberlin, 19881. Region 2.4 interacts 
111 
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with the -10 element of promoters. There have been extensive 
genetic and biochemical studies on amino acid residues thought to 
be involved in the process of promoter opening. Together with the 
resolved crystal structure of a fragment of 070  (residues 114-442) 
[Maihotra et al., 1996] these studies have provided a powerful 
insight into the mechanisms of DNA recognition and melting. 
Many residues in region 2.3 are tolerant to amino acid 
substitutions. Waldburger and Susskind [1994] used a 070(R588H) 
which has an altered specificity for the -35 element. They were able 
to make conservative and non-conservative substitutions at almost 
all the residues of region 2.3 of a70(R588H), except for T429 (changing 
this residue to alanine makes the protein inactive) and K426 (only 
a conservative change to arginine is permissible), while retaining 
functionality of 70  in vivo as measured by the activation of reporter 
genes from mutated antL-33A and laci-34A promoters. Amongst 
these there were Y430M, single substitutions to cysteine at 
positions Y421, Y425 and W433, a multiple substitutions 
containing S428C (S428C Y425F F427L or S428C Y425D F4271) and 
S428A. Y42 10, F427A, W433C and W430A retained only 25-45% of 
functionality, as judged by their ability to activate the reporter 
gene. 
Helmanns group studied primary sigma A  of Bacillus subtilis with 
substitutions in region 2.3. They made a number of conserved 
aromatic amino acid substitutions and found that A  with Y180A 
substitution supports transcription initiation; Y184A, Y184L, 
Y184S, Y189A, Y189F, Y189W, Y189S, Y189L, W192A, W193A, 
W192S + W193S substitution lead to cold-sensitive transcription 
from B. subtilis P, promoter, indicative of melting impairment. 
Finally, F178A and F186A substitutions lead to the most impaired 
transcription in vitro but even these substitutions can allow 
transcription from supercoiled templates [Juang and Helmann, 
1994] or from a "bubble" template (F178A, Y180A, Y184A, F186A, 
Y189A, W192A, W193A) [Aiyar et al., 19941. EA(\'189A)  and E(h192A) 
are defective in nucleation and propagation of the melted region of 
B. subtilis PtrnS promoter in vitro, while EA(W193A) can initiate 
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transcription but is defective in propagation [Juang and Helmann, 
1995]. Y180A and Y184A substitutions in GA  support cell growth in 
single copy, while overexpressing cyA  with Y189A, W 192 and W193A 
substitutions is lethal to cells [Rong and Helmann, 1994]. 
EaA(Y 1 80A), EaA(Y189A) and EaA(W192A)  are able to bind dsDNA or 
ssDNA (nontemplate strand) with the consensus -10 element as 
effectively as EaA. EaA(W193A) shows enhanced, and EaA(Y184A) 
impaired, binding to ssDNA, but they demonstrate normal binding 
to double-stranded promoter DNA. EA(F 178A) and EaA(F186A)  are 
grossly defective in DNA binding. Despite good binding of the 
nontemplate DNA, however, in EaA(\'189A) and EaA(W 1 93A) a poorly 
cross-linked to this DNA comparative to the a in the wild-type 
holoenzyme, indicating that these amino acids contribute to 
sequence-selective nontemplate strand binding [Huang et al., 1997]. 
F178, Y180, Y184, F186, Y189, W192, W193 of a 70 correspond to 
F419, Y421, Y425, F427, Y430, W433 and W444 of aA. 
Single amino acid substitutions were performed at all positions of 
region 2.3 and first eight positions of region 2.4 of B. subtilis aE 
responsible for endospore development [Jones et al., 1992]. 
Substitutions at positions 113, 115, 117 and 120 (Y113C, Y113A, 
Si 15P, N120A and several C117 substitutions including C1 17W, 
C1 17R) lead to the most severe effects on sporulation. C117 of OE 
aligns with W434 of 070 . E(yE(C 1 17R) cannot transcribe from linear 
templates in vitro, but are able to do so from a supercoiled template, 
with the transcription becoming temperature-dependent, as tested 
with aEdependent promoter spoIIID [Jones and Moran, 19921. 
Amongst the substitutions which allow cells to sporulate are P104 
to Q or T; 1108 to A, S or V; All  to V; R116 to P or A; L123 to A 
[Jones et al., 19921. These amino acids correspond to several of 
those in E. coli a70 that we intended to study (see Fig. 1.1.2). M 124 
replacement in region 2.4 (aligned with R441 of a 70 ) suppresses 
single base pair mutations at the two upstream positions of -10 
element of aEdependent spolilD, spoliD and cotEPi promoters [Tatti 
et al., 1991; Diederich et al., 19921. aE  with double substitution E119 
and N120 to isoleucine and glycine (1119 and G120), which are 
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amino acids that another sigma factor of B. subtilis, aB,  has at 
these positions, is capable of recognising &-dependent promoter 
ctc in vivo. However, it can no longer transcribe from the (YE-  
dependent promoter spoilD or from the ctc promoter with its first 
two base pairs GG substituted to CA, the latter being characteristic 
of GE-dependent promoters [Tatti and Moran, 1995]. This suggests 
that either or both El 19 and N120 of E,  which align with R436 and 
Q437 of , directly interact with first two base pairs of(YE cognate 
promoters and are responsible for their recognition. 
a70 417 DKFEYRRGYKFSTYATWWIRQITRSIADQARTIRIPVHN 456 
OA 176 EKFDYRKGYKFSTYAT1IRQAIIFAIADQARTIRIPVHM  215 
CFE 100 NTFNPEKKIKLATXAI.NEIYLRRNNKIRS ----- 134 
GB 71 KRYDPVVGKSFEAFAIPTIIGEIKRFLRDKTWSVHVPRRI 111 
aH 76 RDFKEDKLTSFKAFAELCITRQIITAIKTATRQKHIPLNS  120 
------ 2.3 ------- >< -------- 2.4---------> 
Fig. 1.1.2. Alignment of regions 2.3 and 2.4 a70 of E. coli and of CFA, OE, aB, and aH 
of B. subtilis. Underlined amino acid residues are those substitutions of which are 
mentioned in the text. 
Siegele et al. [1989] and Waldburger et al. [1990] demonstrated that 
T4401 and Q437H substitutions in &O  region 2.4 suppress T-->C 
mutation at -12 position of 70-dependent lac and ant promoters. 
A438V substitution had no significant effect on the tested mutant 
promoters [Siegele et al., 19891. 
Marr and Roberts [1997] have shown that E070 of E. coli binds a 
template oligonucleotide containing -10 element of ?PR promoter in 
vitro, but does not bind the oligonucleotide with T-C replacement 
at -12 of this promoter. E70(Q437H)  is able to bind both 
oligonucleotides specifically. 
Dombroski [1997] used fragments of 070  which did not have region 1 
and therefore are able to bind duplex promoter DNA, in DNA 
binding competition assays. She has shown that those fragments 
which contain region 2 can distinguish the identity of first three 
nucleotides in the -10 element of the tac promoter. 
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The substitution Q 196 in CA  of B. subtilis strongly suppressed a 
T-C mutation at the upstream position of -10 element of the 
spoliG promoter, while T1991 substitution has only a slight effect 
(Q196 and T199 of CA  align with Q437 and 1440 of a70) [Kenney et 
al., 19891. 
Genetic studies on region 2.4 of yH,  one of B. subtilis sporulation 
sigma factors, have shown that T100I substitution suppresses 
mutation of -13, and R96A of -12 base pair (the first two positions 
of the -10 element) of the &'-dependent spoVG promoter (T100 and 
R96 of CH  align with R441 and Q437 of 70)  [Daniels et al., 1990]. 
EyH(T1001) can also transcribe from the mutant promoter (G-.A at 
position -13 of PspovG) in vitro [Zuber et al., 1989]. 199A substitution 
causes some impairment of OH  function in vivo, as judged by 
reduced ability of cells to sporulate, and cells with Q97A 
substitution in CH  behaved normally (199 and Q97 of CH align with 
T440 and A438 of &0) [Daniels et al., 19901. 
W434G substitution in y 70 has been shown to cause a 30% 
decrease in helicity in the free sigma subunit and changes its 
mobility on SDS-PAGE. The reconstituted holoenzyme displayed 
decreased level of productive, but normal level of abortive, 
transcription at T7 Al, lacUV5 and rpsA promoters. U70  with W433F 
substitution behaves like wt G70 , whereas W433G substitution 
leads to a decreased level of transcription in vitro [Gopal et al., 
1994]. 
Callaci and Heyduk [1998] replaced tryptophan residues with a 
fluorescent tryptophan analogue and showed that W433 and W444 
become less exposed to a solvent when CF 70 binds core enzyme. 
Conformational changes around these residues in region 2.3 also 
occur after addition of promoter DNA, when these residues become 
inaccessible to solvent. 
Parts of regions 2.3 and 2.4 form helix 14 within the crystal 
structure of the C70  fragment. This helix is amphipathic, and on the 
hydrophilic face there are amino acids which are known to interact 
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with the -10 element of nontemplate strand of the promoter: Y430 
and W433 (-10 and -11), Q437 and T440 (-11 and -12) [Maihotra et 
al., 1996; Gross et al., 1998] (see Fig. 1.1.3.). On the hydrophobic 
face of the helix there are several absolutely conserved hydrophobic 
residues in region 2.4 (1435, 1439 and 1443), which together with 
other conserved hydrophobic residues on helices 1, 12 and 13, 
belonging to regions 1.2, 2.1, 2.2 and 2.3, contribute the to 
hydrophobic core of the a protein. This amphipathic helix is thought 
to play a role in melting by acting as a single-strand nucleic acid 
binding protein and neutralising the DNA phosphate backbone 
[Malhotra et al., 1996]. 
N3j 
3-LfiHIiIIHI1IHIIHIIHIIIi--- 5 
Figure 1.1.3. A proposed interaction between amino acids in helix 14 [Malhotra 
et at., 1996; Gross et at., 19981 (parts of regions 2.3 and 2.4) with nucleotides of the 
nontemplate strand of a promoter DNA. 
1.1.4. Possible roles of region 3 in transcription initiation. 
Region 3 is not as extensively investigated as regions 2.3 and 2.4. 
The spacial location and role of the conserved regions 3.1 and 3.2 is 
not clear. However a number of studies have made an attempt to 
elucidate their role in a function. 
Several studies have indicated that region 3 is involved in core 
binding [Zhou et al., 1992; Jo0 et al., 1998] and becomes 
inaccessible from outside upon the holoenzyme formation [Nagai 
and Shimamoto, 1997]. Severinov et al. [1994] have shown that a 
site between E508 and M561, which is mostly a C-terminal part of 
region 3, cross-links to the priming ribonucleotide. With a subunit 
RNA polymerase is able to localise transcriptional start site (when 
transcription is initiated from heteroduplex or nicked templates 
[Fredrick and Helmann, 19971. 
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Owens et al. [1998a] have shown that K496 in region 3.1 is located 
very close to both strands of the E. coli lacUV5 promoter between 
positions -14 to -31. S517C in region 3.2 mapped close to position 
-4 of the template strand. 
E598K in the primary sigma of Myxococcus xanthus (corresponds to 
E503 of E. coli 70)  was reported to be impaired in function because 
it leads to growth problems and failure to produce an extracellular 
signal [Davis et al., 1995]. 
The single amino acid substitutions P504L and S506F in Cy 70 have 
been shown to compensate for the lack of ppGpp-dependent 
functions in ppGpp-null strain [Hernandez and Cashel, 1995]. In 
vitro studies have shown that these substitutions also affect the 
pattern of abortive transcripts differently from those of productive 
complexes at T7 Al, T5 N25 and T5 N25an tiDSR promoters, in a 
promoter sequence-specific manner [Hernandez et al., 19961. 
E&0P504 L and E70P506F  form binary complexes with a smaller 
fraction of open complexes at ?PRAL promoter which suggests that 
region 3.1 can be involved in melting dsDNA or in maintenance of 
the open complex [Sen et al., 19981. The abortive complexes 
(EYPabort) with ?PRAL promoter dissociated faster in the E& 0P506F 
holoenzyme [Sen et al., 1998]. These data suggest that region 3.1 is 
important for RNAP to choose between either productive or non-
productive mode of transcription in vitro. 
1.1.5. Use of cysteine residues and modification producing 
free radicals in structural and functional studies of &Q 
Cysteine residues in proteins can be chemically modified by a 
variety of reagents, which allows studies on structure of proteins, 
their interaction with adjacent molecules, and conformational 
changes during the reactions catalysed by these proteins. Such 
studies have recently been applied to G 7 0 , and they included 
modification of cysteines with reagent Fe-BABE which is capable of 
generating hydroxyl radicals upon induction [Owens et al., 1998a; 
Owens et al., 1998b; Bown et al., 1999; Traviglia et al., 1999], and the 
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use of fluorescent probes [Callaci et al., 1998; Heyduk and Heyduk, 
1999] 
c 70 contains three cysteine residues at positions 132, 291 and 295, 
all of which are not crucial for function [Narayanan and Krakow, 
1983]. They are all located within the non-conserved 245 amino acid 
domain. 
The analysed single-cysteine U70 derivatives demonstrate different 
reactivity in vitro. Owens et al. [1998a] and Callaci et al. [1998] used 
y7Oicys which is Cy70  with all three cysteines replaced with serine 
residues. These substitutions have no negative effects on UMAcys 
function. Callaci et al. reported that in vitro activity of GMAcysS438C, 
y70i\cysT440C and 70AcysS442C  is 37, 59 and 95% of that of CF70Acys , 
respectively. Single cysteine substitutions created by Owens et al. 
at different conserved regions of &O, including S517C in region 3.2, 
(K376C (2. 1), N396C (2.2), R422C (2.3), K496C (3. 1), S517C (3.2) 
retained 70-95% of wild-type transcriptional activity at the E. coli 
lacUV5 promoter [Owens et al., 1998a]. 
Callaci et al. [1998] using U70  with single cysteine replacements 
analysed cysteine accessibility and fluorescence spectra of 
fluoroprobe -modified cysteines of free Q70 and E 70 . They showed 
that upon binding to the core enzyme conformational changes occur 
at positions 1, 59, 336, 440, 583, 596. Cysteines at positions 440 
(T440C, region 2.4), 583 and 596 (T583C and R596C, region 4.2), and 
1 become more exposed to solution, whereas T440C and R596C find 
themselves in more polar environments upon 70  binding to the 
core enzyme. Cysteines replacing S438 and S442 which belong to 
the same a-helix as T440 [Malhotra et al., 1996] undergo no 
significant changes. Cysteines at positions 59 (A59C, region 1.1) 
and 366 (S366C, nonconserved region) become less exposed, with 




1.1.6. The region of 0  between the conserved regions 1.2 and 
2.1. 
The so called non-conserved region of CF70  is a 245 amino acids long 
stretch of peptide between the conserved regions 1.2 and 2.1. It is 
absent from all the alternative sigmas, and all of the primary 
sigmas from gram-positive bacteria analysed so far [reviewed by 
Lonetto et al., 19921. 
The previously analysed single amino acid substitutions in this 
region do not affect the function of the protein [e.g. Callaci et at., 
1998; Callaci and Heyduk, 1998; Owens et at., 1998b]. However the 
part of the nonconserved region proximal to 2. 1, together with part 
of 2. 1, is thought to be essential for core binding [Lesley and 
Burgess, 1989]. A small deletion in this region (Aaa 330-343, 
encoded by rpoD800, or rpoD285 allele) results in temperature 
sensitivity [Liebke et at., 1980; Hu and Gross, 1983]. from E. coli 
C, apart from three substitutions of non-conserved amino acids, 
differs from 70  from E. coli K-12 by a short deletion in the non-
conserved region (A195-204) [Christie and Cale, 19951. 
On the basis of homology of A  of Bacillus subtilis and 	of E. coli 
Kumar et al. [1995b] created 245  by deletion of amino acid residues 
130 through 374 of cr70.  The resulting protein reconstituted with the 
core enzyme exhibits in vitro activity indistinguishable from that of 
70, in that it can generate transcripts at 37°C from many different 
promoters : trp, dnaQ (P1 and P2), rnh, lacUV5, leuX, rrnE (P1, P2 
and Ps), gal (P1, CRP-dependent, and P2, CRP-independent), 
although it had significantly reduced ability to transcribe from alaS 
in vitro [Kumar et at., 1995b]. 
Gene rpoDz.%245 encoding 245  failed to complement rpoD285 (ts) in 
vivo at 42°C [Kumar et al., 1995b]. However, rpoD285 itself encodes 
cy 70 with a deletion of aa 330-343 (see above), therefore it was not 




In the hybrid sigma test (described in Chapter 2.5.9), the 245 aa 
deletion was introduced into a hybrid a70t 32 , consisting of 529 
N-terminal amino acids of 070 followed by 82 C-terminal amino acids 
of 032 [Kumar et al., 1995a]. This hybrid sigma has region 2 from 
a70245 and region 4 from a32 (heat shock sigma [Grossman et al., 
1984]), and was shown to be able to activate a hybrid promoter (a32 
consensus for -35, (y 70 consensus for -10 element) in vivo, but less 
effectively as a70132 hybrid sigma at 30, 37 and 42°C with the activity 
of a70245132 shown to be 55, 30 and 24% of that of a70132 , 
respectively. 
The nonconserved region is seen as a separate domain in the 
crystal structure of the a70 fragment, thus confirming the correctly 
chosen position for 245 amino acid deletion [Maihotra et al., 1996] 
(Fig. 1.1.4). The C-terminus of region 1.2 on helix 1 is in close 
proximity to the N-terminus of region 2.1 on antiparallel helix 12a, 
and a short amino acid bridge would be enough to connect them 
without distorting the overall structure of the rest of the fragment. 
In protein footprinting experiments, Nagai and Shimamoto [1997] 
observed that the environment around part of a70 between amino 
acids 167 and 200, which includes the acidic region, does not 
change upon a70 binding to the core enzyme. However this part 
becomes more exposed after the binary complex formation. In the 
crystal structure of the a70 fragment this stretch of amino acids is 
partly a loop, with the acidic region being unstructured [Maihotra et 
al., 19961. Whether this indicates a significant conformational 
change in a70 during binary complex formation is unclear. 
We decided to study the role of individual amino acids of a 70 of 
E. coli in the process of DNA melting by introducing single cysteine 
residues in several positions of a 245 , so using it as a source of 
Cys-less but still functional sigma. If the resulting proteins retain 
activity in vitro and in vivo, they will be useful for studying the 
mechanisms of sigma function. The single cysteines can be 
specifically modified with either reagents capable of generating free 
radicals, or with fluoroprobes, which would allow us to study the 
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proximity of the modified cysteines to different regions of both 
strands of promoters at different steps of melting, by regulating 
temperature and salt concentration, or to analyse conformational 
changes of different parts of the sigma molecule during 
transcription initiation steps. 
243 
320 	 - 
32 
Figure 1.1.4. The structure of a fragment of 070  (residues 114-442) [Maihotra et 
al., 19961. The conserved region 1.2 ends in the middle of helix 1, and the conserved 
region 2.1 begins in the middle of helix 12a. 
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1.2. scrP, an erstwhile candidate minor sigma gene of 
Escherichia coli. 
1.2.1. Discovery and early studies of ScrP. 
While searching for yet unidentified sigma subunits in E. coli, 
Fujita et al. [1987] identified a 27 kDa protein designated ScrP 
(Sigma Cross-Reacting Protein) as one of several proteins which 
cross-reacted with antibodies raised against a polypeptide 
consisting of an amino acid sequence present in the highly 
conserved region 2.2 of RNA polymerase 70  and cy32 subunits. The 
polyclonal antiserum raised against the synthetic tetradecameric 
peptide (DLIQEGNIGLMKAV) was tested for cross-reaction with an 
SDS-PAGE-fractionated whole cell lysate from E. coli by Western 
blotting. It was found that there was cross-reaction not only with 
known y70 and cN 32 , but also with several other proteins in the 
extract, one of which had an apparent molecular size of 27 kDa. 
Subsequently this was found to be a mixture of two proteins, both 
of which demonstrated cross-reactivity with the antiserum 
[Ueshima et al., 1992]. One of these was found to be ribosomal 
protein S2. The other, ScrP-27A (now abbreviated to ScrP), behaved 
differently during purification, migrating more slowly on high-
resolution SDS-PAGE, and had an N-terminal sequence with no 
similarity to known proteins: MKKIGVILSGXGVYDGSEIHEAVL (X = 
unknown). More specifically, it was found that immunological cross-
reactions between ScrP and anti-a peptide antibodies were 
specifically competed out by hexapeptide GLMKAV, which 
constitutes the carboxyl terminus of the original tetradecameric 
peptide, while the reaction of 070  with the antiserum was not 
competed out by GLMKAV. This observation lead the authors to 
suggest that ScrP should contain a sequence similar, if not 
identical, to GLMKAV [Ueshima et al., 19921. However, ScrP, whose 
sequence is now known, does not contain a amino acid stretch 
resembling GLMKAV. The nature of the relevant epitope(s) in ScrP 
remains unknown. 
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Figure 1.2.1. A part of 72 min of E. coli chromosome with the genes, relevant 
restriction sites and A phages of Kohara library [Kohara et al., 19871 shown. 
C 
Introduction 
After centrifugation of a crude E. coli extract (DNase and RNase 
treated) through a glycerol gradient the 27 kDa proteins (not then 
distinguished) were found to be distributed throughout all 
fractions, despite their low molecular size [Fujita et al., 1987]. This 
was due to either self-aggregation or association with other cellular 
components. Attempts to detect complex formation between 
purified ScrP and RNA polymerase core enzyme were unsuccessful, 
suggesting that this is not a sigma factor [Ueshima et al., 1992]. 
The map position of the gene, scrP, encoding the above protein, was 
found by reverse genetics. A pair of degenerate oligonucleotides 
corresponding to the N-terminus of ScrP hybridised with a pair of 
contiguous clones of the Kohara library [Kohara et al., 1987], X522 
and X523, which overlap by about 9 kb near 72 min on the genetic 
map, or near 3350 kb on the physical map [R. Hayward, T. Suzuki, 
N. Fujita and A. Ishihama, unpublished]. The physical location of 
scrP was more precisely defined by restriction and Southern 
hybridisation analyses [Townsley, 1991]. The closest mapped genes 
were arcB at 3350 kb and rpoN at 3342 kb (Fig. 1.2.1.). In order to 
characterise the scrP locus an EcoR I - Hind III fragment of X522 
DNA was subcloned into the pJJW1 1 [Wright and Hayward, 1987]. 
The resulting recombinant plasmid pFMT1 was thought to carry N-
terminally truncated arcB and full length scrP. The minicells with 
pFMT1 specifically expressed two major polypeptides of about 28 
and 14 kDa, as was detected by SDS-PAGE. The 28 kDa protein was 
assumed to be ScrP; the nature of 14 kDa polypeptide was unclear. 
It was also determined that the direction of transcription of scrP on 
the chromosome was counter clockwise and therefore the same as 
for arcB [Smillie, 19941. 
Sequence analysis of the scrP locus identified a good ribosome-
binding site Shine-Dalgarno consensus, AGGAuG, situated 6 nt 
upstream from the initiation codon. Primer extension analysis of 
total E. coli RNA using a primer complementary to 78 through 61 nt 
of the scrP coding sequence generated reverse transcripts 
terminating at many locations within downstream end of arcB and 
the arcB-scrP intergenic region, some of them closest to scrP 
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marked here by arrows. Possible -10 and -35 elements of a 
dependent promoter were proposed [Smillie, 1994]: 
GTTACAAGGGCACAGCACTGTTTTTCAGGCCGCACGCAGTTAAGATAG AAAACTTAA 
-35 	 -10 
ATGATTTGT_ACATGAATCAG AAATGT_TGATGCGTAC ATTTTTATTAAAAAAAT 
TAATGTGTTTCAGTCAATTGCGAAAGGATGATCACAATGAAGAAAATT 
RBS 	 ScrP start 
This preliminary result suggested that scrP was cotranscribed with 
arcB, from the arcB promoter, but also raised a possibility of 
independent transcription from a putative promoter(s) within the 
scrP-arcB intergenic region. The other signals by primer extension 
could reflect mRNA processing sites and/or pause sites in the 
reverse transcription [Smillie, 1994]. 
1.2.2. Characterisation of scrP by gene disruption. 
The genomic copy of scrP in two different E. coli strains (NM62 1 and 
MM38) was mutated by insertion of a kanamycin resistance 
cassette between 518 and 519 base pair of the scrP coding 
sequence. Cells carrying this disrupted scrP did not differ from their 
isogenic scrP parents in growth rate either in rich medium (L-
broth) or glucose minimal medium. They were able to grow on a 
variety of carbon sources and at various temperatures between 30 
and 46°C, and under anaerobic conditions at 37 °C [Smillie, 1994]. 
The possibility that ScrP is important for Arc function (see below) 
was also investigated by dye-sensitivity tests [Buxton and Drury, 
19831. The scrP-disrupted strains were no more dye-sensitive than 
their parents [Smillie, 19941. 
It had previously been demonstrated that all the genes between 
rpoN and arcB (these include scrP) were inessential for viability in 
media supplemented with glutamine, based on studies of strain 
ECL593 carrying A(zgi: :Tn 1 O-rpolV) which included rpoN-arcB region 
[luchi et al., 1989a]. 
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1.2.3. ScrP protein. 
ScrP has a calculated molecular size of 22,982 which is less than 
the 27 kDa value estimated from its mobility on SDS-PAGE. 
Hydrophilicity analysis has shown no major hydrophobic or charged 
regions within the ScrP polypeptide sequence. However, short 
moderately hydrophobic stretches of amino acid residues near the 
N-terminus might allow ScrP to associate with the cell membrane 
[Smillie, 1994]. 
[ 35S]Methionine labelling of minicells carrying the pFMT1 or its 
vector parent pJJW1 1 demonstrated that polypeptides with 
estimated molecular sizes of about 14 kDa and 28 kDa were 
encoded only by pFMT1. These polypeptides were presumed to be 
the products of scrP, or restart fragments encoded by supposedly 
truncated arcB, or products of unmapped genes lying downstream of 
scrP and present on pFMT1 [Smillie, 1994]. Preliminary attempts to 
immunoprecipitate proteins from the minicell extracts with the 
anti-2.2-peptide antiserum failed to recover the 28 kDa polypeptide, 
suggesting either a difference in the accessibility of relevant 
epitopes on ScrP in solution and on blotting membranes, or that 
the 28 kDa polypeptide produced by pFMT1 was not ScrP, but one of 
the products of then unmapped genes lying downstream of arcB and 
present on pFMT1. 
These early studies failed to cast light on the function of ScrP. 
Moreover, there was no sequence similarity between ScrP and any 
other known sequences available in DNA and protein databases, 
including a subunits [Smillie, 19941. 
Because of the complete lack of similarity between ScrP and the 
conserved regions of a subunits, and the apparent absence of 
interaction between ScrP and RNA polymerase [Ueshima et al., 
1992], it was clear that ScrP was not a transcription protein. It was 
a novel protein with unknown function, not required for E. coli 
survival under normal grown conditions. It was possible to find out 
more about this protein by finding out if scrP expression is co- 
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regulated with that of the genes neighbouring it on the E. coli 
chromosome, and potentially belonging to the same operon. 
1.2.4. Polypeptides with sequence similarities to ScrP. 
Recently the sequences of two eukaryotic proteins with a 
significant similarity to ScrP have been reported. One of these is 
the ES1 protein from zebrafish, which is specifically expressed in 
the photoreceptor cells of the retina, but neither in the adult 
zebrafish brain nor in non-neuronal tissues (including muscle, skin 
and connecting tissue). ES1 open reading frame encodes a 
polypeptide of 270 amino acids, with a calculated molecular size of 
30.7 kDa [Chang and Gilbert, 1997]. ES1 has 31% identity and 57% 
overall sequence similarity to ScrP. 
There are four types of photoreceptor cells in zebrafish retina: short 
single cones, long single cones, double cones, and rods. ES1 
protein has been detected by immunostaining only in the inner 
segments of cone, but not in rod, photoreceptor cells (inner 
segment is outside of outer nuclear layer of the cells) [Chang and 
Gilbert, 19971. No staining appeared in the nuclei of photoreceptor 
cells, and in detergent phase separation experiment ES1 largely 
partitioned into the aqueous phase, suggesting that it is not an 
integral membrane protein [Chang and Gilbert, 19971. 
ES1 is not detected in zebrafish embryos until they are about 20 
days old, when they complete major differentiation processes and 
begin to become adult-like, although all photoreceptor cells can 
already be identified at 12 days postfertilisation. Therefore it seems 
that ES 1 protein is only expressed in mature photoreceptors 
[Chang and Gilbert, 19971. 
The 21q22.3 region of human chromosome 21 has been searched for 
genes responsible for several inherited disorders which have been 
genetically or physically mapped to this region. As a result three 
research groups have identified a human gene, variously named 
KNP-1, GT335, or HES1, mapping to 21q22.3 [Nagamine et al., 1996; 
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Lafreniere et al., 1996; Scott et al., 1997]. This gene spans an 
estimated 12-13 kb of genomic DNA and contains seven exons 
expressed as a 1.7-1.8 kb mature transcript. Some cDNA samples 
isolated from foetal brain have demonstrated that exon 5 is 
involved in alternative splicing, resulting in a mRNA species lacking 
this 93 nt exon and predicting to produce a polypeptide 31 amino 
acids shorter than the full-length protein [Lafreniere et al., 1996; 
Nagamine et al., 19961. The gene is predicted to encode a full-length 
protein of 268 amino acids, which has 44% identity and 62% 
similarity to ScrP, and 49% identity and 66% similarity to ES 1. The 
protein itself has not been detected. 
The KNP-1/GT335/HES1 mRNA is expressed in various human 
tissues, but is particularly highly abundant in heart and skeletal 
muscle [Lafreniere et al., 1996; Nagamine et al., 1996; Scott et al., 
19971, and relatively abundant in some tissues involved in the 
endocrine system [Nagamine et al., 1996]. 
Potential mitochondrial targeting signals have been found in both 
the human and the zebrafish proteins, with a possible cleavage site 
after Val-45 in the human protein. This is consistent with the high 
expression level in human muscle tissues, the cells of which are 
rich in mitochondria [Nagamine et al., 1996; Scott et al., 19971. 
The similarity of ScrP, ES1 and KNP-1/GT335/HES1 extends 
throughout their entire sequences, with the exception of the N-
terminus which is 21 (ES 1) or 38 (KNP- 1 /GT335/HES 1) amino acids 
longer than that of ScrP [Nagamine et al., 1996; Scott et al., 1997; 
Lafreniere et al., 1996; Chang and Gilbert, 1997]. These differences 
might be related to different polypeptide targeting systems in 
eukaryotic tissues. 
Since ES1 seems to be more specialised than the human protein, 
Nagamine et al. [1996] have speculated that the zebrafish genome 
may contain another gene that has a greater similarity to human 
KNP-1/GT335/HES1 and bacterial scrP genes, and the human 
genome may contain another homologue of the ES1 gene, 
25 
Introduction 
functionally more closely related to it. Functions of either of them 
remains unknown. 
1.2.5. Environment of the scrP gene on the bacterial 
chromosome. 
Now when the E. coli K-12 genome has been fully sequenced 
[Blattner et al., 19971 we know that four contiguous genes or ORFs, 
yhcC, arcB, scrP and mtgA are orientated in the same direction and 
located at 72 min on the genetic map of the chromosome. The 
genes immediately downstream and upstream of these are 
transcribed in the opposite direction. (Fig. 1.2.1). 
The scrP gene lies 229 base pairs downstream of arcB which 
encodes a known protein involved in regulation of anaerobic 
metabolism. Adjacent to scrP there is an open reading frame, mtgA, 
whose translational initiation codon overlaps with the translational 
termination codon of scrP, raising a strong possibility of their 
translational coupling and co-transcription. The translational 
termination codon of mtgA in turn overlaps with the translational 
termination codon of ORF yrbL, which would be transcribed in the 
opposite direction. If mtgA and yrbL are transcribed under the same 
growth conditions, their transcription might interfere with each 
other, and the complementary downstream ends of their transcripts 
are likely to interact with each other. 
Among other identified genes lying downstream and transcribed in 
the same direction as yrbL are rpoN, encoding the alternative sigma 
subunit cy 54 , required for transcription of genes controlled by 
availability of N-sources [Merrick et al., 19931; ptsN, whose product 
is involved in PTS (phosphotransferase system)-related carbon and 
organic nitrogen regulation [Powell et al., 19951; npr, which encodes 
a phosphocarrier protein of the PTS [Powell et al., 19951. 
It seems that arcB is transcribed from its own contiguous promoter 
(see later). Thus the putative gene yhcC will not be further 
discussed. However, in order to understand the possible function of 
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ScrP it is of interest to investigate what is known about the 
functions of the other two genes which belong to the same putative 
operon as scrP. 
1.2.6. The mtgA gene and its product. 
The E. coli genome sequencing project revealed an open reading 
frame whose beginning overlapped with the end of scrP by 4 bp and 
was orientated in the same direction. The overlap of the stop and 
start codons and relatively poor agreement of this ORF's ribosome-
binding site with Shine-Dalgarno consensus suggest that 
translational coupling with scrP would be likely and perhaps even 
obligatory. The ORF contains 729 bp and codes for a putative 
protein of 242 amino acid residues with calculated a molecular size 
of 27.3 kDa. Comparison of the predicted amino acid sequence with 
those of other known and putative proteins showed a strong 
similarity of its product (and an almost identical putative protein 
from Kiebsiella pneumoniae) to the N-terminal (transglycosylase) 
region of class A bacterial penicillin-binding proteins represented in 
E. coli by PBP1A and PBP1B. It was therefore suggested that the 
ORF encodes a nionofunctional biosynthetic peptidoglycan 
transglycosylase, and the name mtgA was proposed [Spratt et al., 
1996]. 
Bacterial penicillin-binding proteins (PBPs) are involved in the 
insertion and cross-linking of new peptidoglycan chains in the 
murein sacculus. They are membrane-bound proteins and are able 
to specifically and covalently bind -lactam antibiotics, such as 
penicillin, via a mechanism involving an internal serine residue, for 
example, Ser-465 in the 850 amino acid PBP1A of E. coli. The 
amino-terminal regions of PBPs 1A and lB form the 
transglycosylase domains that catalyse glycan chain elongation, 
while their penicillin-binding C-terminal domains are 
transpeptidases that catalyse peptidoglycan crosslinking. The latter 
is inhibited by binding of penicillin. The bifunctionality of the PBPs 
is revealed by the reaction products they generate upon incubation 
with the lipid-linked precursor G1cNAc-MurNAc pentapeptide 
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diphosphoryl-undecaprenol [Nakagawa et al., 1984]. E. coli mutants 
lacking either PBP1A or PBP1B are viable, but the double deletion is 
lethal [e.g. Yousif et al., 1985]. None the other known E. coli PBPs 
have been shown to possess biosynthetic glycosyltransferase 
activity. On the basis of sequence similarity analysis, recently 
discovered PBP 1C can be another candidate for bifunctional 
transglycosylase/transpeptidase enzyme [Schiffer et al., 1997]. 
Monofunctional transglycosylases (deficient in transpeptidase 
activities and unable to bind penicillin) have been isolated from 
Bacillus megaterium [Taku et al., 1982], Staphylococcus aureus, 
Micrococcus luteus [Park and Matsuhashi, 19841 and Streptococcus 
pneumoniae [Park et al., 1985]. A monofunctional biosynthetic 
transglycosylase was also isolated from E. coli [Hara and Suzuki, 
1984]. It had an apparent molecular size of 34 kDa and showed 
peptidoglycan synthesis activity, i. e. it synthesised chains from 
disaccharide lipid intermediates UDP-N- ace tylmuramil-
pentapeptide and UDP-N-[ 14 C]glucosamine. It did not bind 
penicillin, and the activity of this enzyme required presence of Ca 2 
or Mn2 , which could not be replaced by Mg 2 . The pH optimum for 
this peptidoglycan synthesis reaction was between pH 6.0 and 6.5, 
whereas that of PBP1B, the major transglycosylase in E. coli, is 
between pH 7.5 and 8.0 [Hara and Suzuki, 19841. 
Di Berardino et al. [1996] cloned and overexpressed mtgA from 
E. coli strain W31 10. They called the gene mgt, for jonofunctional 
glyco syltransferase, to distinguish this glycan- synthesising enzyme 
from the well known lytic transglycosylases, involved in lysis of 
peptidoglycan (all five known E. coli lytic transglycosylases are 
listed in Holtje, 1998 #79). 
Even when the mtgA gene was overexpressed, it was possible to 
visualise its product on SDS-PAGE only after fractionation of cells 
into cytoplasmic and membrane fractions. A band corresponding to 
the expected size of mtgA product (-27 kDa) appeared in the 
membrane fraction. This suggests that the putative transmembrane 
domain in the N-terminal amino acid sequence of MtgA may serve 
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as a membrane anchor. The W31 10 cells stopped growing after 
induction of mtgA overexpression, indicating that the overexpressed 
gene product is deleterious, although the cells did not lyse for at 
least 30 minutes [Di Berardino et al., 1996]. It was also 
demonstrated that the membrane fraction of cells in which mtgA 
was overexpressed showed an up to 7-fold increase in glycan 
polymerisation activity, with a pH optimum between pH 6.0 and 6.5. 
This activity was not significantly inhibited by flavomycin, a potent 
inhibitor of the glycosyltransferase activity of PBPs 1A and lB [Di 
Berardino et al., 1996]. It is unclear whether or not mgt/mtgA 
encodes the same monofunctional synthetic transglycosylase as 
that described by Hara and Suzuki [Hara and Suzuki, 1984]. Both 
enzymes are not sensitive to flavomycin and have the same pH 
optimum, but they do not seem to have the same requirements for 
bivalent cations, and their reported mobility on SDS-PAGE is 
noticeably different. 
Denome et al. [1999] attempted to make a comprehensive set of 
deletion mutants lacking eight murein synthesis proteins (PBPs 1A, 
1B, 4, 5, 6 and 7, AmpC, and AmpH) in all possible combinations 
(apart from double mutants of the genes encoding PBP 1A and 1B), 
thus creating genetic backgrounds to study the physiological roles 
of nonessential peptidoglycan-reactive enzymes. In the extreme 
case where peptidoglycan was still synthesised in the absence of 
ten PBPs (missing or inactivated PBPs 1A, 2, 3, 4, 5, 6, and 7, 
AmpC, AmpH, and DacD), the structure of the murein sacculus was 
still sufficiently strong to prevent lysis in L-broth. The known 
proteins with biosynthetic transglycosylase function remaining in 
this case were PBP 1B, PBP 1C and MtgA. These authors also 
constructed a strain carrying a partially deleted mtgA (from BstB I to 
Hind III), which was viable, as expected from the work of luchi et al. 
[1989], but they have not yet reported the construction of multiple 
mutants lacking any PBPs together with MtgA. 
The possible role of MtgA in murein synthesis is unclear. One 
model for the growth of the murein sacculus suggests that it is 
synthesised by a hypothetical multienzyme complex, a view based 
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on observations that many proteins involved in murein synthesis 
are able to interact with each other in vitro. It is suggested that the 
holoenzyme for cell elongation might consist of a dimer of a 
transglycosylase/transpeptidase bifunctional enzyme, a dimer of a 
transpeptidase, a dimer of an endopeptidase, and a lytic 
transglycosylase. On the other hand, the "constriction" 
multienzyme complex, necessary for synthesising the septum 
during bacterial division, would consist of a similar set of enzymes 
plus a monofunctional transglycosylase [Holtje, 19981. The actual 
physiological role of MtgA, and its any possible functional 
relationship to ScrP, remain unknown, especially as both of them 
are inessential at least under laboratory growth conditions. 
1.2.7. The arcB gene and ArcB/ArcA signal transduction 
system. 
Two-component regulatory systems. 
ArcB protein is a sensor kinase and ArcA is the response regulator 
of the Arc (for anoxic redox control, formerly aerobic respiration 
control) phosphorelay regulatory system. Arc is one of the many the 
so-called two-component regulatory systems. These signalling 
systems are widespread in eubacteria, and they allow many 
different environmental changes to elicit adaptive responses in the 
bacteria. Homologous pathways have also been identified in other 
organisms, including archaebacteria [Rudolph and Oesterhelt, 1995; 
Klenk et al., 19971, yeast Saccharomyces cerevisiae [Ota and 
Varshavsky, 1993; Brown et al., 1994] fungus Neurospora crassa [Alex 
et al., 1996], slime mould Dictyostelium discoideum [Schuster et al., 
1996; Wang et al., 1996], plant Arabidopsis thaliana [Chang, 1993; 
Kakimoto, 1996; Wilkinson, 1995]. Inspection of the entire 
nucleotide sequence of E. coli reveals that there are at least 30 
different sensor-regulator pairs in this organism alone [Mizuno, 
1997]. 
The prototypical two-component pathway is comprised of two 









response regulator (Fig. 1.2.2.). The N-terminal portion of the 
sensor kinase usually functions as an input domain, which detects 
environmental stimuli directly or via upstream receptors. The 
C-terminal portion functions as the transmitter module. This 
generally consists of approximately 240 amino acids and contains 
several short blocks of conserved residues. The Hi box includes 
the histidine residue which serves as the site of 
autophosphorylation with y-phosphoryl group of ATP. The G1 and 
G2 boxes are glycine-rich motifs of nucleotide-binding domains; 
they are separated by a spacer containing a central F box with as 
yet unknown function. Box N is involved in autokinase activity 
[Parkinson and Kofoid, 19921. The large variable region between 
boxes Hi and N may contain determinants for specific recognition 
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Figure 1.2.2. A prototypical two-component regulatory system with its conserved 
blocks of residues and transfer of a phosphate group. 
The typical response regulator has a receiver domain of about 120 
amino acids and contains an invariant aspartate residue (Di) as a 
phosphorylation site, as well as several other conserved blocks of 
sequences including an acidic pocket (DD) with the side chain of 




response regulator CheY is an a/P barrel containing five sets of 
alternating 3 strands and a helices connected by short loops or 
turns, with f3 strands forming a hydrophobic inner core and a 
helices wrapped around them, with the residues important for 
Figure 1.2.3. Structure of the HPt domain of ArcB [Kato et al., 19971, with 
ribbons representing the main chain folding and some conserved amino acids. 
phosphorylation located on the same apical surface [Parkinson and 
Kofoid, 1992; Volz, 19951. That this fold may be general for receiver 
domains has been confirmed by the structures of the nitrate-
signalling response regulator NarL from E. coli, the sporulation 
response regulator SpoOF from Bacillus subtilis, and the nitrogen 
response regulator NtrC from E. coli [Baikalov et al., 1996; Feher et 
al., 1997; Volkman et al., 1995]. The receiver domain catalyses 
transfer of the phosphoryl group from the histidine of the sensor 
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kinase to the aspartate Dl (Fig. 1.2.2.), and in vitro can also utilise 
a variety of small molecules, but not ATP, as alternative 
phosphodonors. The phosphorylation state of the receiver domain 
modulates the activity of the output domain, in bacteria it is 
usually a C-terminal DNA-binding domain which triggers the 
response to the initial environmental stimulus by appropriate 
regulation of gene transcription. 
Multi-step phosphorelay regulatory systems. 
Although the basic sequence of the regulatory pathway is similar 
for all two-component systems there are many variations, allowing 
each pathway to suit its specific task. It has been shown that many 
two-component systems actually comprise four-step phosphorelay 
(histidine (Hi) - aspartate (Dl) - histidine (H2) - aspartate (D2)) 
within two, three or four proteins, some of them containing two or 
three phosphorelay domains [Appleby et al., 1996] (Fig. 1.2.4.). 
ArcB 	 ArcA 
Figure 1.2.4. Four-step phosphorelay within ArcB/ArcA regulatory system. The 
first three phosphorelay domains are within one protein, ArcB (from [Appleby et al., 
1996]). 
In one family of multi-step phosphorelay systems the first three 
steps of phosphorelay occur within a single polypeptide. Examples 
include ArcB, BarA, EvgS, TorS, and YojN (E. coli), BvgS (Bordetella 
pertussis), LemA (Pseudomonas syringae), RpfC (Xanthomonas 
campestris), RteA (Bacteroides thetaiotaomicron) [Appleby et al., 1996; 
Parkinson and Kofoid, 1992; Ishige et al., 1994; Matsushika and 
Mizuno, 1998b]. These proteins contain the first transmitter and 
receiver domains (Hi and Di) and the second transmitter domain 
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(H2). The latter, first identified within ArcB, is approximately 120 
amino acids long and contains an invariant histidine residue 
flanked by conserved sequences, but lacks other motifs conserved 
in the prototypical transmitter domain Hi [Ishige et al., 1994]. This 
led Mizuno and co-workers to call H2 the unusual histidine 
phosphotransfer domain, or HPt [Tsuzuki et al., 1995]. X-ray 
analysis of the isolated HPt part of ArcB revealed a kidney-shaped 
domain consisting of six a helices and involving an antiparallel 
four-helix bundle-folding (Fig. 1.2.3) [Kato et al., 1997]. The compact 
core is predominantly composed of hydrophobic residues 
contributed to by five of the a helices, with the active His-717 lying 
in the internal curvature of the kidney-shaped molecule and 
exposed to the solvent. It has been observed that there is a general 
shape complementarity between the round surface of the known 
receiver domains and the concavity of the HPt domain [Kato et al., 
19971. All five of the single amino acid mutations within this 
domain which were found to impair its function in vivo (G685R, 
E714K, G721D, G724E, as well as H717Y), lie on the same concave 
surface of the kidney-shaped molecule; moreover, four of these are 
on the same a helix (Fig. 1.2.3) [Matsushika and Mizuno, 1998b]. 
Here the replacement of glycines with bulky or charged amino acid 
residues may hinder the presumed interaction between the HPt 
domain and the cognate receiver domain. 
The ArcB/ArcA signal transduction system. 
The ArcB/ArcA system regulates expression of as many as 30 
operons in E. coli (which comprise the Arc modulon) in response to 
the redox conditions of growth [luchi and Lin, 1988; Lynch and Lin, 
1996]. Under anaerobic conditions, ArcA-P (phosphorylated ArcA) is 
known to repress the expression of at least 17 operons, which 
contain the genes encoding many aerobic respiratory enzymes, 
including several dehydrogenases of the flavoprotein class, the 
cytochrome o complex, tricarboxylic acid cycle proteins, enzymes of 
the glyoxylate shunt and of the pathways for fatty acid degradation. 
All these enzymes share a common function - they participate in 
pathways that ultimately donate electrons to molecular oxygen, 
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with the generation of proton-motive force across the cytoplasmic 
membrane. ArcA-P also activates at least 9 operons under 
anaerobic conditions, among them genes encoding enzymes 
associated with oxygen-limited conditions, such as pyruvate-
formate lyase and cytochrome d. ArcA-P (but not ArcB - see later) is 
also required, together with TraJ, to activate the tra operon which 
includes several genes needed to promote conjugative DNA transfer 
of F-like plasmids [Strohmaier et al., 1998]. ArcA is essential as an 
accessory protein for Xer site-specific recombination at psi to 
maintain the monomeric form of plasmid pSC 101 in vivo, but is not 
absolutely required in vitro [Colloms et al., 19981. With the discovery 
of the Arc system the term modulon was proposed by luchi and Lin 
[1988] for a group of operons and/or regulons that are under 
different specific controls, but their expression is modulated by a 
common pleiotropic trans-acting regulatory protein (a global 
regulator). In contrast to regulons, modulons comprise target 
operons that do not all share a single specific regulator [luchi and 
Lin, 1993]. However, it is not clear whether to include the tra 
operon in Arc modulon, since ArcB is not involved in its activation 
(see below) [Silverman et al., 1991a]. 
The arcB gene and its product. 
arcB was identified by screening for mutants with elevated 
anaerobic expression of 3-galactosidase by a A-prophage-borne 
succinate dehydrogenase transcriptional fusion sdh-lacZ in a sdh 
background [luchi et al., 1989a]. The Arc system represses sdh-lacZ 
transcription up to three times even under aerobic, and up to 26 
times under anaerobic conditions, judging from its expression in 
arcA and arcB [luchi and Lin, 1992a; Matsushika and Mizuno, 
1998b]. 
Sequencing of the arcB locus revealed an open reading frame of 778 
[luchi et al., 1990b] or 776 [Blattner et al., 1997], codons (the 
numbering of amino acids in ArcB in this work is according to luchi 
et al. [1990a]). Analysis of the deduced sequence of ArcB suggested 
that, as discussed previously, the protein belongs to a subgroup of 
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response sensors consisting of both a transmitter domain and a 
receiver domain (Fig. 1.2.5). Moreover, it carries two putative 
transmembrane segments, Phe-23 to Val-50 and Ser-58 to Val-77, 
to be buried in the plasma membrane with a loop of only 7 amino 
acid residues in the periplasm. It is not clear whether such a small 
segment of protein is sufficient to sense a specific external signal. 
It is possible that either the transmembrane sequences of ArcB are 
themselves involved in the signal reception or they only anchor the 
rest of the protein to the cytoplasmic membrane, with stimulus 
reception then probably occurring near the inner surface of the 
membrane (in the PAS domain, see below). ArcB has been found in 
the insoluble cellular fraction, supporting the suggestion that it is 
a membrane protein. It should be noted that when an N-terminally 
truncated 'ArcB retaining the H1-D1-H2 domains, but lacking the 
two putative transmembrane regions, was overexpressed in E. coli, 
it was also mainly found in the insoluble fraction. However, this 
could be an artefact due to the likelihood of overexpressed Hi-Di-
H2 aggregating in solution [luchi et al., 1990b]. 
luchi et al. [1990a] showed that ATG(+1) is a real translational start 
codon for ArcB, and suggested that AGGAauU, 5 nucleotides 
upstream from it, is the ribosome-binding sequence. They also 
proposed a putative promoter for arcB as shown below. This has a 
good agreement with -35 and -10 consensus sequences for cy 70 
(marked in bold), and the optimal (17 bp) spacing between: 
end of yhcC 	 EcoR I 
ACG GAG TAGGTCGTTGAGGGGAATTCCGCATTTCTCACACAATTTATAACGTA 
Thr Glu * 	 —35 
EcoR I 
ACTGTCAGAATTGGGTATTATTGGGGCAGGTTGTCGTGAAGGAATTCCCTAATG... 
—10 	 RBS 	+1 
The arcB promoter is likely to be in the EcoR 1-EcoR I region, 
because the Kpn I-Bsp1286 I DNA fragment containing a part of 
yhcC and the full length arcB cloned on a multicopy plasmid under 
a weak plasmid promoter resulted in slow growth of host cells, 
presumably due to overproduction of ArcB, which is a membrane 
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protein. Deletion of the EcoR 1-EcoR I region resulted in normal 
growth rate and still good yield of ArcB [luchi and Lin, 1992a]. This 
is either due to the destroying of arcB promoter, resulting in 
transcription of arcB only from the weak plasmid promoter; or due 
to creating a weaker ribosome-binding site for arcB, gGGAauU, 
instead of AGGAauU. 
ArcB sensor kinase protein 
Leucine 	PAS 
zippe 1 domair1 
73 115167 26 
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Figure 1.2.5. Schematic representations of ArcB and ArcA. The two 
transmembrane segments (TM) were predicted on the basis of hydrophobicity plot 
[luchi et al,, 1990b]. The sensor PAS domain was identified by Taylor and Zhulin 
11999]. Some conserved amino acids in transmitter and receiver domains and 
catalytic determinants of the first transmitter domain are indicated. Hi, H2, Di and 
D2 show polypeptides used in studies in vitro described further. 
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They also suggested that the GC-rich sequence which immediately 
follows the open reading frame of arcB might be a Rho-independent 
terminator: 
• .ACT.AAA AAA TGACCCCGGCTAGACCGGGGTGCGCGAATAC.. 
Thr Lys Lys * 
776 777 778 
This proposal is not very plausible, because there is no U-rich RNA 
sequence characteristic of such terminators downstream of the 
stem-loop [e.g. d'Aubenton-Carafa, 19901; moreover, unless arcB is 
poorly translated, ribosomes terminating the polypeptide might 
inhibit stem-loop formation [e.g. Wright, 1987]. If the stem-loop 
does from, its function might rather be to protect the arcB mRNA 
from 3-exonuclease attack [McLaren et al., 19911. In fact the 
sequence is a very good candidate for Rho-independent termination 
of transcription converging on arcB from downstream, because the 
DNA sequence encoding the lysine codons would produce a U-rich 
tail downstream of the stemloop in any complementary RNA. This 
terminator might be required to protect significant upstream 
progression of RNA polymerase into arcB, originating from an 
unknown promoter between arcB and scrP, or even from the genes 
distal to rntgA (Fig. 1.2.1). 
To study if the expression of arcB changes itself during 
anaerobiosis, luchi and Lin [1992b] constructed a strain carrying a 
X-prophage-borne arcB-lacZ fusion. The lacZ expression appeared to 
be a little higher under aerobic (mid-exponential phase) than under 
anaerobic (non-shaken overnight cultures) growth conditions, with 
the levels of 3-galactosidase activity remaining essentially the 
same whether or not ArcB+  function was provided by a 
complementing plasmid. 
Possible signals for Arc system activation. 
Available data indicate that signals to ArcB may come both from the 
membrane and the cytoplasm. D-Lactate, pyruvate, NADH and 
acetate, which are cellular metabolites whose levels are 
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increasingly accumulated during anaerobiosis, stimulate ArcB 
phosphorylation levels in membrane preparations in vitro [luchi, 
1993]. It has also been shown that the generation of the signal 
activating Arc system in vivo requires terminal cytochromes, 
suggesting that the stimulus sensed by ArcB could be a terminal 
electron carrier in a reduced form that accumulates in the absence 
Of 02 [luchi et al., 1990a]. Possible candidates include the lipid-
soluble electron carriers ubiquinone and menaquinone [Lynch, 
19961. Another suggestion is that a source of signalling for ArcB is 
the proton potential across the membrane, which is high during 
aerobic respiration. ArcB would thus act as a protonmeter 
[Bogachev et al., 1993; Lynch, 1996]. Taylor and Zhulin [1999] 
identified a PAS signal module within the cytoplasmic part of ArcB 
(Fig. 1.2.5.). The PAS sensor domains are found in a variety of 
proteins involved in signal transduction, are located inside cells 
and sense redox changes in the electron transport system or 
overall cellular redox status. Therefore it seems likely that PAS 
domain of ArcB senses a cytoplasmic signal(s). Activation of PAS 
domain should bring conformational changes to Hi domain of ArcB; 
another possibility is that it causes dimerisation of PAS domains of 
two neighbouring ArcB proteins, as it was observed with some other 
proteins possessing PAS domains [Taylor and Zhulin, 1999]. 
Aerobic repression of (sdh-lacZ) by ArcB has been observed in 
cells grown in L-broth or minimal media supplemented with 
glucose, galactose or xylose. However, in minimal media with 
acetate, succinate or fumarate (intermediate products of the 
aerobic respiration pathway) as the source of carbon and energy, 
the aerobic repression of (sdh-lacZ) is completely eliminated, such 
that the levels of its expression in an arcB+  and in an arcB null 
mutant become indistinguishable. It has also been observed that 
the derepressed levels of c1i(sdh-lacZ) expression in arcB strain 
differs for different sources of carbon and energy. Thus factors 
other than the ArcB/ArcA system must also be implicated in the 
regulation of sdh under the observed conditions [Matsushika and 
Mizuno, 1998a], and it is not clear whether acetate, succinate or 
fumarate can be signals for ArcB. 
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The arcA gene and its product. 
Mutations in arcA, also referred to as cpxC (for conjugative Plasmid 
expression), dye (for sensitivity to redox dyes), fexA (for E 
expression), msp (for male-specific phage), seg (forgregation of F-
plasmid), or sfrA (for sex factor regulation), were initially identified 
as having impairment of sex pilus synthesis in F+  or Hfr cells, 
which also made them resistant to male-specific bacteriophages 
which use the pilus for attachment [Buxton and Drury, 1983; 
Buxton and Drury, 1984]. luchi and Lin [1988] then showed that in 
arcA mutants the levels of various enzymes associated with 
anaerobic metabolism were not increased, under anaerobic 
conditions, in the normal way. At the same time phosphorylated 
ArcA acts as activator for another set of genes, such as cydAB 
(encoding cytochrome d oxidase) and pfl (pyruvate formate lyase) 
under anaerobic and microaerobic conditions [Lynch, 1996]. It was 
later shown that the anaerobic regulation and sex factor regulation 
functions of the arcA gene product are separable. A strain with the 
sfrA5 mutation (producing ArcA with a V203M substitution in its C-
terminal region) is impaired in expression of tra genes, but shows 
normal repression of sdh during anaerobiosis, whereas arcB 
mutants and the arcAl mutant (with an 8 amino acid insertion in 
the N-terminal region of ArcA) show derepressed sdh expression, 
but have only slightly reduced levels of pilus production and tra 
operon expression [Silverman et al., 1991a; luchi et al., 1989b; luchi 
and Lin, 1992a]. There is also evidence that anaerobiosis only 
slightly affects traY promoter activity [Silverman et al., 1991b]. 
It was proposed that the second regulator of ArcA function, which is 
implied by the above evidence, could be the cpxA gene product, 
which could serve as sensor for the sexual state of the cell [luchi et 
al., 1989b]. However, it has recently been established that another 
gene, cpxR, encodes the cognate response regulator for the CpxA 
sensor protein, and this two-component system is involved in 
protein trafficking in E. coli envelope [Pogliano et al., 19971. 
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By utilising arcA-lacZ transcriptional and translational fusions it 
has been found that both transcription and translation of the arcA 
gene during anaerobic growth are about four times higher than that 
during aerobic growth. Both ArcA and Fnr (for fumarate and nitrate 
reduction), another anaerobic global regulator, are required for full 
expression of J(arcA-lacZ), Fnr has been found to bind and activate 
one of at least two arcA promoters [Compan and Touati, 19941. 
Phosphorelay within the Arc system. 
The conserved amino acids taking part in the ArcB/ArcA 
phosphorelay are His-292 (Hi), Asp-576 (Dl) and His-717 (H2) of 
ArcB and Asp-52 (D2) of ArcA (Fig. 1.2.5.). The importance of His-292 
and Asp-576 in ArcB has been demonstrated in vivo, when the 
plasmid-borne arcB (H292Q), arcB (H292L), arcB (D576Q) mutant 
alleles failed to repress either aerobic or anaerobic expression of 
ct(sdh-lacZ) in strains carrying arcB null or arcBl (a 1.3 kb insertion 
which introduces a stop-codon at arcB codon 241) on their 
chromosomes. arcB (D533A) and arcB (D576A) mutant alleles also 
failed to repress cti(sdh-lacZ) anaerobically. Plasmid-borne alleles 
containing only transmitter domain Hi, as well as ArcBH717L,  have 
repressed aerobic expression of the fusion to a degree similar to 
that of the wild type [luchi and Lin, 1992a; Matsushika and Mizuno, 
1998a]. 
The ArcBH292Q  or ArcBH 292 L proteins show essentially no 
autophosphorylation in vitro [luchi, 1993; Tsuzuki et al., 19951, while 
ArcBD 533 A, ArcBD576A  and ArcB truncated at amino acid 516 
(ArcBtr 516) show reduced autophosphorylation [luchi, 1993], 
whereas ArcBD 576Q, somewhat surprisingly, exhibits very good 
autophosphorylation in vitro LTsuzuki et al., 19951. 
The importance of His-717 was first demonstrated by Ishige et al. 
[Ishige et al., 1994] when they showed that the ArcB and BarA 
proteins, as well as their HPt domains alone, can act as multicopy 
suppressors of the z%envZ mutation, whereas HPt domain carrying 
the H717L replacement cannot. However, although ArcBH 717L does 
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not repress L-lactate dehydrogenase (one of the enzymes under Arc 
control) anaerobically, it is nevertheless dye-resistant. This led to 
the suggestion that H2 might be only an alternative to Hi 
phosphodonor to Hi [Ishige et al., 19941. Later studies in vitro, 
however, showed that H2 is in fact the major phosphodonor for 
ArcA (see ArcA Phosphorylation In Vitro). 
Autophosphorylation of ArcB 
The H1-D1-H2  polypeptide (N-truncated ArcB) rapidly undergoes 
autophosphorylation, in which 32P-labelling occurs from [7- 32P]ATP 
but not from [a- 32P]ATP or [7-32P]GTP [luchi and Lin, 1992b]. Hi-
D1-H2 (and also to some extent ArcBtr 516 ) can then 
transphosphorylate ArcBH292Q,  but not the double mutant 
ArcBH292Q, D576A [luchi, 1993]. Georgellis et al. [1997], using 
purified individual ArcB/ArcA transmitter and receiver domains (Hi-
D1-H2, Hi-Di, D1-H2, Hi, Di, H2 and ArcA) in various 
combinations, showed that only those polypeptides containing Hi 
(with His-292) undergo autophosphorylation. The kinetic analysis 
has demonstrated that initial rates of autophosphorylation of the 
Hi-Di and H1-D1-H2 polypeptides are very rapid, reaching a peak 
and subsequently declining, whereas labelling of the isolated H1 is 
slow and increases continually throughout the experiment. This 
suggests that the D1 domain assists in releasing phosphate from 
the Hi and/or the Di domains. 
The purified HPt (H2) domain of ArcB is not capable of 
autophosphorylation, but can be phosphorylated intermolecularly by 
ArcB-P, ArcBD576Q_P, ArcBH717I_P, although not by ArcBH292L_P 
[Ishige et al., 1994; Tsuzuki et al., 1995]. 
The study with purified ArcB/ArcA domains showed that the Di 
domain is significantly more active than ArcA as an acceptor of 
phosphoryl group from the Hi-P domain and that ArcA in turn is 
significantly more active than H2 [Georgellis et al., 1997]. It was 




Phosphorylation of ArcA in vitro. 
ArcA is phosphorylated by ArcB-P, but does not undergo 
autophosphorylation in the presence of ATP [Juchi and Lin, 1992b; 
Georgellis et al., 19971. Tsuzuki et al. [1995] were the first to 
demonstrate direct phosphotransfer from the isolated H2 domain to 
D2 in vitro, i. e. when ArcA rapidly acquired phosphate from the 
phospho-HPt domain. luchi [1993b] showed that truncated ArcB-P 
possessing only the transmitter domain Hi-P (ArcBtr 516_P) can 
phosphorylate ArcA at a low level, whereas ArcB-P with mutated 
aspartates in the receiver domain (ArcBD 533AP and ArcBD576AP) 
do not transphosphorylate ArcA at all. However, Tsuzuki et al. 
[Tsuzuki et al., 19951 have shown that ArcA can be phosphorylated 
by ArcBD576Q_P  almost as efficiently as by ArcB-P, and much less 
efficiently by ArcBH717L_P.  These data are consistent with the 
results of phosphorylation of ArcA by a mixture of the Hi-P and 
H2-P domains: firstly ArcA rapidly receives a phosphoryl group from 
H2-P, and then slowly from Hi-P [Georgellis et al., 1997]. In 
another experiment a mixture of Hi-P and Di slowly 
phosphorylated ArcA, but after addition of H2 to the reaction ArcA 
phosphorylation rapidly increased [Georgellis et al., 1997]. They 
have also shown that phospho-Hi-Di barely phosphorylates ArcB, 
while phospho-Hi-Di-H2 and phospho-Hi-Di with the addition of 
H2 are capable of doing so. 
The apparently contradictory behaviour of ArcBD576A  and  ArcBD576Q 
is presumably due to the nature of the amino acid replacements. 
Asp-576 is assumed to be the crucial active residue, since it is 
conserved amongst receiver domains in other phosphorelay 
systems. This assumption is confirmed by the behavior of the 
ArcBD 576A mutant protein. Perhaps in ArcBD 576Q the acidic pocket, 
including among other conserved residues Asp-533, is to some 
extent still able to accept the phosphoryl group. Another possible 
explanation is that phosphotransfer in ArcBD576Q  is carried out by 
an Hi-H2 route, bypassing the D2 domain. This reaction was 
observed to some extent in vitro by Georgellis et al. [1997], when 
fragments of normal ArcB were used. 
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Based on the kinetics of autophosphorylation of H1-D1-H2, Hi-Di 
and Hi described above, Georgellis et al. [1997] and Tsuzuki et al 
[1995] have proposed models for signal transduction in the Arc 
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Fig. 1.2.6. a) Model for signal transduction by the Arc system. Arrows show the 
directions of phosphoryl group transfer along alternative pathways, with the 
thickness of arrows indicating the relative activity of these pathways observed in 
studies in vitro. b) Signal transduction and signal decay in the ArcB/ArcA 
phosphorelay system. The reverse phosphorelay pathway is based on the data of 
Tsuzuki et al. [Tsuzuki et al., 1995], Georgellis et al. [Georgellis et al., 19981, and 
Ogino et al. [Ogino et al., 1998]. 
Signal decay in the ArcB/ArcA phosphorelay system. 
The phosphate from H2-P can be transferred in vitro to another site 
on ArcB and ArcBH 717 L rapidly and transiently, and to a lesser 
extent to ArcBH 292 T, although the latter reaction is not transient. 
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ArcBD 576 Q also exhibits some transient ability to acquire 
phosphate from the phospho-HPt domain [Ishige et al., 1994; 
Tsuzuki et al., 1995]. 
ArcB domains H1-D1-H2, D1-H2 or a mixture of Dl and H2 rapidly 
catalyse dephosphorylation of ArcA-P and of ArcA'-P (the isolated 
D2 domain of ArcA), and H1-D1-H2 and D1-H2 undergo only 
transient phosphorylation during these reactions. Tested 
separately, Hi, Hi-Di, Dl or H2 polypeptides do not exhibit ArcA-
P dephosphorylating activity and do not acquire detectable levels of 
phosphoryl group from ArcA'-P [Georgellis et al., 1998]. Thus it has 
been concluded that Dl and H2 each provide an essential catalytic 
function for the ArcA'-P dephosphorylation process (Fig. 1.2.6.). 
D1_H2H77Q, a mixture of D1D576A and H2 or a mixture of Dl and 
H2H717Q do not exhibit significant phosphatase activity towards 
ArcA'-P. However, when ArcA'-P is incubated with D1D576A_H2,  the 
phosphoryl group is transferred to the mutant polypeptide. It was 
therefore concluded that ArcAt-P dephosphorylation proceeds by a 
reversal direction of the normal His->Asp--*His--Asp phosphorelay, 
except that Hi seems to be dispensable [Georgellis et al., 19981. On 
the other hand, the observations that phosphotransfer from H2-P 
to ArcBH 292 L is non-transient [Tsuzuki et al., 1995], suggest that 
the H 1 domain is expected to be involved in release of the 
phosphate from D1-P. Further work need to be done to confirm 
which residue - Hi or Dl - releases phosphate from ArcB/ArcA in 
the reverse phosphorelay (Fig. 1.2.6.). 
Effectors, possible candidates for an input signal for ArcB 
activation, found to accelerate the rate of autophosphorylation of 
ArcB (D-lactate, acetate, pyruvate), as well as ATP, show no 
significant effect on dephosphorylating activity of H1-D1-H2 and 
D1-H2 on ArcA'-P [Georgellis et al., 1998]. The object of the 
possible action of effectors may be Hi domain, provided it is not 
involved in phosphatase activity of ArcB. They also may affect only 
the direct, but not reverse, phosphorelay. 
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SixA as a specific phosphatase for ArcB. 
As mentioned previously, arcB (or its HPt-encoding fragment) can 
act as a multicopy suppressor of an AenvZ deletion. Moreover, ArcB-
P can phosphorylate OmpR, the cognate regulator of EnvZ, in vivo 
(see next chapter). Recently Ogino et al. [1998] identified, cloned 
and expressed sixA (for signal inhibitory factor-X), a gene whose 
presence on a plasmid eliminates multicopy arcB suppression of 
zAenvZ, presumably by preventing His-Asp phosphorelay between the 
HPt domain of ArcB and the receiver domain of OmpR. SixA 
contains an arginine-histidine-glycine motif, including a crucial 
histidine, which is found in a number of phosphatases. Purified 
SixA can rapidly dephosphorylate the phospho-HPt domain of ArcB. 
During this reaction no phosphorylated SixA is detected. SixA 
exhibits no such in vitro activity with the phosphorylated 
transmitter domain (Hi) of EnvZ. These data allowed the authors to 
suggest that SixA can function as a phosphohistidine phosphatase 
that may affect the H2-D2 phosphorelay through regulating the 
phosphorylation state of the HPt domain of ArcB [Ogino et al., 
19981. SixA has been crystallised recently, and its structure should 
soon be resolved [Hamada et al., 1999]. 
Based on all the known data about ArcB/ArcA signal transduction 
the scheme described in Fig. 1.2.6. can be proposed. 
Does "cross-talk" between members of non-cognate 
phosphorelay families occur under physiological conditions? 
It has been reported that receivers can acquire phosphoryl groups 
not only from their cognate transmitters, but also from 
heterologous transmitters in vivo and in vitro, and directly from 
small molecules such as, in case of ArcA, acetylphosphate or 
carbamoylphophate in vitro [Drapal and Sawers, 1995; Lynch and 
Lin, 1996]. However, most in vitro and in vivo observations of such 
"cross-talk" have involved protein stoichiometries not relevant 
under physiological conditions [Parkinson and Kofoid, 19921. 
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In case of ArcB, there have been reports of such cross-talk between 
ArcB and OmpR or CheY, the cognate response regulators of EnvZ 
and CheA, respectively. As mentioned previously, the genes arcB 
and barA are multicopy suppressors of the AenvZ mutation. The 
corresponding phosphoproteins in vitro can phosphorylate OmpR, 
which is the cognate regulator of EnvZ [Ishige et al., 19941. CheY 
and OmpR have been shown to compete for interaction with ArcB, 
when both ArcB (or its HPt domain) and CheY are overexpressed in 
AenvZ cells carrying ti(ompC-lacZ). Moreover the phosphorylated HPt 
domain of ArcB can efficiently transfer its phosphoryl group to CheY 
in vivo and in vitro [Yaku et al., 1997]. 
However, in single copy ArcB and ArcBH717L  are indistinguishable in 
respect of OmpC and OmpF production in envZ 1 background, which 
suggests that under physiological conditions ArcB does not play any 
role in OmpR regulation [Ishige et al., 1994; Tsuzuki et al., 1995]. 
Similarly, luchi and Lin [1992b] showed that ArcB and ArcBtr 516 
supplied on a multicopy plasmid do not significantly affect 
expression of t'(ompF-lacZ), t'(ompC-lacZ), or t(narC-lacZ). This 
suggests that ArcB does not communicate with OmpR or NarL, the 
response regulators of other two-component regulatory systems, 
when their cognate sensors (EnvZ and NarX, respectively) are 
functioning normally. 
Finally, Georgellis et al. [1997] compared the ability of the two ArcB 
phosphoryl transmitters to donate phosphoryl groups to ArcA and to 
the non-cognate response regulators PhoB and CpxR. H 1-D 1-P was 
incubated with ArcA, PhoB and CpxR for a short time in the 
presence or absence of H2. Significant phosphorylation occurred 
only with ArcA and only when H2 was present. Therefore, neither 
H1 nor H2 of ArcB efficiently recognises its non-cognate response 
regulators PhoB and CpxR. 
Thus, considering the available data on ArcB and other transmitter-
containing proteins, the cross-talk between non-cognate 




MATERIALS AND METHODS 
2. 1. Bacterial strains, phages, plasmids, oligonucleotides and 
proteins. 
Bacterial strains used in this study are listed in Table 2.1. Bacteria 
were stored in frozen storage buffer at -70°C. 
Bacteriophages used in this study were P1 and M13mp18-14 
(M13mp18 with its Sac I-Pst I segment replaced with the Sac I-
rpoD-HgiA I fragment of pSAK3 [Kumar et al., 1993]). P1 phage 
lysates were stored at 4°C as broth suspensions to which a few 
drops of chloroform had been added to prevent microbial growth. 
M13 phage infected bacteria (strain TG1) were stored in frozen 
storage buffer at -70°C. 
Plasmids used and constructed in the course of this study are 
listed in Table 2.2. 
Table 2.1. Bacterial strains. 
I Strain 	I Genotype 	 I Source/Reference I 
AF681 	MC4100 ,poS::KariR A(uspA-lacZ) 	 [Farewell et al., 
1996] 






BL21(XDE3) 	E. coii B F'- dcm ompT hsdS (rB mB) gal ion Laboratory stock 
pLysS 	X(DE3) [pLysS CmR] 	 [Studier et al., 19901 
BW3 13 	thi- 1 relA 1 spo Ti? dut- 1 ung- 1 HfrKL 1 6(P045) Laboratory stock 
[Kunkel, 19851 
DA26 	zlarcB::CmR araBi Lt(lac-pro) 	 S. McAteer [Ishige et 
al., 19941 
DH5(x 	F- supE44 lacEU 169 hsdRl 7 recAl endAl Laboratory stock 
080(lacZM15) gyrA96 (Na1R)  thi-i relAi 	[Hanahan, 19831 
ME 
I Strain 	I Genotype 	 I Source/Reference I 
DS941 	AB 1157 recF lac1QM15 (F- thr-1 leu-6 thi-1 S. Colloms [Colloms 
kalK2 ara-14 xyl-5 proA2 his-4 argE3 supE44 et al., 1998] 
StrR) 
DS941 	 S. Colloms [Colloms 
arcB::Tn55.4 	 et al., 19981 
DS941 	 S. Colloms [Colloms 
arcA::Tn52.3 	 et al., 19981 
ECL590 	MC4 100 sdh (sdh-lacZ) arcBl zfrd-1 	S. Colloms [luchi et 
al., 1989] 
ECL1601 	F araD139 6(argF-lac)U169 rpsL150 relAl S. Colloms [luchi 
flb5301 deoCi ptsF25 rbsR 4(frd)101 sdh and Lin, 19881 
sdh-lacZ 
MC4100 	F- araD139 zl(argF-lacZ)U169 rpsL150 relAl [Casadaban, 1976] 
flb5301 deoCi ptsF25 rbsR 
MM20asn 	F argG6 hisGi leuB6 metBi pyrE gal-6 lacYl S. McAteer 
xyl-7 supE44 uhp bgr JhuA2 (T1R) (ØSQR) gyrA 
(Na1R) rpsL104  (StrR)  tsx-1 (TO) polA (Amp) 
MM38 
NM621 
F- argG6 hisGi leuB6 metBi pyrE gal-6 lacYl S. McAteer 
xyl-7supE44 uhp bgiJhuA2 ( T1R) (080R) gyrA 
(Na1R) rpsllO4  (StrR)  tsx-1 arcB?c 
F- hsdR (rK MK ' ) mcrA mcrB supE44 Laboratory stock 




thr leu thi minB 
	
S. McAteer 
TA6 	TP8 503 zi('arcB-scrP-mtgA-yrbL-'npr)::(arcB- This work (Fig. 4.12) 
lacZ, CAT). TP8503 transduced with P1(TA5) 
(37C). CmR, Amps.  
TA8 	TP8503 arcA2 zjj::TnlO arcB--lacZ CAT 	This work 
TA9 	TP8503 arcA::Tn5 2.3 arcB'-'lacZ CAT 	This work 
[Strain 	I Genotype 	 I Source/Reference ] 
TA10 	TP8503 zjj:TnlO arcB-lacZ CAT 
	
This work 
TG1 	F' [traD36 proAB lacJQ lacZiM 151 thi-1 supE [Sambrook et al., 
hsdii5 4(lac-proAB) 	 1989] 
TM5 	MM20 transduced with P1(TP8503 [pMLC3]), This work 
CmR (300C). 
TM6 	TP8503 4 ('mtgA-yrbL- 'npr):: (mtgA 'lacZ, This work (Fig. 4.12) 
CAT). TP8503 transduced with P1(TM5) 
(370C). CmR, AMpS. 
TP8503 	thi-1 leu thr supE42 4(lac-pro) JhuA Tn 7, S. McAteer 
(tmpR) 
TP8503 	 This work 
arcA2 
zjj::TnlO 
TS5 	MM20 transduced with P1(TP8503 [pSLC3]), This work 
CmR (300C). 
TS6 	TP8503 4('scrP-mtgA-yrbL-'npr)::(scrP-'lacZ, This work (Fig. 4.12) 
CAT). TP8503 transduced with P1(TS5) (37C). 
CmR, p. pS 
TS6 rpoS 	TS6 ,poS::KanR CmR 	 This work 
TS9 	MM20asn transduced with P1(TP8503 This work (Fig. 4.12) 
[pSLK3]), KanR pimpS CMS (300C). 
TS 10 	TP8503 4('scrP-mtgA-yrbL-'npr)::(scrP-'lacZ, This work (Fig. 4.12) 
KanR) 4arcB::CAT 
TS 11 	TP8503 4('scrP-mtgA-yrbL-npr)::(scrP-lacZ, This work (Fig. 4.12) 
CmR) arc5::Tn5 5.4 
TS 12 	TS6 zjj::7h1 0 arcA2 CmR TetR 	 - This work 
TS 13 	TS6 zjj::Tn 10 CmR TetR 	 This work 
-C. 
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I Strain 	I Genotype 	 I Source/Reference I 
TS 14 	TP8503 arcA::Tn5 2.3 4('scrP-mtgA-yrbL- This work 
'npr)::(scrP'-lacZ CA2) CmR KanR 
Table 2.2. Plasmids. 




5.34 kb BamH I-EcoR I fragment from the A. Elding (Fig. 4.2) 
A523 clone of the Kohara library inserted [Elding, 19951 
into the pJJW11. 
Asc I-Bgl II fragment of PCRed lacZ-CAT This work (Fig 4.11) 
cassette cloned into pBRU12 digested with 
Mu I and Bgl II. 





Amp R, TetR, pMB 1 replicon. 
into pUC18. 
to scrP). 
[Bolivar et al., 1977] 
EcoR I-BamH I fragment of pACE 1 cloned This work (Fig. 4.11) 
Insertion of Kan 1 (from Tn903) cassette into D. Smillie (Fig. 4.2) 
the Nsi I site of scrP in pFMT1 (antiparallel [Smilhie, 19941 
pFMT1 	EcoR I - Hind III fragment of A522 clone of 
the Kohara library (arcB-scrP--mtgA) 
inserted into the pJJW 11. 
pHW ill 	A hybrid a70132 donor, under control of Plac. 
lacIQ (divergent from Piac),  Rep15A, KanR 
(Tn5). 
Laboratory stock 
(Fig. 4.2) [Townsley, 
1991] 
Laboratory stock 
[R. Hayward and 
H. S. Williamson, 
unpublished] 
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I Plasmid 	I Description 	 I Source/reference 
pJJW1 1 	Derivative of pHR9. EcoR I - Pgal - Hind III Laboratory stock 
-BamH I followed by (promoterless) galK. (Fig. 4.2) [Wright 
and Hayward, 1987] 
pMLHM::lacZ 	Hybrid promoter plasmid with regions -35 Laboratory stock 
for a32 and -10 for a70 . lacZ reporter. AmpR  LA. Kumar] 
pMB1 replicon. 
pMLC1 	BstB 1-Bgl II fragment of PCRed lacZ-CAT This work (Fig 4.11) 
cassette cloned into pBRU12 digested with 
BstB I and Bgl II. 
pMLC2 	pALC1 with lacZ' sequence (of pUC18) This work (Fig. 4.11) 
removed. 
pMLC3 	Aoc I-Mfe I portion of pSLC3 cloned into This work (Fig. 4.11) 
pMLC1. 
pSAK15-70/32 A hybrid a70132 donor, under control of Plac. Laboratory stock 
Rep15A, ArnpR. 	 [Kumar et at., 
1995aj 
pSLC1 	BstB I-Bgl II fragment of PCRed lacZ.-CAT This work (Fig. 4.11) 
cassette cloned into pBRU12 digested with 
Cia land Bgl II. 
pSLC2 	pALC1 with lacZ' sequence (of pUC18) This work (Fig. 4.11) 
removed. 
pSLC3 	Aoc I-Nde I portion of lac.Z in pSLC2 replaced This work (Fig. 4.11) 
with that from pMLHM::lacZ. 
pSLK3 	pSLC3 with Hind 111-CA T-BarnH I replaced This work (Fig. 4.11) 
with Hind III_KanR_BaniH  I from pUC4K. 
pTAK1 	Hind III-BamH I fragment from PACE 1 This work (Fig. 4.2) 
replaced with a synthetic Hind III - Not I - 
Bgl II linker (primers TK1 and TK2). 
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pTAK2 	Insertion of KanR cassette (Acc I fragment This work (Fig 4.4) 
from pUC4K) into the BstB I site of mtgA in 
pTAK 1 (parallel to mtgA). 
pTAK3 	The same as pTAK2, but KanR is This work (Fig 4.4) 
antiparallel to mtgA. 
pTAK4 	Insertion of KanR cassette (Acc I fragment This work (Fig 4.4) 
from pUC4K) between the BstB I sites of 
mtgA and galK in pTAK1 (antiparallel to 
mtgA). 
pTAK5 	The same as pTAK4, but KanR is This work (Fig 4.4) 
antiparallel to mtgA. 
pTAK6 	Insertion of KanR cassette (Acc I fragment This work (Fig 4.4) 
from pUC4K) into the BstB I site of galK in 
pTAK1 (parallel to galK). 
pTAK7 	Overproducer of fusion protein P7-'ScrP and This work (Fig 4.4) 
MtgA. Xmn I-Hind III fragment of pTAK 1 was 
cloned into pT7-7 digested with Sma I and 
Hind III. jR 
pTAK8 	Overproducer of fusion protein P8-'ScrP and This work (Fig 4.6) 
MtgA. Nsi I-Hind III fragment of pTAK1 
cloned into pT7-7 digested with Pst I and 
Hind III. p.pR 
pTAK9 	Overproducer of ScrP and MtgA. Mfe I- This work (Fig 4.6) 
Hind III fragment of pTAK 1 cloned into the 
pT7-7 vector digested with EcoR I and 
Hind III. ppR 
pTAK1 1 	Overproducer of ScrP and MtgA. Bfa I- This work (Fig 4.6) 
Hind III fragment of pTAK 1 cloned into the 
pT7-7 vector digested with Nde I and 
Hind III. 
Eli 
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I Plasmid 	I Description 	 I Source/ reference 	I 
pTK1 11 	BamH I-Xho I regions of pHW1 11 replaced This work (Fig 4.1) 
with a BamH I-Not I-Xho I linker 
(oligonucleotides N4356 and N4357). 
pTK1 13- 	Described in Table 4.1. 	 This work 
pTK424 
pTK2 10 	Xba I-Not I-Nsi I fragment of pGEMD245 (in This work (Fig 4.1) 
front of rpoD 245) is replaced with Xba I- 
Sac I-Nsi I (oligonucleotides RH7 and RH8). 
pTK2 11 	BamH I-Xho I regions of pTK2 10 replaced This work (Fig 4.1) 
with a BamH I-Not I-Xho I linker 
(oligonucleotides N4356 and N4357). 
pTK310 	Xba I-Not I-Nsi I fragment of pGEMD (in This work (Fig 4.1) 
front of rpoD) is replaced with Xba I-Sac I- 
Nsi I (oligonucleotides RH7 and RH8). 
pTK3 11 	BamH I-Xho I regions of pTK3 10 replaced 	This work (Fig 4.1) 
with a Barnl-I I-Not I-Xho I linker 
(oligonucleotides N4356 and N4357). 
pUC4K 	Co1E1 derived replicon (pMB1). A source of 	[Vieira and Messing, 
Kan R (Tn903) cassette. AmpR. 	 19821 
pUC18 	ColE 1 derived replicon. jac promoter region, [Vieira and Messing, 
polylinker and lacZ. 2.7 kb. AmpR. 	 19821 
Oligonucleotides. 
5 1 P denotes 5' phosphorylated oligonucleotide. 
083V 5' -CTGATGCATCGCTTGTGC-3' 
287M 5 '-GGCACAATCAACGCATC-3 I 
876L 5' -CAACGTCAACACCGCTTC-3' 
877L 5' -GAAGCGGTGTTGACGTTG- 3 
834T 5' -ATGTGTGATGCGTACCAT-3' 
997M 5' -CTGCGCCAACACCAGGGA-3' 
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3 'Cml 5 ' -CGAAGCTTAGATcCAGGCGTTTJGGGCACCAAT?JCTGCCT_3I 
Bgl II 
839F 	5 '-ACTGACTGAAATGCC-3 
Asc I 
ASCI -LACZ 5 ' -ACGGCGCGC CTG GCC GTC GTT TTA CAA CGT C-3' 
7 	8 	9 10 11. 	(codons of LacZ) 
.BstB I 
Bscrp 5'-GTCTTCGAA CTG GCC GTC GTT TTA CAA CGT CG-3' 
7 	8 	9 10 11. . . (codons of LacZ) 
.BstB I 
Bmtga 5'-CTGTTCGA ATG ATT ACG GAT TCA CTG GCC GTC G-3' 
3 	4 	5 	6 	7 . 	(codons of LacZ) 
C308 	5 ' -GCAGAACTTTTGCTTCACGC-3' 
CATout2 5 '-CGAAGTGATCTTCCGTCACAGGTA- 3' 
ExtP 	5 ' -CTTTGACGTGCGCTTCTTGCC-3 I 
G0752 5 ' -CACCGCGGACGAAGATGCTGC-3' 
G0754 5 ' -GTTCCTTGACCTGATTCAGG-3' 
IntP 	5 -TGCGATGAGTGGCAGGGCGG- 3' 
N4356 5' -GATCCGTCAGGCGGCCGCATAATAGC- 3' 
N4357 5' -TCGAGCTATTATGCGGCCGCCTGACG- 3' 
NS10 	5' Pj-GCGTAGGTGCAGAACTTGTAACC-3' 
NS1 1 5' -CGGATCCACGCGGTTGCGTAGGTGCAGAACTTGTAAC- 3' 
NS12 	5 ' P -GGAGAACTTGCAACCACGGC- 3' 
NS13 5 , P± -CGGATCCACGCGGTTGCGTAGGTGGAGAACTTGCAACCACGGC 3' 
NS14 	5 ' Pj-CACGGCGGCATTCGAATTTATCACC-3' 
RH1 5' -CCTGGTGGATCCGTTGa3CGATCACCCGC-3' 
BarnH I 437 
RH2 	5' -GGTGGATCaTCAGGCGATCTGcX2GCTCTATCG-3' 
BamH I 	 440 
RH3 	5' -GGTGGATCCGTCAGGCGATCACCCGCTGThTCG- 3' 
BamH I 	 442 
RH4 	5' Pj-GGAGATTGGCTCGCAGGCGATCTTCAGC- 3' 
RH5 5' P-CCCCAGATGGCAATCTTCATCATCACC-3' 
RH6 	5' -GTCGGTCAGACGGTTTGCCGCC-3' 
R1-17 5' -CTAGTCGTATGAGCTCCGCACCTGCA-3' 
RH8 	5' -GGTGCGGAGCTCATACGA- 3' 
TK1 5 I -GATCTCAGCGGCCGCTCACA-3' 
TK2 	5' -AGCTTGTGAGCGGCCGCTGA- 3' 
Univ. P 5' -TCCCAGTCACGACGT-3' 
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Restriction endonucleases were purchased from Boehringer 
Mannheim, New England Biolabs and Promega. DNA modification 
enzymes used were Sequenase® Version 2.0 T7 DNA Polymerase 
were (USB), Vent DNA Polymerase (New England Biolabs), T4 DNA 
Ligase (Boehringer Mannheim and New England Biolabs), Taq DNA 
Polymerase (Promega). RNase and Proteinase K were from Sigma. 
Core RNA polymerase and U70  were purified and kindly provided by 
N. Shimamoto. 70HMK and 245-HMK were purified and kindly 
provided by H. Nagai. Other a subunits were purified according to 
the protocol below. 
2.2. Growth media and buffers. 
L-broth and L-agar were used routinely for most bacterial 
manipulations. For phage P1 2.5 mM CaC1 2 was added to the 
medium. In certain cases M9 minimal medium, supplemented with 
appropriate carbon sources, vitamins and amino acids, was used. 
2.2.1. Growth media. 
L-broth 	 Difco bacto tryptone 	 log 
Difco bacto yeast extract 	5g 
NaCl 	 5g 
pH to 7.2 with NaOH 
Distilled water 	 to 1 litre 
L- agar 	 L-broth + 15 g Difco agar per litre 
LB top agar 	L-broth + 6.5 g Difco agar per litre 
M9 minimal medium 	4 x M9 salts 	 100 ml 
20% carbon source 	 4 ml 
Supplements as required 
Distilled water 	 to 400 ml 
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M9 minimal agar As M9 minimal medium + 15 g Difco agar per litre 
4 x M9 salts 	NaH2PO4 	 28 g 
KH2PO4 12g 
NaCl 	 2g 
NH4C1 4g 
Distilled water 	 to 1 litre 
4 x M9 salts 	MgSO4.7H20 	 4 g 
Citric acid 40 g 
KH2PO4 	 400g 
NaNH4.HPO4.4H20 	 70 g 
Distilled water 	 to 1 litre 
2.2.2. Commonly used buffers. 
Phage buffer 	 Na2 HPO4 	 7g 
KH 2 PO 4 3g 
NaCl 	 5g 
MgSO4 (0.1M) 	 10 ml 
CaCl2 (0.1 M) 10 ml 
1% gelatine solution 	 1 ml 
Distilled water 	 to 1 litre 
Bacterial buffer 	KH 2 PO4 	 3 g 
Na2 HPO 4 7g 
NaCl 	 4g 
MgSO4 .7H 20 	 2 g 
Distilled water to 1 litre 
TAE buffer 	Working solution: 
40 mM Tris-acetate 
2 mM EDTA 
50x Conc. stock solution: 
Tris base 	 242 g 
Glacial acetic acid 	 57.1 ml 
0.5 M EDTA (pH 8.0) 100 ml 
Distilled water 	 to 1 litre 
TBE buffer 
89 mM Tris-borate 
89mM boric acid 
5x Conc. stock solution: 
Tris base 	 54 g 
Boric acid 27.5g 
0.05 M EDTA (pH 8.0) 	 20 ml 
Distilled water 	 to 1 litre 
TE buffer 	 10 mM Tris-HC1 (pH 8.0) 
1 mM EDTA (pH 8.0) 
2.2.3. Minimal medium supplements. 
Amino acid supplements were stored in stock solutions of pure 
amino acids at a concentration of between 2-10 mg m1 1 depending 
upon the solubility of the particular amino acid. Sparingly soluble 
amino acids, such as tyrosine, were dissolved in 0.01 M NaOH. The 
final concentration of the amino acids in the media was usually in 
the order of 20-100 pg m1 1 . If a rich minimal medium was required, 
vitamin-free casamjno acids (CAA) were used. The stock 
concentration of CAA was 100 mg ml -1 and the final concentration 
in the medium was typically 1-5 mg ml-1 . It should be noted that 
casamino acids lack tryptophan and this should therefore be added 
to CAA medium if the bacterial strain to be used is auxotrophic for 
this amino acid. 
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Purines and pyrimidines were added to minimal media when 
required. Thymine and uracil were 'stored at a concentration of 2 
mg ml-1  in water, and their final concentration in minimal medium 
was usually 20-40 .tg ml -1 . 
The only vitamin supplement found necessary in the entire course 
of this work was thiamine hydrochloride (vitamin BI). This was 
stored as a 1 mg ml-1 solution in water and its final concentration 
in minimal medium was 2 mg ml-1 . 
2.2.4. Growth of bacteria. 
Bacteria were routinely grown as liquid cultures at 37°C (or 30°C for 
temperature-sensitive strains). Usually fresh overnight cultures 
that had been inoculated from a single colony were diluted back the 
following day and grown as required. 
To screen colonies for 3-galactosidase activity, cells were plated on 
L-agar containing X-Gal (5-bromo-4-ch1oro3-indo1y1-3-ga1actoside) at 
40 pg ml-1 . 
For -ga1actosidase activity assays in the scrP studies L-broth was 
boiled, cooled down, glucose (to 40 mM) and antibiotics (where 
necessary) were added. Glucose (as an electron acceptor) is 
necessary for growth of bacteria under anaerobic conditions, and it 
was used both in aerobic and anaerobic experiments. Into this 
media bacteria were diluted 10000-fold from fresh overnight 
cultures. Aerobic cultures were then grown as usual with vigorous 
shaking, while for anaerobic growth sealable bottles were filled to 
top with the liquid cultures, and nitrogen was bubbled continuously 
through a needle in the seal. A syringe was used to take 1 ml 
samples through the needle. 
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2.2.5. Selection of antibiotic resistance. 
The concentrations for the antibiotics used in this work are shown 
in Table 2.3. All antibiotics were used in both complex and minimal 
media at the same concentrations. 
Table 2.3. Antibiotic solutions. 
Antibiotic Abbreviation Solvent Concentration 
Stock Final 
(mgmf 1 ) (j.tgmf 1 ) 
Ampicillin Amp 50% ethanol 100 100 
Chioramphenicol Cm Ethanol 35 35 
D-cycloserine H20 15 150 
Kanamycin Kan H20 50 50 
sulphate 
Tetracycline Tet 50% ethanol 10 10 
hydrochloride 
Rifampicin Rif Ethanol 50 50 
2.2.6. Dye sensitivity tests [luchi et al., 19901. 
Fresh colonies were restreaked on dye agar and incubated overnight 
at 37°C. After this dye-sensitive fells formed no or tiny colonies, 




0.2 mg m1 1 toluidine blue o or methylene blue 
15 g Difco agar per litre 
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2.3. Bacterial and phage techniques. 
2.3.1. Preparation of competent cells and transformation with 
plasmid DNA using DMSO. 
To prepare competent E. coli cells the method of Chung et al. [1 9891 
was employed. Five ml of L-broth was inoculated with a single 
colony and incubated overnight with shaking at a suitable 
temperature. This culture was diluted 1 in 50 into fresh L-broth and 
grown with good aeration to an A600 of between 0.3 and 0.4. The 
culture was chilled on ice, transferred to a universal bottle and 
centrifuged at 3600 x g for 10-15 mm. The supernatant was removed 
and the bacterial pellet resuspended in 0. lx the original volume of 
ice-cold TSS buffer. At this point the cells could be frozen at -70°C, 
or could be used immediately for transformation. Freshly prepared 
cells always gave the highest transformation efficiency. The plasmid 
DNA (typically 1-100 ng in <10 il) was added to 0.1 ml aliquots of 
the competent cells, mixed gently and stored on ice for 15-30 mm. 
After this time 1 ml of LBG (L-broth + 20 mM glucose) was added 
and the cells incubated with aeration at an appropriate temperature 
for 1 h to allow expression of plasmid antibiotic-resistance genes. 
Two hundred microlitres of this mixture was then spread onto 
antibiotic-containing plates and incubated until bacterial colonies 
appeared. Whenever a transformation was performed an aliquot of 
competent cells lacking plasmid DNA was used as a control. 
Cells can be transformed with replicative form M13 DNA using this 
method. In this case the LBG step is omitted and 0.25 ml of M13-
sensitive plating cells added to the transformed cells. The mixture 
is added to 3 ml of molten L-top agar, mixed gently and poured onto 
a L-agar plate which, once set, is incubated at 37°C overnight, after 
which M13 plaques should be clearly visible. 
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TS 	buffer: 
Difco Bacto Tryptone log 
Difco Yeast Extract 5 g 
NaCl lOg 
PEG 3350 100  
MgSO4 20 	m 
DMSO 50m1 
PIPES Buffer pH 6.5 10 mm 
distilled water to 1 litre 
2.3.2. Preparation of competent cells and transformation 
with plasmid DNA using calcium chloride. 
1 litre of L broth was inoculated with 1 ml of a fresh overnight 
culture and incubated with good aeration until the A 600 reached 
0.4. The culture was chilled on ice for 15 mm. The cells were 
pelleted in at 4000 rpm in a Sorwall GS3 rotor at 4°C for 5 mm. The 
pellets were resuspended in 1/10 of the initial volume of ice-cold 
0.1 M CaC12 and stored on ice. 
To 100 tl aliquots 1-10 ng of plasmid DNA or 5-20 jtl of ligation 
reaction was added, and the mixture was incubated on ice for 1-1.5 
hours. After heat shock for 1.5-2 min in a water bath at 42°C the 
transformation mixture was put on ice for 5 mm, then 1 ml of LBG 
was added to it, and the tube was incubated for 1 hour at 37°C with 
shaking to allow expression of antibiotic genes. Aliquots of 100-500 
ml were plated on L-agar with appropriate antibiotic selection and 
the plates were incubated overnight at 37°C (or 30°C where stated). 
2.3.3. Frozen storage of bacterial strains. 
Strains of E. coli can be conveniently stored at -70°C without 
suffering a dramatic loss of viability, this includes strains 
harbouring plasmids that might otherwise be lost. A fresh 5 ml 
overnight culture was prepared with antibiotic selection if required. 
This was centrifuged at 4000 rpm for 10-15 mm, the supernatant 
discarded and the cells resuspended in 0. lx the original volume of 
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Frozen Storage Buffer. The cells were then left on ice for a couple of 
hours before storing at -70°C. 
Frozen storage buffer: 
50% bacterial buffer 
50% glycerol (v/v) 
2.3.4. Preparation of phage P1 plate lysates. 
Cells were grown in L-broth with 2.5 mM CaC12 until late log phase. 
1 ml of the culture was then mixed with 106 phage, incubated at 
37°C for 30 mm, and 3 ml of L-top agar containing 2.5 mM CaC12 
was added. This was poured onto a L-agar plate, left to set and 
incubated at 37°C overnight or until visible lysis occurred. The layer 
of top agar was scraped off into a sterile universal bottle. Equal 
volume of L-broth with 2.5 mM CaC12 and 100 jil of chloroform were 
added to the bottle. The bottle was shaken gently for 15 min at 
30°C, centrifuged 5 min at 5,000 rpm at room temperature. The 
supernatant was transferred to a fresh bottle and a few drops of 
chloroform were added. The lysate was stored at 4°C. 
2.3.5. Phage P1-mediated transduction. 
The recipient strain was grown up to late-log phase in L-broth. The 
cells were harvested by centrifugation and the bacterial pellet 
resuspended in 0. lx the original volume of L-broth with 2.5 mM 
CaCl2 . 100 j.tl aliquots of the concentrated culture were mixed with 
either 100 J.tl or 100 p.1 of a 10 x dilution of the phage stock. These 
were incubated at 37°C for 30 mm. 1 ml of phage buffer was added, 
the cells were centrifuged and resuspended in 0.6 ml of LBG. This 
was incubated at 37°C for 1 h to allow expression of the antibiotic 
resistance and then 0.2 ml aliquots were plated out on L-broth agar 
plates containing the appropriate antibiotic. Plates were incubated 
at a suitable temperature until colonies appeared. 
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2.3.6. Phage P1-mediated transfer of plasmid DNA to 
chromosome. 
To transfer DNA cloned in pUC-based plasmid the phage P1-
mediated transfer protocol was used [Draper et al., 1998]. The DNA 
to be transferred had a selection marker (CmR  or KanR) attached to 
it, and was flanked on each side by at least 1 kb of DNA 
homologous to chromosome. A reck strain (TP8503) was transformed 
with a pUC-based plasmid with both (Amp and Cm, or Amp and Kan) 
antibiotics selection. A P1 lysate was prepared on a purified 
transformant and this was used to transduce MM20 or MM20asn 
strain to CmR  or  KanR.  MM20 is a polA strain and plasmid DNA can 
not replicate in it. Transductants were selected only in presence of 
the second antibiotic (Cm or Kan), purified, and one of Amps 
colonies was used to prepare a second P1 lysate. This lysate was in 
turn used to transduce TP8503 strain to CmR or KanR. 
Chromosomal structure of the resulting purified transductants was 
checked by PCR analysis and by Southern hybridisation. 
2.3.7. Purification of minicells for in vivo protein synthesis 
studies [Stoker et al., 1983]. 
Three 500 ml batches of L-broth containing appropriate antibiotics 
were inoculated with a culture of minicell strain P678.54, 
transformed with the required plasmid, and were grown overnight 
with vigorous shaking. At the same time eight sucrose gradients 
were prepared by freezing 35 ml aliquots of 20% (w/v) sucrose in M9 
glucose medium in 50 ml polycarbonate centrifuge tubes (-70°C) 
and allowing the frozen solutions to thaw undisturbed at 4°C 
overnight. 
Parental cells were removed from the culture by centrifugation at 
2500 rpm in a Sorvall GS-3 rotor for 15 min at 4°C. Minicells were 
harvested from the supernatant by centrifugation at 8500 rpm in a 
GS-3 rotor for 20 min at 4°C. The minicell pellets were resuspended 
in a total of 10 ml of supernatant and the suspensions were 
transferred to a 30 ml Corex tube on ice. The suspension was 
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whirlimixed vigourously 3 times for 1 minute intervals to disperse 
aggregated minicells. 2.5 of minicell suspension was layered onto 
each of 4 x 35 ml sucrose gradients and these were centrifuged at 
5000 rpm in a Sorvall HB-4 rotor for 20 min at 4°C. The minicell 
bands were collected from the upper part of the gradients and 
pooled samples from pairs of gradients were pelleted by 
centrifugation in a Sorvall SS-34 rotor at 13000 rpm for 10 min at 
4°C. The resulting minicell pellets resuspended in a pooled total of 
4 ml M9 glucose medium, and 2 ml were layered onto each of 2 
glucose gradients. The minicell bands were harvested from the 
gradients as before and the minicells were pelleted. The pellet was 
resuspended in 2 ml M9 glucose, layered onto a sucrose gradient 
and centrifuged. The minicells were pelleted in a Sorvall SS-34 rotor 
at 8000 rpm for 10 min and resuspended in 1 ml of 30% (w:v) 
glycerol in M9 glucose medium. The A600 of a 0.1 ml aliquot diluted 
to 1 ml was measured and the suspension was aliquoted into 
Eppendorf tubes so that the volume diluted to 1 ml gave A 600 0.2, 
which is equivalent to approximately 2 x 10 9 minicells. The cells 
were then stored at -70°C. 
2.3.8. Labelling of plasmid-encoded proteins in minicells. 
The minicell preparations were thawed at room temperature and 
diluted to 1 ml in M9 glucose. The cells were then spun in a 
microfuge for 2 minutes at 4°C. The pellet was resuspended in 0.1 
ml M9 glucose and the samples were incubated for 1 hour at 37°C 
to remove any bacterial DNA. 20 j.tCi [35S]methionine was added 
(this was prepared by diluting [35S]methionine five-fold in 25% (w/v) 
filter-sterilised Difco methionine assay mix in M9 glucose), and 
samples were incubated at 37°C for 3 hours. Samples were chased 
with 5 pJ cold methionine (8 mg m1 1 ) for 3 minutes and then spun 
for 2 minutes in a microcentrifuge. The pellets were washed with 
1 ml 0.05 M Tris-HC1 pH 6.8, then resuspended in the residual 
liquid. 15 pl loading buffer containing J-mercaptoethanol was 
added, and the samples were fractionated by SDS-PAGE. Labelled 
proteins were detected by autoradiography. 
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2.3.9. Labelling of plasmid-encoded proteins in maxicells 
[Close and Rodriguez, 19821. 
Cultures of plasmid-containing CSR603 cells were grown in 3 ml of 
M9, CAA medium at 37°C with shaking until A600 reached 0.4. A 
2.5 ml portion of this culture was transferred to a sterile 100-mm 
diametre petri dish and irradiated for 15 seconds with 254 nm 
ultraviolet lamp at an intensity of 1.25 J rn-2 s 1 . 2 ml of irradiated 
cells was transferred into a tube, D-cycloserine was added to a final 
concentration 150 jig ml -1 , and the cells were incubated for 16 
hours at 37°C with shaking. Cells from 1.5 ml of his culture were 
then pelleted, washed twice with M9 medium and resuspended in 
0.8 ml of M9 medium. The culture was incubated at 37°C without 
shaking, after which 0.2 jil M9 medium containing 5 jiC i 
[ 35 S]rnethionine (1380 Ci rnmoll, Amersham) was added. After 
another hour of incubation at 37°C the cells were pelleted, washed 
twice with 1 ml of 100 mM NaCl, resuspended in SDS-PAGE loading 
buffer and separated on 12% SDS-PAGE. 
2.4. DNA Techniques. 
Most DNA manipulations were performed according to Sambrook et 
al., [1989] with some modifications, or according to instructions of 
manufacturers of certain reagents/kits. 
2.4.1. Plasmid preparation. 
All preparations of plasmid DNA were performed using a 
modification of the alkaline lysis method of Birnboim and Doly 
[1979]. When possible, DNA was prepared from an endA strain, 
typically DH5a, to avoid DNA degradation by the EndA 
endonuclease. 
Large scale plasmid preparations. 
A single colony of the plasmid -carryingbacterial strain was 
inoculated into 5 ml of L-broth with the appropriate selection and 
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incubated overnight at appropriate temperature (typically 37°C) with 
vigorous shaking. One millilitre of this culture was then used to 
inoculate 25-500 ml of L-broth, with similar selection, in a 2 litre 
flask, which was then incubated at 37°C overnight, again with 
vigorous agitation. The culture was chilled on ice for 15 mm, 
transferred to two 250 ml centrifuge bottles and cells were collected 
by centrifugation at 6,000 x g in a Sorvall GSA or GS-3 rotor for 10 
min at 4°C. The bacterial pellets were then each washed in 100 ml 
of TE buffer, pooled to give a total volume of 200 ml, and 
recentrifuged as above. The DNA usually was isolated by using 
QIAGEN® Plasmid Midi Kit. The resultant cell pellet was 
resuspended in 4 ml (or in a bigger volume, according to the 
manufacturer instructions) of cold QIAGEN buffer P1 containing 
50 mM Tris-HC1, pH 8.0; 10 mM EDTA; 100 pg m1 1 RNase A and 
transferred into a 50 ml centrifuge tube. An equal volume of 
QIAGEN buffer P2 (200 mM NaOH, 1% SDS) was added, the 
solution was mixed gently by inverting the tube several times, and 
incubated at room temperature for 5 mm. 4 ml of pre-chilled 
QIAGEN buffer P3 (3.0 M potassium acetate, pH5.5) was added, the 
solution was mixed gently by inverting the tube several times, and 
incubated on ice for 15 mm. The mixture was centrifuged at 
20,000 x  (13,000 rpm for a Sorvall SS-34 rotor) for 30 min at 4°C, 
and the supernatant was carefully removed. Any suspended 
material would be re-centrifuged. QIAGEN-tip 100 column was 
equilibrated by applying 4 ml of buffer QBT (750 mM NaCl; 50 mM 
MOPS, pH7.0; 15% ethanol; 0.15% Triton X-100), after which the 
supernatant was applied to it. After all the solution entered the 
resin of the column, it was washed with 10 ml of QIAGEN buffer QC 
(1.0 M NaCl; 50 mM MOPS, pH7.0; 15% ethanol) twice, and DNA 
was eluted with 5 ml of buffer QF (1.25 M NaCl; 50 mM Tris-HC1, 
pH8.5; 15% ethanol). The DNA was precipitated with 0.7 volumes of 
room-temperature isopropanol and centrifuged immediately at 
15,000 x  (11,000 rpm for a Sorvall SS-34 rotor) for 30 min at 4°C. 
The supernatant was carefully removed, the DNA pellet was washed 
with 70% ethanol, air-dried for 10 mm, and redissolved in a 
suitable volume of TE buffer or nuclease-free water, depending on 
further applications. 
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Small-scale plasmid preparation. 
For small-scale preparations Wizards Plus SV Minipreps DNA 
Purification System (Promega) was used, following the 
manufacturer's protocol. This includes small scale method based 
on Birnboim protocol [1979], followed by the addition of a chaotropic 
salt (4.09 M guanidine hydrochloride) during neutralisation step. 
The cleared lysate after neutralisation and precipitation was 
applied to Wizards Plus SV Minipreps Spin Column, the column was 
washed twice with Wizards Plus SV Minipreps Column Wash 
Solution (162.8 mM potassium acetate, 27.1 mM Tris-HC1, pH7.5), 
and the DNA was eluted by nuclease-free water. The resulting 
plasmid DNA eluted from a column would normally be ethanol 
precipitated, unless it was used for restriction digestion only. 
2.4.2. Phenol extraction and ethanol precipitation of DNA. 
Phenol extraction followed by ethanol precipitation was the 
standard method of purification of crude DNA preparations and 
inactivation of enzymes after reactions. 
An equal volume of phenol: chloroform: isoamyl alcohol (25:24:1) was 
added to the DNA solution, the suspension was mixed vigorously 
by inverting the tube or by vortexing until homogeneity, and 
centrifuged in a microcentrifuge at 10,000 rpm for 1 mini The 
aqueous phase was carefully transferred to a clean Eppendorf tube. 
If a white precipitate was present at the aqueous/organic interface, 
the procedure was repeated (several times if necessary). This was 
followed by chloroform treatment, by adding an equal volume of 
chloroform and proceeding as above. 
DNA was routinely precipitated from aqueous solution by adding 
1/10 volume of 3M sodium acetate (pH5.5) and 3 volumes of 
absolute ethanol, mixing thoroughly and leaving on ice for a 
minimum of 10 mm. This was then centrifuged in a microcentrifuge 
at maximal speed for at least 10 min at 4°C. The supernatant was 
discarded, the pellet washed with the same volume of 70% ethanol, 
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recentrifuged as above for 5 min and the supernatant was removed 
by aspiration. The pellet was left to dry on a bench for a couple of 
mm. The dried DNA pellet could then be resuspended in a suitable 
volume of TE buffer (for storage or restriction digests) or water (for 
other manipulations). Sometimes, to keep the total volume small, 
0.6 volume of isopropanol was used instead of ethanol. After 
isopropanol precipitation and centrifugation, the pellet was washed 
with 70% ethanol as described above. 
2.4.3. Determination of DNA concentrations. 
DNA concentrations were determined by measuring the absorption 
of appropriately diluted (usually 1:500) solutions at 260 nm, as an 
A 260 value of 1.0 corresponds to double-stranded DNA 
concentration of 50 mg ml -1 . DNA purity was determined by 
measuring the ratio of absorption at 260 and 280 nm. Pure DNA 
should have a 260/280 ratio of at least 1.8. DNA concentration was 
always confirmed by running an aliquot on an agarose gel along 
with other DNAs of known concentrations. 
2.4.4. Restriction of DNA. 
Endonuclease reactions were typically performed in volumes of 
between 20 and 100 jil. The reactions contained the appropriate 
Boehringer Mannheim, New England Biolabs or Promega restriction 
buffer at lx concentration. BSA was added (to 1 mg ml') if 
recommended by the manufacturer of an enzyme. The restriction 
enzyme was usually present in a two- to fivefold excess, i.e. 2-5 
units per microgram of DNA. The digests were made up to their 
final volume using distilled water. The complete restriction 
mixtures were incubated at the temperature recommended for a 
particular enzyme for 1-3 h. The products of the reaction were 
either directly analysed by agarose gel electrophoresis, or phenol 
extracted, ethanol precipitated and dissolved in a suitable volume 
of TE buffer for further manipulations. 
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Partial digestion of DNA. For partial digestion of DNA, ten two-fold 
serial dilutions of restriction enzyme were added to fixed amounts 
of DNA, with 0.5 units of enzyme per gg DNA representing the 
highest enzyme:DNA ratio. The digests were incubated at the 
appropriate temperature for 1 h and terminated by addition of 
tracking dye. The products of the reactions could then be analysed 
by agarose gel electrophoresis. 
2.4.5. Ligation of DNA. 
DNA ligation was performed in a final volume of 10-20 pl. These 
usually contained between 0.5-1 pg of total DNA with insert DNA in 
a 2- to 20-fold molar excess over the vector DNA, lx ligation buffer 
and T4 DNA ligase (Boehringer Mannheim or New England Biolabs). 
0.2 unit (Weiss unit) of ligase was used for the ligation of cohesive 
DNA termini, and 1 unit of the enzyme for the ligation of blunt-
ended molecules. The reactions were incubated for at least 30 mm 
at room temperature for cohesive termini or at least 8 h at 16°C for 
blunt end ligation. Between 2 and 5 p1 of the reaction mixture was 
directly used to transform competent cells of an appropriate strain 
of E. coli. 
2.4.6. 'Filling in' of recessed 3' termini. 
Sequenase® Version 2.0 T7 DNA polymerase (USB) was used to give 
blunt-ended DNA molecules by filling in the recessed 3' termini 
generated by various restriction enzymes. Reactions were 
performed in a final volume of 20 il containing up to 1 pg DNA, lx 
Sequencing buffer (USB), all four dNTPs each at a concentration of 
20 mM and 2 units of the enzyme. The reactions were incubated at 
room temperature for 30 mm. The reactions were stopped and the 
unincorporated nucleotides removed by increasing the reaction 
volume to 100 pA with TE, phenol extracting and ethanol 
precipitating the DNA. 
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2.4.7. Agarose gel electrophoresis. 
Agarose gels for electrophoretic analysis of DNA were prepared with 
TAE buffer. The gels were made-up by melting the appropriate 
amount of agarose (usually between 0.8 and 1.5%) in lx TAE buffer. 
Samples containing 1 x loading dye (6 x stock is 0.25% bromophenol 
blue, 0.25% xylene cyanol and 40% (w/v) sucrose in H 2 0) were 
always loaded after immersion of the gels in TAE buffer. The gels 
were run at 80-100 mA at room temperature. Gels either contained 
0.5 .tg mF 1 of ethidium bromide or were stained in water containing 
2 pg mr' ethidium bromide for about 20 min after completion of 
electrophoresis, and subsequently destained in fresh water for 5-10 
mm. After the run the DNA fragments were visualised by UV 
illumination and photographed. 
2.4.8. Isolation of DNA from agarose gel slices. 
DNA fragments of up to 15kb were isolated from agarose gels using 
Geneclean II kit from BlO 101. The procedure is based on a specific 
DNA binding to silica matrix (Glassmilk) at high salt concentration 
and its further release in low salt solution. The appropriate DNA 
bands were excised from ethidium bromide stained agarose gels 
under UV light in the minimal gel volume possible. The gel piece 
was placed in an Eppendorf tube, weighted and three volumes of 6 
M Nal solution added. The tube was incubated at 50°C with periodic 
mixing until the agarose was dissolved (usually 2-5 mm). s p1 of 
Glassmilk was added, mixed and the tube stored on ice for at least 
5 min with periodic mixing to keep the Glassmilk suspended. Silica 
matrix with bound DNA was pelleted by brief (5 seconds) 
centrifugation. The supernatant was discarded and the pellet 
washed three times with 400 il of New Wash (an ethanol based 
buffer supplied with the kit), centrifuging and resuspending the 
pellet each time. The washed pellet was resuspended in 5 pl of TE 
buffer and incubated at 50°C for 2-3 mm. The mixture was 
centrifuged for 30 seconds and DNA containing supernatant 
collected. The elution step was sometimes repeated to extract the 
DNA still bound to the matrix after the first elution. 
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2.4.9. Labelling DNA fragments by random priming. 
The labelling of DNA fragments was performed using High Prime 
premixed solution (Boehringer Mannheim). The method is based on 
the hybridisation of nucleotides of all possible sequences to the 
denatured DNA to be labelled. High Prime mixture contains random 
oligonucleotides, Klenow polymerase, dATP, dGTP, dTTP and an 
optimised reaction buffer for rapid and efficient labelling of DNA 
with radioactive dCTP. 1Ong X. DNA and 100 ng of a plasmid 
fragment in 11 jtl of H20 were denatured by heating in a boiling 
water bath for 10 min and chilled quickly on ice. 4 .d of High Prime 
solution and 5 j.il (50 pCi) [a32P]dCTP, 3000 Ci mMoF 1 , was added 
to the DNA, and the solution was incubated for 10 min at 37°C. The 
reaction was stopped by addition of 2 i1 0.2 M EDTA. The labelled 
DNA was purified from low molecular size products on MicroSpmnTM 
Column S-200 (Pharmacia). 
2.4.10. Preparation of chromosomal DNA. 
A single colony of the appropriate strain of E. coli was used to 
inoculate 5 ml of L-broth, which was incubated overnight at 37°C, 
(or 30°C for temperature-sensitive strains) with vigorous shaking. 
One millilitre of this culture was used to inoculate 100 ml of L-
broth, which was again incubated at a suitable temperature 
overnight with constant agitation. The culture was then chilled on 
ice and transferred to a 250 ml centrifuge bottle and centrifuged at 
5000 rpm. for 15 min at 4°C using a Sorvall GSA rotor. The 
supernatant was removed and the bacterial pellet was resuspended 
in 20 ml of STE, which is TE buffer with 10 mM sodium chloride. 
One millilitre of 10% SDS solution and 1 ml of proteinase K 
solution (4 mg ml-1 ) were added, mixed gently and incubated at 
50°C for 6 hours without shaking. To this solution an equal volume 
of phenol: chloroform: isoamyl alcohol (25:24:1) was added, the 
suspension mixed gently by inversion and allowed to stand at room 
temperature for 10 mm. This was centrifuged in a benchtop 
centrifuge for 15 min to separate the aqueous and phenolic phases. 
The upper aqueous phase was then carefully removed avoiding the 
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protein interface. The nucleic acids in this phase were precipitated 
by adjusting the sample to 0.2 M sodium acetate (pH 5.5) and gently 
layering 2 volumes of ice-cold ethanol on top. The DNA was 
collected at the aqueous-ethanol interface by spooling it out with a 
glass rod. 
The spooled DNA was washed in 70% ethanol, dried briefly in air 
and dissolved overnight in 10 ml of TE at room temperature. To this 
solution 0.1 ml of RNase A (10 mg ml - ') was added and the mixture 
incubated at 37°C for 1 hour. Five hundred microlitres of a 10% SDS 
solution and 250 pJ of proteinase K solution (4 mg ml -1 ) were now 
added and the mixture incubated at 50°C for 1 h. The sample was 
extracted with phenol: chloroform: isoamyl alcohol and the DNA 
precipitated by spooling as above. After washing in 70% ethanol the 
DNA was air dried and solubilised in 1 ml of TE. This solubilisation 
took between 1 and 3 days. The yield of DNA was determined by UV 
spectrophotometry as described previously; from 100 ml of culture 
about 500 pg of chromosomal DNA was typically obtained. 
2.4.11. Preparation of bacteriophage M13 DNA. 
In all preparations of M13 DNA the E. coli strain TG1 was used. A 
5 ml overnight culture of TG 1 was prepared in the usual way. This 
culture was used to set up a culture infected with bacteriophage 
M13. Fifty microlitres of the overnight culture was used to inoculate 
2 ml of L-broth. To this either 100 p1 of an M13 phage suspension, 
(about 1/10 of a single plaque), or an entire M 13 plaque from an 
agar plate was added. This culture was incubated at 37°C with 
vigorous shaking for about 5 h. One-and-a-half millilitres of this 
culture was transferred to an Eppendorf tube and centrifuged in a 
microfuge for 5 mm. The resulting bacterial pellet could be used to 
preparç the double-stranded replicative form of M 13 DNA, and the 
supernatant used to prepare single-stranded M13 DNA (or as a 
fresh bacteriophage suspension). 
Preparation of double-stranded M13 DNA. The bacterial pellet was 
washed once in bacterial buffer and the double-stranded DNA 
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isolated in essentially the same way as was described for the 
small-scale isolation of plasmid DNA. 
Preparation of single-stranded M13 DNA. 1.2-1.3 ml of the 
bacteriophage suspension was transferred to an Eppendorf tube 
and 200 pA of a solution containing 20% polyethylene glycol 
(PEG8000) in 2.5 M sodium chloride was added, the solution mixed 
thoroughly and allowed to stand at room temperature for 15 mm. 
The precipitated bacteriophage particles were recovered by 
centrifuging in a microfuge for 5 min and the supernatant was 
removed carefully leaving the pellet as dry as possible. The 
bacteriophage pellet was resuspended in 100 il TE with vigorous 
vortexing. Fifty microlitres of phenol (equilibrated with Tris-HC1 
(pH 8.0)) was added and the suspension mixed thoroughly by 
vortexing for 1 mm. This was then centrifuged for 2 min and the 
upper aqueous layer carefully removed and placed in a fresh tube. 
The volume of the sample was adjusted to 0.5 ml and the single-
stranded DNA recovered by phenol-chloroform extraction and 
ethanol precipitation as has been described earlier. An optional 
step was to chloroform extract the sample after the phenol-
chloroform extraction. Using this method the yield of single-
stranded DNA tended to be approximately 5-10 .tg DNA per 
millilitre of infected culture and was of sufficient quality for both 
DNA sequencing and site-directed mutagenesis reactions. 
2.4.12. Southern blotting procedures. 
Transfer of DNA from aga rose gels to a nylon membrane. The DNA was 
digested with the desired restriction enzymes, electrophoresed 
through agarose, stained and photographed as has been described 
above. The DNA fragments were depurinated by soaking the gel in 2 
volumes of 0.25 M HC1 with gentle agitation for 15 mm. The gel was 
then rinsed with distilled water and the DNA denatured by soaking 
in 2 volumes of 0.5 M NaOH/ 1.5 M NaCl with gentle agitation for 30 
mm. The gel the was rinsed again in distilled water and placed in 
neutralisation buffer (1.5 M NaCl, 0.5 M Tris-HC1 pH7.2, 1 mM 
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EDTA) for 15 min at room temperature with shaking. The last step 
was repeated. 
A sheet of HybondTMN+ membrane (Amersham) cut to the size of 
the gel saturated with 10 x SSC was placed on top of three sheets 
of blotting paper (saturated with the same buffer) on a clean glass 
plate. The pretreated gel was placed on top of the nitrocellulose, 
taking care to exclude any air bubbles; this was followed by a 
further three sheets of saturated blotting paper, and by another 
glass plate. The whole 'sandwich' was then inverted so that the 
glass plate which formed the base could. be  removed and a wad of 
dry paper towels placed on top. The whole structure was inverted 
again and weighted to provide even pressure and maintain good 
contact between the gel, nylon membrane, and paper towels. 
Transfer was allowed to continue overnight. After transfer was 
complete the membrane was removed, rinsed in 6x SSC for 2 mm, 
blotted dry, and the DNA was fixed by UV crosslinking. 
Pre-hybridisation of membranes. The nylon membrane was pre-
hybridised for 1-2 hours at 65°C in 20 ml of pre-hybridisation 
solution (typically 0.1 ml solution per cm 2 of filter) in a 
hybridisation oven. 
Hybridisation of membranes. A labelled DNA probe was boiled for 5 
min and cooled on ice before adding to the hybridisation tube into 
pre-hybridisation solution, and hybridisation was carried out at the 
same temperature overnight. 
The membrane was rinsed briefly at room temperature in Wash 
buffer. The membrane was then washed 3 times in 250 ml of Wash 
buffer for 10-15 min at 30°C. Membranes are then usually ready for 
exposure and detecting the presence of the probe DNA either by 
autoradiography, or by phosphoimaging analysis. 
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Solutions for Southern hybridisation. 
2OxSSC 
3MNaC1 
0.3 M sodium citrate 
Pre-hybridisation and hybridisation solution 
7% SDS (7 ml of 20% stock solution) 
0.5 M sodium phosphate buffer pH 7.2 
1 mM EDTA 
Wash buffer 
0.5% SDS 
0.5 M sodium phosphate buffer pH 7.2 
1 mM EDTA 
2.4.13. Amplification of DNA by polymerase chain reaction 
Polymerase chain reaction (PCR) was used for amplifying fragments 
of known DNA. Plasmid or chromosomal DNA was used as 
template. Oligonucleotide primers were obtained from various 
commercial sources. Vent DNA polymerase from New England 
Biolabs was used when higher fidelity of reaction was required, 
otherwise Taq polymerase from Promega was used. Buffer supplied 
by the manufacturer was used with each polymerase. Magnesium 
was usually present in Taq buffer. When using Vent polymerase, 
magnesium chloride was added to concentration of 2 mM. The usual 
reaction mix was as follows: 
Polymerase buffer (lOx) 	 5 p1 
dNTP mix (5 mM each) 2 p1 
Oligonucleotide primers 	 10 pmol each 
Thermostable DNA polymerase 	1 unit 
distilled water 	 to 50 p1 
Reactions were performed in a Techne thermal cycler in a volume of 
10-100 jtl with a layer mineral oil on top of the reaction mix. Typical 
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cycling parameters were denaturing at 94 ° C (95 ° C for Vent 
polymerase) for 1 mm, annealing for 1 min at the appropriate 
temperature for the primer-template pairs (usually 5-10 ° lower than 
theoretical Tm of the primers) and polymerisation at 72 ° C (75°C for 
Vent polymerase) for 2 mm (plus 1 min for every kb of template 
above 1,000 bases). 
2.4.14. Site-directed mutagenesis. 
Mutagenesis based on PCR. 
The described technique was used to mutagenise several bases in 
rpoD which were lying closely enough to BamH I site within this 
gene to be covered by one oligonucleotide, therefore the 
mutagenesis can be carried out in one step. A mutagenising primer 
had the BamH I site near its 5' terminus. The second primer for 
PCR was about 300 bp away on the template DNA, and between it 
and the first, mutagenising, primer there was a Xho I site. 
To optimise PCR the template concentration was increased 
approximately 100-fold over conventional PCR conditions 
(approximately 0.5 pM), the number of cycles was reduced from 25-
30 to 5-10, and a high-fidelity VentR DNA polymerase (New England 
Biolabs) was used. This steps would prevent clonal expansions of 
any undesired second-site mutations. 
After the completion of PCR and checking an aliquot on an agarose 
gel electrophoresis, the DNA was precipitated, digested with Xho I 
and BamH I and cloned into a plasmid (pTK1 11) which allowed for 
an enrichment of the ligation product. The ligation mixture was 
then transformed into DH5a competent cells, plasmid DNAs from 
three transformants were purified, and the region between Xho I 
and BamH I sites was sequenced. Unexpectedly, given a relatively 
short length of PCRed and cloned DN. and all the PCR optimising 
conditions, about a half of all the secuenced inserts had a second 
undesired mutation. The plasmids with the desired DNA sequences 
were used for further manipulations. 
W. 
Materials and methods 
Mutagenesis after Kunkel. 
E. coli strain BW313 which is dut-1 and ung-1 and therefore allows 
incorporation of uracils into phage M13 DNA was transformed with 
replicative form of M13mp18-14 DNA. A single plaque was picked up 
and propagated for approximately 5 hours at 37°C in 5 ml L-broth 
supplemented with 25 mg 1-1 uridine. 
After this the relative titres of the bacteriophage suspension were 
determined on strains BW313 (dut-1 ung-1) and TG1 (dut-1 ung-1). 
M13 lysate was diluted down to 10-10  (initial 1:100 followed 1:10 
dilutions). 100 j.il of each dilution from iO to 10-10  was mixed with 
200 pl  of overnight cultures of both strains, incubated for 10 min at 
37°C, after which 3 ml of molten top agar was added and the 
mixture was plated on L-agar. If the titre of strain BW313 is less 
than five orders of magnitude than that of strain TG 1, the phage 
particles would undergo another passage on BW313 cells. 
When uracil enrichment which is the ratio between titres of the 
phage on BW313 and TG1 strains was better than iO (after 5 
passages) the uracil-enriched single stranded DNA template was 
isolated. 
The mutagenesis was performed by annealing a 5-phosphorylated 
mutagenising oligonucleotide to the U-rich single-stranded 
template DNA (at a molar ration 20:1) in 1 x Sequenase buffer 
(USB) (total volume 20 pl) by placing the tube into a beaker with 
water at 75°C (20 0 above the theoretical T m for a primer) for 5 mm 
and then cooling slowly in the same beaker to 30°C for 
approximately 40 mm. 
To synthesise the second strand the following mixture was added 
to the reaction: 
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MgC12 200 mM 
IYFTO.1 M 
dNTPs 2.5 mM 
ATP 10 m 
T4 DNA ligase (Boehringer Mannheim) 







The reaction was incubated on ice for 5 mm, at 25°C for 5 min and 
at 37°C for 90 mm. After this the reaction was placed on ice, 80 .tl 
EDTA buffer (Tris-HC1 10 mM pH 8.0, EDTA 10 mM) was added to it, 
and 3-10 p.11 of it was used to transform 300 p.tl competent TG1 cells. 
Then 50-300 p1 exponentially growing TG1 cells were added, and 
the phage was plated out. Single plaques were picked up, single 
stranded and RF phage DNA was isolated and the region which 
would be further cloned was sequenced. All the sequenced phage 
DNAs contained desired and no secondary mutations. 
2.4.15. DNA sequencing. 
DNA sequencing was performed using the Dye Terminator Cycle 
Sequencing kits with AmpliTaq® Polymerase (Perkin Elmer). Gel 
images were analysed with Sequence Navigator computer package. 
2.5. Protein Techniques. 
2.5.1. Polyacrylamide gel electrophoresis of proteins. 
E. coli proteins were routinely separated using SDS-polyacrylamide 
gel electrophoresis with a discontinuous buffer system [Laemmli, 
19701. 7-12% resolving gel and 4% stacking gel were employed. The 
composition of typical gel solutions was as follows: 
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10% Resolving gel. 
acrylamide stock solution (40%) 	 6.25 ml 
4x resolving gel buffer 	 6.25 ml 
glycerol 50% 	 5 ml 
7.5% ammonium persuiphate (freshly prepared) 0.25 ml 
distilled water 	 12 ml 
TEMED 	 15 p1 
Total 	25m1 
4% stacking gel. 
acrylamide stock solution (40%) 	 1.0 ml 
4x stacking gel buffer 	 2.5 ml 
7.5% ammonium persuiphate (freshly prepared) 0.1 ml 
distilled water 	 6.3 ml 
TEMED 	 10 .tl 
Total 	10 ml 
These solutions were made up immediately prior to use, with the 
TEMED being added last before casting a gel. The depth of the 
stacking gel between the bottom of the comb and the resolving gel 
was about 1 cm. Once the resolving gel had been poured the 
stacking-gel solution was carefully poured on top of the resolving 
gel, the comb inserted and polymerisation allowed to occur. The 
comb was then removed and the wells washed out with lx reservoir 
buffer, which was also used to fill up the buffer chambers of the 
apparatus. The sample could be loaded onto the gel at this stage. 
Samples were mixed 1:1 with 2x PAGE-loading buffer, kept at 37°C 
for 1 hour or boiled for 3 min if the whole cell lysates were 
analysed, and centrifuged in a microcentrifuge for 5 min prior to 
loading. Gels were typically electrophoresed until the bromophenol 
blue dye-front had run off the bottom of the gel. Once 
electrophoresis was complete the gel was removed from the 
apparatus and stained. 
If stained with Coomassie, the gel was placed in staining solution 
for 45-60 min with constant gentle agitation. Gels were the 
transferred into destaining solution and left for anything between 
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2-24 h. For preservation, the stained/destained gel was soaked in 
destaining solution plus 5% glycerol for 30 min and dried down on 
blotting paper using a vacuum gel drier at 80°C for about 1 h. 
If reverse-stained [Fernandez-Patron et al., 1992], the gel was 
rinsed with water, incubated in 0.2 M imidazole, 0.1% SDS with 
agitation for 15-20 mm, rinsed with water again and incubated with 
0.2 M Zn2SO4 for 120 seconds exactly, after which the staining 
solution was rapidly diluted with water and the gel was rinsed. 
Solutions used in SDS-PAGE (glycine SDS-PAGE). 
4x stacking-gel buffer (0.5 M Tris) 
15.25 g of Tris base, dissolved in 200 ml distilled water, 
adjusted to pH 6.8 with concentrated HC1; 0.4% (w/v) SDS, 
made up to 250 ml, filtered and autoclaved. 
4x resolving-gel buffer (1.5 M Tris) 
45.5 g of Tris base, dissolved in 200 ml distilled water, 
adjusted to pH 8.8 with concentrated HC1; 0.4% (w/v) SDS, 
made up to 250 ml, filtered and autoclaved. 
1 Ox reservoir buffer 
30.2 g of Tris base, 144 g of glycine dissolved in 600 ml 
distilled water, made up to a final volume of 1 litre and 
filtered. SDS was added to 0.1% in the final lx buffer. 
2x PAGE loading buffer 
4x stacking gel buffer 	 0.125 ml 
10% SDS 	 0.300 ml 
50% glycerol 0.200 ml 
2-mercaptoethanol 	 0.050 ml 
0.1% bromophenol blue 	 0.200 ml 
Distilled water 	 0.125 ml 
Total 	1.0 ml 
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Stock acrylamide 
37 g acrylamide, 1 g NN'-methylene--bis-acrylamide, made up to 
100 ml with distilled water, filtered and stored at 4°C. 
Coomassie staining solution 
9% (v/v) acetic acid, 45% (v/v) methanol, and 0.1% (w/v) 
Coomassie brilliant blue. 
Destaining solution 
7% (v/v) acetic acid, and 5% (v/v) methanol. 
Tris-tricine SDS-PAGE. 
Tricine allows a resolution of small proteins at lower acrylamide 
concentrations than in glycine-SDS-PAGE systems. [Schagger and 
von Jagow, 19871. For each minigel (Hoeffer "Mighty Small" or 
BioRad "Mini Protean-II") the following solutions were prepared:: 
10% separating gel 
1.22 ml separating acrylamide (46.5% acrylamide/ 1.5% bis- 
acrylamide) 
2 ml gel buffer 
2 ml 50% glycerol 
0.78 ml water 
75p]. 10%APS 
7.5 gl TEMED 
Stacking gel: 
0.25 ml stacking acrylamide (48% acrylamide/ 1.5% bis- 
acrylamide) 
0.75 ml gel buffer 
2.0 ml water 
20p1 10%APS 
2 .t1 TEMED 
Both the stacking and separating gels were polymerised at the 
same time, and stacking gel was carefully poured directly onto the 
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separating gel. Each separating gel mixture was made separately 
and TEMED and APS were added right before pouring. 
Electrophoresis was carried out at 25-35 mA (constant current) per 
gel in minigel setup, and additional cathode buffer was added 
during the run. After electrophoresis was complete gels were 
stained as above. 
Solutions used in tricine SDS-PAGE. 
Anode buffer (+) (can be diluted from 10 x stock) 
200 mM Tris pH 8.9 
Cathode buffer (-) (can be diluted from 10  stock) 
100 mM Tris 
100 mM Tricine 
0.1% SDS (no need to pH, but it should be 8.25) 
Gel buffer 
3.0 M Iris pH 8.45 
0.3% SDS 
The pH of the anode and gel buffers are essential. 
2 x sample buffer, for 20 ml: 
5 ml 0.5 M Tris, pH 6.8 
4 ml 20% SDS 
1 ml 2-mercaptoethanol 
4 ml 50% glycerol 
0.004 g bromophenol blue 
6 ml water 
2.5.2. Western blotting procedures 
Western blotting was performed using a BioRad electrophoretic 
transfer. cell. The previously run gel was trimmed down by removing 
the stacking gel and placed on top of several sheets of blotting 
paper saturated in protein-transfer buffer (which is lx protein gel 
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reservoir buffer but without any SDS). A sheet of nitrocellulose 
saturated in the same buffer was placed on top of the gel excluding 
any bubbles followed by several more sheets of saturated blotting 
paper. The whole sandwich was secured in the transfer apparatus 
and transfer was allowed to continue at 30 mA for 14 hours. 
After this, non-specific binding sites were blocked by immersing the 
membrane in 5% blocking reagent (skimmed milk) in PBS-T buffer 
for one hour. The membrane was briefly rinsed twice with fresh 
changes of PBS-T, then washed three times, once for 15 min and 
twice for 5 mm, with fresh changes of washing buffer. All washing 
steps, as well as incubations with antibodies were performed at 
room temperature with gentle agitation. At least 200 ml of the 
buffer was used for each washing step. 
The membrane was incubated in the appropriately diluted primary 
antibody (mouse monoclonal antibody to E. coli 0-galactosidase, 
Boehringer Mannheim) for 1 hour. Dilutions ranged from 1:500 to 
1:2000. The incubation was performed in square plastic dishes with 
5 ml of antibody dilution. The washing step described above was 
repeated and the membrane was incubated in the secondary 
antibody (horseradish peroxidase conjugated anti-mouse Ig, 
Amersham) diluted 1:1000 for 1 hour. The filter was then removed 
and washed in PBS-T as before. 
The blot was removed and treated with 1:1 mixture of Amersham 
"ECU detection reagents, with just enough liquid to cover the blot, 
for 1 mm. Then the blot, excess liquid removed, was wrapped in 
SaranWrap and quickly exposed to a film. A series of exposures was 
performed, usually from 15 seconds to several hours. 
Phosphate buffered saline - Tween (PBS-T)pH 7.5 
di-sodium hydrogen orthophosphate anhydrous 








to 1 litre 
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2.5.3. Overexpression of proteins in E. coli cells. 
Overexpression of 	245-HMK Y425C , y L245-HMK S428C , 
(YA245-HMK Q437C, and i\245HMK K502C was carried out as followed. 
E. coli BL21(XDE3) cells were transformed with pTK413, pTK418, 
pTK420, and pTK422. Overnight culture of a purified transformant 
was diluted 1:100 in 1 1 L-broth supplemented with glucose 13-
15 g 1 and ampicillin 100 mg 1. The culture was grown in 11 
fermenter with constant aeration, and in a mid-log phase at 
A600 of 3-4 T7 RNA polymerase was induced by addition of IPTG to 
final concentration 1.5 mM. pH of the medium was kept within 7.4-
7.6 with automatic addition of concentrated HC1 or 10 M NaOH 
solutions. Cells were harvested 3 hours after IPTG induction and 
were ready for isolation of inclusion bodies. 
Overexpression of ScrP and MtgA was performed according to 
Khattar et al. [1994]. E. coli BL21(XDE3)pLysS cells were 
transformed with plasmids which have a gene encoding a protein to 
express under T7 010 promoter. Cells were grown in minimal 
medium supplemented with glucose (0.4%), thiamine (1 tg m1 1 ), 
ampicillin (100 pg m1 1 ), and chioramphenicol (20 jig m1 1 ) at 37°C 
until they reached A 600 0.7. Then 0.5 ml was removed from each 
culture, and the expression of the T7 RNA polymerase was induced 
by addition of IPTG to final concentration 0.5 mM. Incubation was 
continued for 30 min before rifampicin was added to final 
concentration 200 jig m1 1 host DNA polymerase. After 45 mm, each 
of the samples was pulse-labelled with 5 jiCi of [ 35S]methionine 
(Amersham) for 5 mm, after which cells were cooled on ice, 
harvested, and resuspended either in 200 j.tl of SDS-PAGE sample 
buffer, or subjected to further cell fractionation. 
2.5.4. Isolation of inclusion bodies. 
Cells were pelleted at 6000 x g at 4°C for 10 mm. Cell pellet was 
homogenised in 160 ml of lysis buffer, the mixture was lysed by 
ultrasonication, stirred at 4°C for 30 min and centrifuged at 
30,000 x g at 4°C for 20 mm. The pellet was washed twice with 80 
Materials and methods 
and 40 ml of NaDoc buffer, once with 40 ml of triton buffer, and 
centrifuged as above. The resulting pellet was dissolved in 20 ml of 
6M guanidine chloride in TGEB buffer. 
Lysis buffer: 
50 mM Tris HC1 pH8 (at 4°C) 
1 mM EDTA 
100 mM NaCl 
0.25 mM PMSF (Phenylmethylsuiphonyl fluoride) 
(stock solution 0.1 M in i-propanol) 
4 mg 11  Lysosyme 
NaDoc buffer: 
50 mM Tris HC1 pH8 (at 4°C) 
1 mM EDTA 
100 mM NaCl 
0.5% sodium deoxycholate 
Triton buffer: 
50 mM Tris HC1 pH8 (at 4°C) 
1 mM EDTA 
100 mM NaCl 
0.5% Triton X-100 
10 mM f3-mercaptoethanol 
TEB buffer: 
50 mM Tris HC1 pH8 (at 4°C) 
1 mM EDTA 
10 mM -mercaptoethanol 
TGEB buffer: 
TEB buffer with 5% glycerol 
2.5.5. Protein purification from inclusion bodies. 
After washing and denaturing inclusion bodies a novel procedure 
[Shimamoto et al., 1998] was applied for renaturing, in which a 
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protein solution containing 6 M guanidine chloride was diluted 2-
fold with glycerol to prevent precipitation during the dialysis, placed 
into dialysis tubing and dialysed against 10 volumes of 1:3 (v/v) 
mixture of TEB and glycerol at 4°C during 10-16 hours and 3-4 
changes of the outer solution during the dialysis. The dialysis was 
performed in 50 ml plastic tubes which were constantly rotated. The 
dialysis was monitored by the conductivity of the outer dialysis 
buffer. After the dialysis and centrifugation the protein solution 
was rapidly diluted against 10 volumes of 0.3 M ammonium 
sulphate in TGEB buffer, and the proteins were precipitated at 4°C 
by adding ammonium sulphate to 1 M. 
The proteins were dissolved in 6 M guanidine chloride/TGEB buffer. 
Phenyl-Toyop earl column with the bed volume 11 ml was 
equilibrated with 6 M guanidine chloride 0.9 M ammonium sulphate 
in TGEB buffer. Protein solution in 6 M guanidine chloride/TGEB 
buffer were loaded on the column and eluted with a 0.9 to 0 M 
gradient of ammonium sulphate in 6 M guanidine chloride/TGEB 
buffer. 
Fractions containing the least impurities were pooled, diluted 2-fold 
with glycerol to prevent precipitation during the dialysis, and 
dialysed as before against 10 volumes of 1:3 (v/v) mixture of TEB 
and glycerol. The proteins were stored at -20°C and rapidly diluted 
in reaction buffer before usage. 
2.5.6. Column chromatography. 
Chromatography was performed on ion exchange columns 
POROS HQ/M, POROS SP/M (PerSeptive Biosystems), with 0.2 to 
1 M NaCl gradient in TGEB buffer with 0.025% Tween-20, at flow 
rate 0.5 ml min 1 , total back pressure 1.2-1.4 mPa, using SMART 
system (Pharmacia). 
Chromatography on Superose 6 column (Pharmacia) was performed 
at 10°C in 0.2 M NaCl, 0.025% Tween-20 in TGEB, at flow rate 
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40 pd min 1 , total back pressure 1.2-1.4 mPa, using SMART system 
(Pharmacia). 
Chromatography on columns filled with hydrophobic resin Phenyl 
Toyopearl M (Tosoh, Tokyo) was performed under denaturing 
conditions using an HPLC system. Phenyl-Toyopearl column with 
the bed volume 11 ml was equilibrated with 6 M guanidine chloride 
0.9 M ammonium sulphate in TGEB buffer. Protein solution in 6 M 
guanidine chloride/TGEB buffer were loaded on the column and 
eluted with a 0.9 to 0 M gradient of ammonium sulphate in 6 M 
guanidine chloride/TGEB buffer. 
2.5.7. Protein concentration determination. 
Concentrations of proteins were determined by BCA protein assay 
(Pierce, Rockford). Calibration curves were constructed using 0-
2 mg m1 1 BSA in "outer buffer solutions", i. e. solutions against 
which a subunits were dialysed at the final of the purification 
process. Series of reactions were performed at room temperature 
for up to 60 min in microtitre plates and absorbance at 562 nm was 
measured. 
2.5.8. Preparation of total and outer E. coli membranes for 
protein analysis [K. Begg, pers. comm]. 
The bacterial cells (0.5 ml) were harvested by centrifugation (3600 g, 
10 min at 4°C) and the pellet was resuspended in 0.5 ml of a 
solution containing 10 mM Tris-HC1 pH 7.6, 5 mM EDTA, 250 !IM 
PMSF and 2 mM 2-mercaptoethanol. The cells were then lysed by 
sonicating four times for 15 sec each at a setting of 5-6 on the MSE 
sonicator with constant chilling on ice. Unlysed cells and other 
debris were removed by centrifuging as above and the resulting 
supernatant ultracentrifuged at 68,000 rpm. in a Beckman TLA100.2 
rotor for 1 h at 4°C. The membrane pellet was resuspended in 2 ml 
of the above buffer and ultracentrifuged as before. The pellet was 
then resuspended in 40 !il of the same buffer and was then ready 
for SDS-PAGE analysis of the resultant total membrane proteins. 
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For preparation of outer membrane proteins the above procedure is 
followed up to pelleting membranes for the first time. This pellet is 
resuspended in 0.5% Sarcosyl containing 250 j.tM PMSF by passing 
gently through a 23 gauge needle. The outer membrane is then 
pelleted by centrifuging for 1 hour at 100,000 x g. This pellet is 
resuspended again in 0.5% Sarcosyl/250 l.tM PMSF and centrifuged. 
This pellet was resuspended directly into the loading buffer for 
SDS-PAGE. 
2.5.9. Preparation of periplasmic protein fraction. 
The bacterial cells (0.5 ml) were harvested by centrifugation 
(8000 x g, 10 min at 4°C) and the pellet was resuspended in 125 jil 
of a solution containing 20% sucrose (w/v), 50 mM Tris-HC1 (pH 
7.4), 250 iM PMSF and 1 mM EDTA. The suspension was incubated 
on ice with shaking for 10 min after which the cells were harvested 
as above. The supernatant was removed and the thoroughly drained 
cell pellet resuspended, this time in 50 j.t1 of ice-cold 5 mM 
MgC12/250 jtM PMSF. Again the suspension was incubated on ice 
with shaking for 10 min and clarified by centrifugation. 
The remaining supernatant (termed the cold osmotic shock fluid) 
was then analysed on SDS-PAGE. The pellet was washed again 
with 5 mM MgC12/250 pM PMSF, re-precipitated, dissolved in the 
buffer for total membrane isolation. After precipitation of total 
membrane fraction the supernatant was concentrated by acetone 
precipitation (with 5 volumes of acetone) and resuspended in the 
loading buffer for SDS-PAGE. This solution was used as a 
"cytoplasmic fraction" on some protein gels. 
2.5.10. Hybrid a assay [Kumar et al., 1995a]. 
A hybrid gene encoding the amino-proximal 529 aa (or its 
derivatives) of the major E. coli a subunit, a70 ! 32 (including region 
2.4) followed by the last 82 aa of the heat-shock a protein, 0 32 
(including region 4.2) is present under the control of Plac On 
pHW 111 (or its derivatives). This plasmid also has a KanR  selection 
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marker. lacIQ, and p15A replicon. A reporter gene, lacZ, is present 
on the second plasmid, pMLHM::lacZ, under control of a hybrid 
promoter with regions -35 for &2  and -10 for 70•  pMLHM::lacZ has 
pMB 1 replicon and Amp   gene (Fig. 2.1). 
Plac 
  








Fig. 2.1. Two compatible plasmids, hybrid a donor pHW111 and reporter 
pMLHM::lacZ, used in the hybrid a assay. T and Ti are transcription terminators in 
both directions. H and M are -35 and -10 promoter elements for a 70 and a32 , 
respectively. 
NM570 strain carrying both hybrid a and reporter plasmids were 
grown in Spitzizen minimal glucose medium supplemented with 
thiamine, Amp and Kan, at 37°C. The cultures were then diluted to 
A600 0.08 with fresh warm medium and grown to A 600 0.6-0.7 in the 
presence or absence of IPTG (15 pg ml -1 ) at a required temperature. 
At this point samples were taken and assayed for 3-galactosidase 
activity, as described in the next section. The activity of a hybrid 
was determined as difference between activities of IPTG-induced 
and non-induced samples. These were compared against the 
activity of a "wild-type" hybrid a encoded by pHW 111. 
2.5.11. -ga1actosidase activity assay. 
The method used was essentially as described by Miller [1982]. 
Samples of either 0.5 ml or 0.1 ml (depending on -galactosidase 
activity of the strain) were taken and added to 0.5 ml or 0.9 ml of Z-
buffer, respectively. To permeabilise the cells Z-buffer contained 
0.005% SDS and in addition 15 p1 of chloroform was added to each 
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sample. The sample was vortexed for 10 seconds and could at this 
point be sealed and stored overnight at 4°C. 
To assay, 200 jil of 4 mg ml-1 ONPG (o-nitrophenyl-13-D-galactoside, 
Sigma) in 0.1 M MOPS (pH7.0) was added to each sample. The 
samples were incubated at 30°C until sufficient yellow colour (o-
nitrophenol) had appeared such that when 0.5 ml of 1 M Na2CO3 
was added to stop the reaction, the absorbance at 420 nm was 
between 0.1 and 2.0 (absorbance measurements are linear within 
this range). Samples were spun in a microcentrifuge to remove cell 
debris. The absorbance at 420 nm was determined. 
Total enzyme activity was calculated as: 1000 x A 420 / (t x V), where 
t is incubation time in minutes and V is the volume of the samples 
in millilitres (generally 0.5 or 0.1). 
The specific activity is defined as total enzyme activity divided by 
A600 of the culture at the time of sampling (i. e. enzyme units per 
total cell mass) and is expressed in Miller Units (MU). 
Z-buffer 	60 mM Na2HPO4 
40 mM NaH2PO4 
1 MM  MgSO4 
10 mM KC1 
0.005% SDS 
0.05 M -mercaptoethanol (3.51 ml per 11) 
2.5.12. Selection for kat (RpoS) phenotype. 
rpoS mutants have reduced expression of katalase activity in 
stationary phase as a result of decreased expression of as -
dependent katE gene. The production of oxygen upon addition of 
hydrogen peroxide was tested by adding 10 jil 3% H202 to 50 il of 
culture that had been grown overnight in L-broth. Bubbling (oxygen 
elevation) was exhibited by rpoS cells immediately upon the 
addition of the agent, but rpoS::KanR strain exhibit 
reduced/delayed activity [Farewell et al., 19961. 
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2.6. RNA polymerase techniques. 
Molar concentrations of RNA polymerase holoenzymes are 
concentrations of their core enzymes, the molarity of a a subunit 
shown as a proportion to the core. 
2.6.1. Promoter DNA templates for transcription. 
Preparation of T7A1 promoter DNA template was carried out as 
described before [Dunn and Studier, 1983] by PCR a fragment using 
pHR 1435 as a template. For the gel shift assays, one of the primers 
was end-labelled with y-[32P]ATP. The product was subjected to 8% 
native PAGE and stained with ethidium bromide. The band of 180 
bp was cut out of the gel, incubated overnight in 5 volumes of the 
running buffer at 4°C, and the DNA was extracted using QlAquick 
DNA purification columns. The concentration of the DNA was 
estimated by comparing the densities of ethidium bromide stained 
bands in agarose gel, with those of DNA standards. 
The template carrying XPR promoter having 32 bp initial A-less 
transcribed sequence instead of the original sequence was prepared 
by PCR of a 190 bp DNA fragment from ALl 130 template [Sen et al., 
1998; Kubori and Shimamoto, 1996]. The distance between the 
transcriptional start and the upstream end of the fragment is 85 bp, 
with the overlapping ?PRM  promoter being inactivated. 
2.6.2. In vitro transcription. 
Before carrying out transcription reactions, holoenzymes were 
formed by incubation of the core enzyme with a a subunit at ratio 
1:4 to 1:10 (as was earlier determined for every holoenzyme) in TI 
buffer at 37°C for 10 mm. Before adding substrates, RNA 
polymerase and DNA were pre-incubated for 10 min at 37°C in TI 
buffer. Transcription was carried out in 8 pl  of TT buffer by adding 
5 jiM 100 Ci mmol 1 of the initiating nucleotide [y- 32P]GTP, 100 tM 
UTP and CTP for A.PR promoter, or 5 pM 100-400 Ci mmol 1 [y-
32P]ATP and 100 iM of each of the other NTPs for T7A1 promoter, 
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for 20 mm. Heparin (40 jig m1 1 ) was added together with the 
substrates to prevent reassociation of released RNA polymerase 
with DNA. 
For pulse-labelling experiments, the unlabelled substrates (5 tM 
GTP, 100 jiM UTP and CTP) and 40 jig m1 1 of heparin were first 
added, and then after the indicated time the reaction was chased 
with 5 p.M 100 Ci mmol 1 [y-32P]GTP for 5 mm. 
Reactions were stopped by mixing with the equal volume of 
phenol/ chloroform/ isoamyl alcohol (25:24:1), the transcripts were 
separated on 20% polyacrylamide-7M urea gel. The gels were 
analysed and radioactivity was quantified on a BAS2000 Image 
Analyser (Fuji Film, Tokyo). 
TT buffer 
50 mM Tris-HC1, pH7.9 
100 mM KC1 
10 MM MgC12 
1mMDTT 
0.1 mg m1 1 partially hydrolysed casein 
0.025% Tween 20 
Gel electrophoresis of run-off transcripts. 
A DNA sequencing apparatus was used for separating RNA 
transcripts. The glass sequencing gel plates were thoroughly 
cleaned with detergent and ethanol, assembled using 0.2 mm 
spacers and taped together to minimise the possibility of leakage. 
The gel was prepared by adding together the following: 
40 % (w/v) acrylamide solution* 	 50 ml 
urea 	 43g 
1OxTBE 	 10 ml 
water to 100 ml 
ammonium persuiphate 10% w/v 	 1 ml 
TEMED 	 35 p.1 
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* 19:1 mix of acrylamide and N,N-methylenebisacrylamide 
This solution was poured between the sequencing plates. After 
polymerisation the gel was then clamped into the sequencing 
apparatus and lx TBE solution poured into the top and bottom 
reservoirs. The gel was then pre-run at about 50 W (-1500 V) for 1 h 
and then loaded with the sequencing reactions. The gel was then 
electrophoresed at 50 W until the blue dye-front ran off the end of 
the gel. Once electrophoresis was complete the top plate was 
removed and the gel was transferred to a sheet of wet blotting 
paper, covered with SaranWrap and dried in a vacuum gel-drier for 1 
h at 80°C. The gel was then analysed and radioactivity was 
quantified on a BAS2000 Image Analyser (Fuji Film, Tokyo). 
2.6.3. Gel-shift assay. 
Binary complexes were formed by incubation of RNA polymerase 
with 10 or 100 nM DNA in 10 pl TT buffer in the presence of 10% 
glycerol at 37°C for 10 mm. Samples were then loaded onto a 
running 4% native polyacrylamide gel containing 45 mM Tris-borate, 
pH 8.0, and 1 mM EDTA. The dye (30% glycerol, 0.2% bromophenol 
blue, 0.2% xylene cyanol) was loaded in a separate lane. If heparin 
was used, 0.5 il of 1 mg m1 1 heparin (to 50 pg m1 1 ) was added 15 
seconds prior to loading. The electrophoresis was carried out at 
20 mA at room temperature. The gels were analysed and 
radioactivity was quantified on a BAS2000 Image Analyser (Fuji 
Film, Tokyo). 
2.7. Sequence analysis. 
Most sequences were obtained from the EMBL, GenBank, SwissProt 
or TrEMBL databases. Sequence similarity searches were performed 
with BLAST2 programmes [Altschul et al., 19971 using usually 
network server at NCBI. Preliminary sequence data was obtained 
from The Institute for Genomic Research website at 
http://www.tigr.org . Sequences from the unfinished genome 
projects (as of September, 1999) were searched using the BLAST2 
programme at www.ncbi.nlm.nih.gov/BLAST/unfinishedgenome.  
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html; these sequences however still contained errors. The ClustaiW 
programme [Thompson et al., 19941 available at ClustaiW WWW 
Service at the European Bioinformatics Institute 
(www2.ebi.ac.uk/clustalw)  was used for multiple sequence 
alignment. 
Prediction of signal peptides of the proteins and their localisation 
was performed using SignaiP 1.1 [Nielsen et al., 1997] (at 
www.cbs.dtu.dk/services/SignaIP/)  and PSORT [Nagai, 1997-1999]  
(at http://psort.nibb.ac.jp:8800/)  programmes, the latter also uses 
other criteria than the presence of signal peptide to predict a 
peptide localisation. 
Prediction of transmembrane regions in polypeptides was performed 
using programmes linked to the ExPASy Molecular Biology Server. 
These include PSORT (see above), 
DAS [Cserzo et al., 19971 
at www.biokemi.su.se/-server/DAS/,  
TMHMM 1.0 [Sonnhammer et al., 1998] 
at www.cbs.dtu.dk/services/TMHMM-1.0/,  
TMpred [Hofmann and Stoffel, 1993] 
at www.ch.embnet.org/software/TMPRED-form.html,  
PHDhtm [Rost et al., 19951 at the Predict Protein server 
http://dodo.cpmc.columbia.edu/predictprotein/,  
HMMTOP [Tusnady and Simon, 19981 
at www.enzim.hu/hmmtop/, and 
SOSUI [Hirokawa et al., 19981 
at http://azusa.proteome.bio.tuat.ac.jp/sosui/.  
Hydrophobicity profiles were built with the ProtScale programme at 
the ExPASy Molecular Biology Server utilising Kyte-Doolittle [Kyte 
and Doolittle, 19821 hydrophobicity scales. 
2.8. Image analysis and densitometry. 
Quantitative results were obtained by comparing sample band 
intensities on the scanned blot images with samples of known 
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concentrations of a standard, using the NIH image 1.62b7 
programme (http://rsb.info.nih.gov/nih-image) . However, many 
protein measurements were not quantitative, and only relative 
amounts of proteins were measured. 
Analysis of gels carrying 32P or 35S label was usually performed on 
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3.1. Substitution of single rpoD codons for amino acid 
residues in regions 2.3, 2.4, 3.1 and 3.2 of Y 70 with cysteine. 
For this study several amino acid residues were chosen to be 
substituted with cysteines: Y421C, Y425C, Y425C W433A, S428C, 
Q437C, T440C, and S442C. These amino acids had been 
demonstrated to participate in promoter recognition (in the 70 
conserved region 2.4) or were suspected to be involved in promoter 
melting (region 2.3). Besides, substitutions to cysteine in these 
cases were thought unlikely to cause loss of Cy 70 activity, as was 
described in Chapter 1. If this is the case and these substitutions 
result in functional Cy70  proteins, then they can be used to probe 
the environments around these cysteines and study the contacts 
made with surrounding DNA as well as peptides, at different steps 
of promoter opening. 
The non-conserved K502 residue in region 3.1 was also chosen for 
study, as it lies close to the conserved P504 and S506 residues 
which play a role in abortive synthesis (Chapter 1). Similarly, the 
less conserved S517 residue in region 3.2 was chosen, as it was 
thought likely that it lies close to the transcriptional start, as 
confirmed later by Owens et al. (see Chapter 1). 
Several vectors were prepared as templates for site-directed 
mutagenesis. Firstly pTK2 10 and pTK310 were constructed. pTK210 
is a derivative of pGEMDA245 (an overproducer of 70(aa130_374)de1, 
referred to henceforth as GA245 [Kumar et al., 1995b] (Fig 3.1), in 
which the Xba I-Not I-Nsi I fragment is replaced with a Sac I 
restriction site (by using oligonucleotides RH7 and RH8). pTK3 10, a 
derivative of pGEMD (an overproducer of 70,  [Igarashi and 
Ishihama, 1991]), was constructed in exactly the same way. 
To facilitate the cloning of inserts carrying mutations, the BamH I-
Xho I regions of pHW111 (Fig. 2.1) [R. Hayward and 
H. S. Williamson, unpublished], pTK210 and pTK310 were replaced 
with a BamH I-Not I-Xho I linker (oligonucleotides N4356 and 
a studies 
N4357). The resulting plasmids were named pTK1 11, pTK21 1 and 
pTK311 (Fig. 3.1). 
Site-directed mutagenesis creating single and double amino acid 
residue substitutions in 070  (Y421C, Y425C, Y425C W433A, S428C, 
K502C, and S517C) was carried out by the Kunkel method (as 
described in 2.4.14), with bacteriophage M13mp18-14 (M13mp18 
with its Sac I-Pst I segment replaced with the Sac I-rpoD-HgiA I 
fragment of pSAK3 [Kumar et al., 19931) as a source of rpoD single-
stranded template DNA. Other mutations (Q437C, S442C, and 
T440C) were introduced by a PCR method (2.4.14), using pSAK15-
70/32 [Kumar et al., 1995a] as a source of rpoD DNA. The second 
primer for PCR mutagenesis was RH6, which contains the Xho I 
site of rpoD. The mutagenic primers are listed in Table 3.1. 
P/ac 	 BamH I Xho IC/a I 
pHW1 11, 
I 	 N 
_... V 	pSAK15-70/32 
II I Sac " "Sac II 	 BamH I Xho I Cla I 	
Hind III 
 
I 	I 	.. 	 i 	i ( HMKtaa 
pGEMD-HMK 
rpoD 
Sac II G0754 BarnH I Xho 1CIa I 
rpoD 
Figure 3.1. Strategy for site directed mutagenesis by PCR. 
- mutagenising primer. Restriction sites used for cloning mutagenised inserts 
are also shown. Primer used for sequencing are shown in the bottom figure. 
The DNA sequences of the BamH I-Xho I fragments from the 
plasmids and M13 phages produced by either methods were verified 
by sequencing using primers C308, G0752 and G0754 (Fig. 3.1). 
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Their BamH I-Xho I or BamH I-Cia I fragments were cloned into 
pTK 111 and pTK2 11, and some of them into pTK3 11, to produce the 
pTK1 18-pTK124, pTK218-pTK224, and pTK318-pTK324 series of 
plasmids (Table 3.1). The presence of the inserts was confirmed by 
restriction analysis using Not I and also Nde I, and, in the cases of 
pTK2 13, pTK2 15, pTK2 17, pTK2 18 and pTK2 19, by sequencing the 
inserted region using primer G0754. 























Wt  pHW111 pTK210 pTK310  
Y421C 2.3 NS14 TAC—TGC pTK124 pTK224 pTK324 pTK424 
Y425C 2.3 NS 12 TAC—TGC pTK122 pTK222 pTK322 pTK422 
Y425C 
W433A 
2.3 NS 13 TAC—TGC pTK123 
 TGG—>GCG  
pTK223 pTK323 pTK423 
S428C 2.3 NS10 TCC—.TGC pTK120 pTK220 pTK32O pTK420 
Q437C 2.4 RH1 CAG—TGC pTK1 13 pTK213  pTK413 
T440C 2.4 RH2 ACC—TGC pTK117 pTK217  pTK417 
S442C 2.4 R1-13 TCT—TGT pTK115 pTK215  pTK415 
K502C 3.1 RH4 AAA—TGC pTK118 pTK218  pTK418 
S517C 13.2 1 RH5 I TCG—*TGC I pTK119 1 pTK219 I pTK419 
Sac II-Xho I fragments of pTK213, pTK215, pTK217, pTK218, 
pTK2 19, pTK220, pTK222, pTK223, and pTK224 were cloned into 
pGEMD-HMK. pGEMD-HMK is pGEMD with a -2 kb insert between 
the Sac II and BamH I sites of rpoD, and an HMK (human muscle 
kinase)-tag coding sequence attached to the downstream terminus 
of the coding sequence of rpoD, and was kindly provided by H. 
Nagai. This resulted in the pTK413-pTK424 series of plasmids, 














and with a sequence encoding SARRASVA (RRASV is the amino acid 
sequence of the HMK-tag) attached to the downstream terminus of 
the gene: 
Eco047 III 	 Hind III 
rpoD agcgc tAGAAGGGCAAGTGTTgcataaGCTT 
SA R R A S VA * 
3.2. The in vivo activities of sigma subunits with single 
cysteine replacements. 
The effects of the mutations on the activity of cr were analysed in 
vivo using the hybrid sigma assay [Kumar et al., 1995a] described in 
2.5.10. The results of the assays in which pTK1 13-124 were tested 
against the pHW1 11 control are presented in Fig. 3.2. 
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Amino acid substitution in sigma 
Figure 3.2. Activities of hybrid a70 ! 32 subunits. The bars indicate ratios of 
activities of the hybrid sigmas with the designed cysteine replacements in the a 70 
portion, to the activity of the hybrid sigma a 70 ! 32 with the wild-type sequence of 
a70 and a32 . Left bars are activities at 37°C, right ones are at 42°C. The activities of 
a70132 Y421C d a70t32 Y425C W433A at 37°C are zero. Error bars show the standard 
error of the ratios for measurements at 37°C. The data for 42°C are the mean of two 
measurements. N/A - these proteins were not assayed at 42°C. 
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As seen from Fig. 3.2, the hybrid 70/32 subunits carrying single 
cysteine replacements Y425C, T440C, K502C, and S517C exhibit 
activities 1.05-1.12 that of the hybrid 70/32  with the wild-type 
sequence at the hybrid promoter at 37°C. The hybrid y 70 / 32 
subunits with the S428C, S442C, and Q437C substitutions show 
activities lower than that of the wild type 70/32  with values of 
0.57-0.84 that of 70/32•  However, the hybrid 70/32  with Y421C and 
double Y425C W433A substitutions are inactive at 37°C. This was 
quite unexpected for Y42 1 C hybrid sigma, because Q70(R588H Y42 1C) 
retained 45% activity compared to y7O(R588H)  at mutated promoter 
antL-33A in vivo [Waldburger and Susskind, 1994]. On the other 
hand, despite of examples of functionality of sigmas with W433 
substitutions, Juang et al. [1995] showed that A(W192A)  of 
B. subtilis was defective in nucleation and propagation of the 
melted region of PtrnS promoter in vitro (W192 of A  corresponds to 
W433 of 70),  and overexpression of yA(W192A)  in vivo was lethal to 
cells [Rong and Helmann, 19941, as was mentioned in Chapter 1. It 
is also possible that, even if Y425C and W433A substitutions 
separately would not make 070  inactive, the double substitution 
could severely damage its ability of promoter melting as these two 
residues are present on the same side of a-helix in the crystal 
structure of a portion of [Maihotra et al., 19961. 
3.3. Hydrophobicity of 245MK and its derivatives with 
single cysteine replacements. 
All the 245  overproduction plasmids (pTK2 1 8-pTK224 series) were 
checked for their ability to overproduce proteins of the expected 
size (2.5.3). As seen from the Fig. 3.3, all the plasmids express 
proteins (245  and its derivatives) of the same apparent molecular 
mass of 59-62 kDa, whereas their calculated molecular mass is 
42 kDa (the estimate of GA245  mobility of Kumar et al. [1995b] is 
55 kDa). The anomalous mobility of cyL 245 on SDS-PAGE is 
consistent with anomalous SDS-PAGE mobility of 70  (86-95 kDa) 
and GA  (55 kDa) [Shorenstein and Losick, 19731, with their 
calculated molecular masses being 70 and 43 kDa, respectively. 
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Four GA245  proteins with single cysteine replacements, namely with 
	
L245-HMK Y425C , 	245-HMK S428C , 	245HMK Q437C, and 
CyA245-HMK K502C, were overproduced and purified according to the 
protocol described in 2.5.3.-7. a 70-HMK [Nagai and Shimamoto, 1997] 
and yE245-HMK  were purified by H. Nagai. 
a 
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Figure 3.3. 10% SDS-PAGE of BL23(XDE3)plysS total cell extracts carrying 
pTK210 or its derivatives pTK213, pTK215, pTK217, pTK218. pTK219, pTK220, 
pTK222, and pTK224. The cells were grown to A 600 0.6, were not induced (IPTG -) 
or induced (IPTG +) with 125 mg 11  (gel a) or 25 mg l- (gel b) IPTG and incubated 
for further 3 (gel a) or 1 (gel b) hour, before harvesting. Arrows indicate bands of 59-
62 kDa corresponding to the induced proteins, derivatives of a 6245 . M - molecular 
mass markers (kDa), their corresponding molecular masses are on the left of the gels. 
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Overproduced cyt\245-HMK  and its single cysteine replacement 
derivatives form inclusion bodies in E. coli cells. These inclusion 
bodies were purified and denatured in 6 M guanidine chloride 
solution. During the refolding step, when the guanidine chloride 
solutions were dialysed against TGEB buffer and further against 
0.5 M ammonium sulphate in TGEB, the solutions became turbid 
even during the early steps of dialysis indicating of hydrophobicity 
Of 245-HMK and its derivatives. A novel procedure [Shimamoto et 
al., 19981 was applied at this stage, in which a protein solution 
containing 6 M guanidine chloride was diluted 2-fold with glycerol to 
prevent precipitation during the dialysis, and dialysed against 10 
volumes of 1:3 (v/v) mixture of TEB and glycerol at 4°C during 10-16 
hours, with constant rotating and 3-4 changes of the outer solution 
during the dialysis. The dialysis was monitored by the conductivity 
of the outer dialysis buffer. The dialysed solution was transparent, 
whereas when the dialysis was performed against mixture of 1 part 
of TEB buffer and 1 part of glycerol, the dialysed solution became 
turbid, indicative of protein precipitation. 
After the dialysis and centrifugation the protein solution was 
rapidly diluted against 10 volumes of 0.3 M ammonium sulphate in 
TGEB buffer, and the proteins were precipitated at 4°C by adding 
ammonium sulphate to 1 M. The proteins were dissolved in 
0.2 M NaC1 in TGEB buffer. These solutions, with estimated 
concentrations of 10-14 mg m1 1 , become opaque and then gelled 
after 3-4 days at 4°C. Addition of Tween-20 to 0.025% reverses the 
polymerisation process. 
The protein solutions were subjected to fractionation on a Phenyl 
Toyopearl (L\245HMK) (H. Nagai) or a POROS-HQ/M 
( yL245HMK Y425C and 245HMK S428C) chromatographic columns. 
(yA245-HMK could not been eluted from the hydrophobic Phenyl 
Toyopearl column by the 1.5 to 0 M ammonium sulphate gradient in 
TGEB buffer (H. Nagai). The fractionation of i\245HMK Y425C and 
yi245HMK S428C on POROS-HQ/M column with 0.2 to 1 M NaCl 
gradient in TGEB buffer with 0.025% Tween-20 was poor, these 
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proteins were eluted together with the whole mixture of injected 
proteins (Fig. 3.4). 
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Figure 3.4. Chromatograms of a 24 5 - HMK S428C and at245HMK Y425C and SDS- 
PAGE of their chosen fractions underneath. POROS-HQ/M column, loaded at flow 
rate 2 ml min 1 , elution by 0.2 to 1 M NaCl gradient in TGEB buffer with 0.025% 
Tween-20 at flow rate 0.5 ml min -1 . 0.5 .i1 of the shown fractions are separated on 
10% SDS-PAGE and the gels are reverse-stained. Several protein bands present in 
the loading solution (S) co-fractionate with a 245MK S428C and a 245 MK Y425 • 
Considering the poor fractionation of re-folded \245-HMK and its 
derivatives on the anion-exchange column and poor solubility in 
TOEB buffer due to high hydrophobicity, an attempt was made to 
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use another technique of fractionating a24 5- HMK derivatives on a 
hydrophobic Phenyl-Toyopearl (medium) column in a denatured form 
(chapter 2.5.6). 
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Figure 3.5. The chromatogram of a 245 HMK Q437C mixture and SDS-PAGE of 
chosen fractions. Phenyl Toyopearl (Tosoh, Tokyo) column was equilibrated with 
0.9 M ammonium sulphate 6 M guanidine chloride in TGEB buffer, elution by 0.9 to 
0 M ammonium sulphate gradient in 6 M guanidine chloride/TGEB buffer. 0.5 il of 
several fractions are separated on 10% SDS-PAGE and the gel was reverse-stained. 
S - loading solution; fractions 26-35 (underlined) were pooled. 
Protein solution (245HMK Y425C , i\245HMK S428C , 
A245HMK Q437C, or y A245-HMK K502C) in 6 M guanidine 
chloride/TGEB buffer were loaded on the column and eluted with a 
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0.9 to 0 M gradient of ammonium sulphate in 6 M guanidine 
chloride /TGEB buffer (Fig. 3.5). 
Fractions containing the least impurities were pooled, diluted 2-fold 
with glycerol to prevent precipitation during the dialysis, and 
dialysed as before against 10 volumes of 1:3 (v/v) mixture of TEB 
and glycerol. The protein concentrations in the resulting solutions 
was determined by BCA protein assay (2.5.7). The proteins were 
stored at -20°C and rapidly diluted in reaction buffer before usage. 
The dialysis against 75% glycerol is a novel technique for 
solubilisation of hydrophobic proteins (see Appendix). However, at 
such high glycerol concentration some the protein folding may not 
be complete. Measurements of activity of i\245-HMK  and its 
derivatives described below show that at least some fraction of the 
proteins is active in vitro. 
3.4. Reversibility of oligomerisation of 245M1C and of its 
single cysteine replacement derivatives. 
In order to determine the size of the purified cyL245HMK it was 
subjected to gel filtration on Superose 6 column. The chromatogram 
is shown on Fig. 3.6, a. Each eluted fraction was analysed by SDS-
PAGE (Fig. 3.6, b). The major peak of eluted yi\245HMK  corresponds 
to the void volume (fraction 11) of this column, which indicates that 
the number of molecules in aggregates in this fraction is not less 
than 45 (the column was calibrated by H. Nagai), whereas y70HMK 
and B. subtilis A  with a His-tag on its C-terminus are eluted at 
volumes corresponding to 117 and 62 kDa, (the data and column 
calibration by H. Nagai), which is molecular weight more than their 
monomer (70 and 43 kDa), but less than their dimer forms. 
The right shoulder of the major peak on the chromatogram in Fig. 
3.6, a (fractions 12-20) indicates the presence of oligomers of sizes 
up to about 650 kDa, that is not less than 12-mers. The peak at 
fractions 27 corresponds to molecular sizes about 53 kDa, and peak 
is: 
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at fraction 35 is not a protein peak (presumably 3-mercaptoethanol 
is eluted and detected at 280 nm in fraction 35). 
Fraction 11 (eluted with the void volume of the column) was kept at 
4°C for 2 hours and then re-injected onto the Superose 6 column 
(Fig. 3.6, b). The eluted fractions were analysed by SDS-PAGE, and 
the relative intensity of the 0,6,245HMK  was measured by 
densitometry (Fig. 3.6, c and ci). This was done to show which peaks 
on the chromatogram actually correspond to protein peaks. 
Fractions 22 (molecular mass about 400 kDa) and 29 (approximately 
29 kDa, presumably the monomer form of Ø245-HMK)  contain 
(YA245-HMK too, and this indicates that during 2 hours at 4°C in the 
elution buffer (0.2 M NaCl, 0.025% Tween-20 in TGEB) the 
equilibrium between high size oligomer and oligomers of smaller 
sizes (8-10-mer) and monomer, is shifted towards the monomer 
form, i. e. the oligomerisation of 245HMK  is reversible. Similar 
chromatograms were obtained for i\245HMK Y425C and 
245-HMK S428C 
When the core RNA polymerase ((X2') is subjected to 
chromatography on the Superose 6 column under the same 
conditions, it is eluted in fraction 22 which corresponds to 
approximate molecular mass of 450 kDa (calculated 378 kDa). The 
mixture of preincubated (10 minutes at 37°C) core enzyme and 
CYA245-HMK (1:4) is eluted in fraction 20, which corresponds to 
approximate molecular mass 500-550 kDa. This indicates binding of 
yL\245-HMK to the core enzyme, however, the number of 245HMK 
molecules bound is unclear from this experiment. The peak of 
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Fig. 3.6. a) Chromatogram of 30 tg 245-HMK in 20 i1 of elution buffer 0.2 M NaCl, 
0.025% Tween 20 in TGEB, 40 .tl mm -1 , 10°C, total back pressure 1.2 to 1.4 MPa. 
Detection at 280 nm (bottom line) and relative conductivity (top line) are shown. b) 
Chromatogram of fraction 11 of the previous chromatography, under the same 
conditions. The fraction was kept at 4°C for 2 hours before re-applying. c) SDS-PAGE 
of fractions 10-39 of the chromatography b; inj, 3 jil of the injected fraction 11. The gel 
was reverse-stained, the relative amount of aA 245 HMK in every lane was determined 
by densitometry and plotted on the graph d. 
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3.5. Activity of E245HMK  and the derivatives in vitro. 
i\245-HMK and its four single-cysteine replacement derivatives were 
titrated against the core enzyme to determine the saturating molar 
ratio of the core enzyme to a subunits at which transcription 
occurs. This assay measured transcription in vitro using the T7A1 
promoter template. The analysis was performed with 30 nM 
promoter template, 40 nM core enzyme and a subunits 
concentrations from 40 to 800 nM. The working ratio of the core 
enzyme to a a subunit at which saturation of full-length transcripts 
occurs is 1:4 for cyl\245 - HMK and A245-HMK Q437C, 1:8 for 
y L245HMK K502C, 1:10 for 245HMK S428C, and 1:15 for 
(yA245-HMK Y425C In these proportions the a subunits were further 
used in the reconstituted holoenzymes; the molar ratio of the core 
to cr70 and y70HMK was 1:4. 
3.6. T7A1 DNA promoter binding and open complex formation. 
To determine how 	245HMK and its four single-cysteine 
replacement derivatives bind T7A1 promoter DNA and form open 
complexes, gel shift assays of the reconstituted holoenzymes (from 
0 to 100 nM) with 10 nM of T7A1 promoter DNA was performed. 
Heparin was added to the reaction mixture before the loading to 
bind all non-specifically bound to the DNA holoenzyme, as well as 
the specific promoter-polymerase complexes non-resistant to 
heparin (closed complexes). The dried gels were subjected to 
phosphoimaging analysis, and the amount of bound DNA was 
plotted against the holoenzyme concentration (Fig. 3.7 and 3.8). It 
can be seen from the figure that E 245HMK Y425C and 
E245MK S428C, which have a subunits with cysteine 
replacements in region 2.3, have reduced ability to form heparin-
resistant open complex, whereas E 245HMK , E245 MK Q437C , 
and E.a245-HMK K502C all form heparin-resistant open complex with 
the core enzyme similar to E 70 . The apparent KD for 
E.245HMK Y425C, which is hard to determine here, is the lowest to 
compare to all the other enzymes tested here. 
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It has also been shown that the molar ratio of a subunit to the 
core in case of yA245HMK  and its four single-cysteine replacement 
derivatives is 1:1. Gel-shift assays of the holoenzymes and of E 70 
with T7A1 promoter DNA with and without the addition of heparin 
were performed. The gel bands were visualised using a BAS2000 
Image Analyser, and the shifted DNA bands were cut out of the 
native gel and subjected to SDS-PAGE, together with the known 
amounts of E 70 holoenzyme. The gel was reverse-stained, and the 
ratio of intensity of a to a subunit bands in each track was 
measured. The data indicated that the amount of a subunit per core 
enzyme in the heparin-resistant complex of the holoenzyme with 
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Figure 3.8. a) The gel-shift assays for holoenzyme concentrations 100 nM in Fig. 
3.7. b) The gel-shift assay corresponding to E 	45HMK data in Fig. 3.7. 
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3.7. The activity of E245HMK  and the derivatives from T7A1 
and XPR promoters in vitro. 
The activity of the reconstituted holoenzymes was studied on two 
promoters - T7A1 and ?,PR. The results for the T7A1 promoter where 
the DNA is present in excess are shown in Fig. 3.9. In the presence 
or absence of heparin, the HMK tag on the C-terminus of 70  does 
not affect the transcription from the T7A1 promoter. However, the 
transcription by E 245HMK is only about 0.18 of that by E 70 , in 
presence or absence of heparin. Therefore, on the T7A1 promoter 
E.a245HMK is less efficient than E 70 and E70M(  in the steps 
following promoter opening. Transcription from T7A1 promoter by 
holoenzymes with single cysteine replacements of i245HMK  does 
not differ much for the K502C substitute, is somewhat lower for the 
Y425C and S428C substitutes, but is significantly lower for 
CyA245-HMK Q437C The latter result is, although consistent with the 
earlier observations that Q437 is involved in promoter recognition 
at position -12 (described in Chapter 1), is inconsistent with the 
relatively high rate of formation of a heparin-resistant complex with 
this promoter described in the previous section. If Q437 is involved 
in binding single-stranded non-template strand with specificity to a 
nucleotide at position -12 of a promoter (T in a consensus 
promoter, U in case of T7A1 and XPR promoters), then the reduction 
of transcription level is expected to be due to the defect in binding 
the non-template strand in the open complex, which is presumably 
observed as a heparin-resistant complex in gel shift assays. In our 
case it seems that the heparin-resistant (open) complexes 
E.245HMK Q437C forms with T7A1 promoter are different from a 
productive open complex and are defective in both productive and 
abortive transcription. 
The ratio of abortive (6-mer) to the full-length transcript under this 
conditions (in the presence of heparin) is similar for E 70 , 
E70HMK, E 245-HMK and its derivatives (Fig. 3.9c). In a multiple- 
round transcription, when heparin is not added to the reaction, this 
ratio is similar again for E&0, E 70 MK and E245 1 MK. 
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The transcription from A,PR promoter was conducted under two 
conditions - with the excess of RNA polymerase and with the 
equimolar amounts of DNA and enzyme. The results are presented 
in Fig. 3.10. When the enzyme is in excess (10 nM promoter DNA 
and 100 nM of RNA polymerase) the deletion of 245 amino acid 
residues from Cy 70 does not make any difference for the level of 
transcription from XPR promoter. Only E 245HMK Q437C exhibits 
the low level of transcription of all the holoenzymes tested, about a 
half that of E 70 . 
The ratio of abortive to the full-length transcript is lower for 
E245MK and its derivatives than that for E70MK  under the 
conditions of excess of a holoenzyme. This can indicate that the 
abortive complex E 245 HMKabort P is weaker than the productive 
complex E 2454dMKprodP under these conditions, while 070  forms 
more abortive complexes per productive complex. 
Under conditions when holoenzymes are not in excess, E245-HMK 
and its derivatives E 245HMK S428C and E 245-HMK K502C do not 
differ significantly in their ability to transcribe from this promoter, 
comparative to E 70 and E 70HMK E  245HMK Y425C and 
E245HMK Q437C show levels of the full-length transcripts much 
less than E.245HMK. The data for single cysteine substitutes of 
(yA245-HMK are from the single experiment, and need confirmation. 
The level of transcription by E 245HMK Q437C is, however, 
consistent with the data where the enzyme was in excess, and with 
the data from transcription from T7A1 promoter described above. 
3.8. Abortive synthesis from XPR promoter. 
As it has been shown previously, E070 is able to produce abortive 
transcripts for some time in vitro after the productive transcription 
had been completed [Kubori and Shimamoto, 19961. An example of 
this is demonstrated on the first gel of Fig. 3.11. On XPR promoter, 
the production of the full length 32 nt transcript ceases after 5 
minutes of the reaction, while the production of abortive 
transcripts continues beyond 20 minutes of reaction. The same is 
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true for E70MK. However, for E 245HMK ,  although the abortive 
complexes survive a little longer than the productive ones, the 
synthesis of both abortive and productive transcripts stops by the 
tenth minute of the reaction (Fig. 3.11). This means that the 
abortive complex E 24SHMKabort •P does not stay on the promoter 
for as long as EY70abortP or E 70  MKabort •P, and the reaction of 
formation of an abortive complex is reversed back to E + P 
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Figure 3.9. a) and Transcription reactions from T7A1 promoter DNA. DNA 
concentration 200 nM (tracks 1-7) and 100 nM (tracks 8-13). The a subunits 
used in each reconstituted holoenzyme, presence or absence of heparin and 
concentrations of holoenzymes are shown on the top. 425, 428, 437, and 502 
stand for UA245 HMK with corresponding amino acid residue substituted for 
cysteine. The ratio of abortive transcript (6-mer) to the full length transcript is 
close to that for the wild type enzyme for all the enzymes used here. b) The 
amount of full length transcript produced relative to the wild type holoenzyme 
in the absence of heparin. c) The amount of abortive (6-mer) transcript relative 
to the full length transcript (in the absence of heparin). 
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Figure 3. 10. Transcription from XPR promoter by reconstituted RNA polymerases with indicated 
a subunits in the presence of heparin. a) and b) RNA polymerase 10-100 nM, promoter DNA 
10 nM; means and standard errors of 3-6 experiments, a) Amount of full length transcripts 
relative to that by wild type enzyme. b) Ratios of abortive (9-mer and 5-mer) transcripts to the full 
length transcripts. c) and d) RNA polymerase 125 nM, promoter DNA 125 nM; means of 2 (E'0 70 , 
E'a70HMK and EyA245- HMK) and 1 (all the rest) experiments. d) a gel as in c). 
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Figure 3.11. Pulse chase assays of Ea70 , E.(y70- HMK and E.aA245 -HMK (100 nM) 
on 100 nM XPR promoter DNA. After the formation of open complex, the 
transcription was started by adding unlabelled NTPs and heparin, and after 
indicated time the reaction was chased with the IY 32 P1GTP (see Chapter 2). 
The reaction products were separated by 20% Urea-PAGE, visualised and 
quantified. a) Gel images of the reactions for the different holoenzymes. The 
reaction substrates (without DNA and RNA polymerase) are run in the first 
tracks of every gel. b) Amount of the full length chased transcripts relative to 
that at 0 minutes after the addition of labelled substrate. c) Ratios of amount 
of the full length transcript to that of abortive transcript during the pulse 




3.9. Sensitivity of both productive and abortive complexes to 
heparin. 
To address the question of sensitivity of productive and abortive 
complexes to heparin, and, therefore, of stability of these 
complexes, they were challenged with heparin for different times 
before the reaction of transcription was started by the addition of 
NTPs (Fig. 3.12). The results indicate that the reaction of formation 
both E L 245 •HMKabort•P and EY 245 MKprod•P is more reversible 
than those for EY70abortP and EiY70prodP, and E 7 HM'< abortP 
and E 70 M%rodP. 
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Figure 3.12. Heparin sensitivity of productive and abortive transcription 
complexes of RNA polymerases with XPR promoter to heparin. 100 nM ?PR promoter 
DNA was incubated with 100 nM holo-RNAP for 15 min to form open complex. Then 
heparin was added to concentration 40 mg m1 1 , and alter 0 to 15 min incubation 
the transcription was started by addition of NTPs as described in 2.6.2. The 
reaction was stopped after 20 mm, the reaction products were separated by 20% 




The purpose of this project was to study several chosen amino 
acids in conserved regions 2 and 3 of G 70 and analyse their 
positions relative to promoter DNA, other regions of &O  and other 
subunits of RNA polymerase during the binding of sigma to core 
enzyme, and the forming of closed and open complexes with 
promoter DNA. The proposed technique suggested using a cysteine-
free sigma and substituting the amino acids of interest with 
cysteine residues. A cysteine-free version of Cy 70 , yi245, earlier 
shown to be a functional enzyme, was chosen for the study. 
However, it appeared that 245  had properties which were different 
from those of 70,  and therefore it transpired that it was not 
entirely suitable for studying the functional mechanisms of &0.  In 
the meantime several publications have appeared where this 
technique was successfully used in 070  where all three natural 
cysteines were substituted with alanines [Owens et al., 1998a; 
Owens et al., 1998b; Bown et al., 1999; Traviglia et al., 19991. In this 
work we concentrated on the effects of the deletion of 245 amino 
acids between conserved regions 1.2 and 2.1 in G70,  and the 
importance of several amino acids in conserved regions 2.3, 2.4, 3.1 
and 3.2 on the function of the subunit. 
70 and 70HMK  of E. coli and 	of B. subtilis are soluble and 
predominantly exist in a monomeric form in aqueous buffers, 
including 0.2 M NaCl or 0.5 M ammonium sulphate in TGEB, which 
is in contrast to hydrophobic nature of 245HMK•  They also do not 
bind hydrophobic chromatography columns (Phenyl Toyopearl) 
irreversibly, and do not precipitate during in vitro refolding when 
their solution in 6 M guanidine chloride in TGEB is dialysed against 
TGEB buffer or 0.5 M ammonium sulphate in TGEB [Burgess, 1996; 
Nagai and Shimamoto, 19971. (y70 is known to have some 
hydrophobic properties. For example, upon its purification there is 
always a portion of protein in an oligomeric form, together with a 
monomeric form, which has to be purified [Burgess, 19961. The 
monomeric form of Cy70 is stable in aqueous buffers at 4°C. The 
equilibrium between monomeric and oligomeric forms is, however, 
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shifted significantly towards the oligomeric form for yL\245-HMK,  as 
has been shown in this work. CA,  the major a factor of B. subtilis, 
does not have a spacer domain between its conserved regions 1.2 
and 2. 1, but is a soluble monomeric protein in vitro. 
Lowe et at. [1981] showed that C70  forms filaments in vitro when 
heated to temperatures above 49°C. 070 subunit isolated from 
rpoD800 (a temperature sensitive allele) strain of E. coli which 
carries a deletion of aa 330-343 in the z245 domain, is capable of 
forming filaments when incubated at temperatures above 37°C in 
vitro. Increasing glycerol or NaCl concentrations reduces the ability 
of rpoD800 a to filament. Filamentous rpoD800 C70  is inactive, but 
denaturation of these filaments in 6 M guanidine chloride and then 
refolding leads to restoration of a activity. It was suggested that 
filamentation is a possible route to inactivating C70  under heat-
shock conditions, by preventing CF70  from interacting with the core 
enzyme and thus allowing the heat-shock specific &2 to interact 
with core RNA polymerase and transcribe the genes of the heat-
shock regulon. An evidence that the deletion of aa 330-343 
(rpoD800 70)  changes properties of 070  is that rpoD800 C70 becomes 
accessible to attack by the La protease under the heat shock 
conditions [Grossman et at., 19831. It can be that the protease 
recognises a filamentous form of rpoD800 or a transitional 
(from active to inactive) form of it. 
Recent work in N. Shimamoto's laboratory has demonstrated that 
i\245HMK oligomers are also filamentous and, therefore, one 
possibility is that the deletion of the 245 residues leads to the 
exposure of two hydrophobic sites in the rest of a, which causes its 
oligomerisation by filamentation. It is also possible that the 245 
residue domain prevents &0 from ifiamentation at normal growth 
temperatures in vivo. The deletion present in rpoD800C70  is only a 
small part of the A245 region; 245, however, seems to be much 
more hydrophobic than rpoD800 C70  which could be easily refolded 
from 6 M guanidine chloride solutions by dilution, and is eluted 
from a gel filtration column as a monomer [Lowe et at., 19811. This 
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suggests that further deletion of the amino acids in A245 region 
increases overall hydrophobicity of &. 
In the X-ray crystal structure of U70  fragment (residues 114-442) 
[Malhotra et al., 1996] amino acids 330-343 (not present in 
rpoD800 70) form a loop between helices 10 and 11, and a part of 
helix 11. This part of the 245 aa domain may be contacting one of 
the hydrophobic patches elsewhere in 70  outwith the crystallised 
fragment, thus normally preventing it from exposure to solvent. 
From comparison of hydrophobicity analyses of GA245  and GA [Kyte 
and Doolittle, 19821 it is not easy to foresee if 245 has more 
pronounced hydrophobicity than GA, and so the reason for the 
tendency of 245  to exist in multimeric forms is unclear from the 
sequence data alone. However, the 245 aa domain in CF70 has a very 
acidic region the role of which is not clear, but presumably this 
stretch of negatively charged amino acid residues (D and E) 
influences the relative positions of other 070 domains in the free 
protein. 
As was mentioned in Chapter 1, in the crystal structure of the 70 
fragment [Maihotra et al., 19961 the 245 amino acid residue segment 
between regions 1.2 and 2.1 consists of several a-helices. Therefore 
by removing these residues from the protein one would expect the 
overall a-helix content of the protein to be reduced. It also seems 
likely that this deletion would not be expected to cause a 
significant change in the structure of the rest of the protein. The 
reduction of a-helix content was indeed observed by Smillie et al. in 
CD studies of (y 70 and 245 (unpublished work by D. A. Smillie, 
M. K. Kumaran, R. S. Hayward, S. Kelly and N. Price). However, 
they also observed that the deletion of the 245 residues caused an 
increase in total f3-sheet content in the rest of the protein by at 
least 23% in the absence of a detergent, which is a radical change 
in the structure of the cy subunit. In the presence of 0.1% SDS 70 
has an increased content of 13-sheet, (estimated 115 amino acid 
residues against 37 in the absence of SDS), closer to that in 245 
both in presence (133 aa) or absence (122 aa) of the detergent. A 
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possible interpretation of the results was that the 245 residues 
domain confers a constraint to the structure of U70  thereby 
preventing some part of it from forming a 13-sheet, and that SDS 
reduces the effect of the 245 residues domain in restraining the 
structure of 70•  It is possible that, with SDS present in solution, 
070 can adopt a favourable 13-sheet-rich conformation and expose 
some of its hydrophobic residues normally inaccessible to solvent 
in the free &0. 
As was mentioned in Chapter 1, the 70  subunit changes its 
conformation upon binding to the core RNA polymerase, and further 
does so when the holoenzyme forms a binary complex with 
promoter DNA. It has also been shown that some proteins which 
bind single-stranded DNA have 13-sheet-rich structures, and that 
this mechanism of binding ssDNA is conserved throughout species 
[Bochkarev et al., 19971. Therefore it can be proposed that 
increases its 13-sheet content upon formation of an open complex 
with promoter DNA. It is possible that similar conformational 
change was observed by Smillie et al., as mentioned above, when 
detergent was added to U70  in solution, or by deletion of the 245 aa 
region from 70 
It has been shown that change in the secondary structure of 
certain proteins (e.g. human lysozyme; a fragment of yeast protein 
Ure2p) from a-helical to 13-sheet is accompanied by their 
polymerisation by filamentation [Booth et al., 1997; Taylor et al., 
19991.Filamentation of amyloidogenic forms of human lysozyme 
happens both in vivo and in vitro, notable that in vitro it is 
temperature induced. The activity of inactive fibrillar lysozyme can 
be reversed by denaturing and refolding the protein. Mutant 
lysozyme proteins were shown to have less constrained domain 
organisation, and they filament more readily. A proposed 
mechanism for this mode of polymerisation includes transient 
unfolding of a part of the protein with some a-helical content and 
then re-folding this part into a 13-sheet structure. These 13-sheets 
can then be arranged in layers intermolecularly causing a specific 
irreversible polymerisation of the protein into filaments. Given the 
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high n-sheet content of GA245  and its filamentation in solution, it is 
possible to speculate that its filaments (more specifically those 
formed by (yL245-HMK) are also generated by intermolecular n-sheet 
polymerisation. The 245 aa domain therefore can possibly help to 
keep the overall domain organisation of the rest of more 
restrained. 
The 245 amino acids in am between the conserved regions 1.2 and 
2.1 are often referred to as 'non-conserved', because they are 
absent from the majority of a subunits from different organisms, 
including the major a subunit of another well studied bacterium, 
B. subtilis. However, this spacer region appears to be conserved 
among many known major a subunits of Proteobacteria, as can be 
found by BLAST 2 searches for the 245 aa sequence. These bacteria 
are: E. coli, Salmonella typhimurium, S. typhi, S. paratyphi A, 
Kiebsiella pneumoniae, Yersinia pestis, Buchnera aphidicola, Shewanella 
put refaciens, S. violacea, Vibrio cholerae, Actinobacillus 
actinomycetemcomitans, Haemophilus influenzae, Pasteurella multocida, 
Pseudomonas chiororaphis, P. putida, P. tolaasii, P. fluorescens, 
P. aeruginosa, P. syringae, Acinetobacter sp., A. iwoffli, Legionella 
pneumophila, Thiobacillus ferrooxidans, Xanthomonas campestris (y 
subdivision); Burkholderia cepacia, Bordetella pertussis, 
B. bronchiseptica, Neisseria gonorrhoeae (P subdivision); Caulobacter 
crescentus, Agro bacterium tumefaciens, Sinorhizobium meliloti, 
Brad yrhizobium japonicum, Rhodobacter capsulatus, Rickettsia 
prowazekii ((x subdivision); Myxococcus xanthus, Campylobacterjejuni 
(olE subdivision). As seen from Fig. 3.13, the conservation of the 
spacer region between regions 1 and 2 of major a factors is more 
significant within subdivisions of Proteobacteria (marked in brackets 
after names of the species), and less significant between 
subdivisions. Even among Proteobacteria the spacer region is much 
less conserved than the highly conserved regions 1, 2, 3 and 4. 
However, it is always present in the major sigmas of this class of 
bacteria. Notably, even sigmas of Proteobacteria with the least 
conserved spacer regions (Myxococcus xanthus, Campylobacterjejuni, 
Geobacter sulfurreducens) still have the region of approximately 
245 aa between their conserved regions 1 and 2. At the same time 
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all the known major o subunits from other groups of bacteria, 
particularly from gram-positive bacteria (Bacillus subtilis, 
B. anthracis, Streptococcus pyo genes, S. pneumoniae, S. pyo genes, 
Clostridium aceta but ylicum, C. dif,ficile, Enterococcus faecalis, 
Staphylococcus aureus, Corynebacterium diphtheriae, Mycobacterium 
leprae, M. aviurn, M. tuberculosis, M. bovis), as well as all the 
alternative sigmas from Proteobacteria, do not have or do not seem 
to have this region. It is possible that under some conditions when 
the activity of major a subunit should be reduced (for example heat-
shock or in the stationary phase) the 245 domain can help 
sequester the a in an inactive form, presumably by polymerisation. 
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Fig. 3.13. ClustaiW alignment of spacer regions of principal sigma factors of proteohacteria (a, f3, 'y and S subdivisions), Colour 
coding: ILVAM (aliphatic/ hydrophobic); FWY (aromatic); KRH (positive); DE (negative); STNQ (hydrophilic); PG (con forma tionally 
special); C (cysteine). Numbers in brackets are positions of amino acids in the spacer regions of bacteria whose genorne sequencing 
is in progress. 
Chapter 4 
scrP gene and its product 
scrP studies 
4. 1. Theoretical analysis of ScrP and MtgA polypeptide 
sequences. 
Recently the genomes of several organisms have been completely 
sequenced, and many more sequencing projects are under way. 
From the results of a BLAST search [Altschul et al., 1997] of the 23 
completely sequenced genomes it is obvious that no amino acid 
sequences with any significant degree of similarity to ScrP are 
encoded, except by E. coli. These scrP-null genomes include those 
of 6 archaea, 15 bacteria (other than E. coli), and 1 eukaryote 
(Saccharornyces cerevisiae). Among the completely sequenced 
bacterial genomes, those of species of Aquificales, Firmicutes, 
Spirochaetales, Chia mydia, Proteobacteria, and Cyanobacteria are 
represented. However, among the genomes whose sequencing is in 
progress, several carry ORFs with a significant degree of similarity 
to scrP. Apart from the eukaryotes discussed below, all of these 
belong to the gamma subdivision of Proteobacteria (Enterobacteriaceae: 
Escherichia coli, Salmonella typhimurium, S. typhi, S. paratyphi A, 
Klebsiella pneumoniae, Yersinia pestis; Vibrionaceae: Vibrio cholerae; 
Pseudomonas group: Pseudomonas aeniginosa; Shewanella: Shewanella 
putrefaciens) or to the Green sulphur bacteria group (Chiorobium 
tepidum) (Fig. 4.1). 
As mentioned in chapter 1, significant sequence similarity to ScrP 
is seen in the potential product of mRNA encoded by human 
chromosome 21 (KNP-1) and in a protein expressed specifically in 
fish eye photoreceptor cells (ES1). Moreover, among mRNAs 
isolated from numerous human, mouse and rat tissues, such as 
lungs, kidney, heart, mammary gland, myotubes, diaphragm, 
embryo, placenta, many potentially encode amino acid sequences 
resembling the KNP-1 protein. It has also worth noting that an 
mRNA isolated from adult human eye [Hillier and al, 19951 seems 
to result from primary KNP-1 transcript, different from the one 
generating the ES 1 protein in zebrafish retina (Fig. 4.1). 
129 
scrP studies 
Esciorh I a 	COAl 12V1L3 	'.' 	DEI 	lt 
£aAmon1a 	typhl IVVLI NvvDrEt 	14 
Klebelella pUE.lfl18 I'3VVLA1 - -YDE: 	10 
YeCslo.a pesis TV1WLA .. 	0- E 
Pseodoxooas 	riJlOa rFVAV1L:'D-E 	io 
Se'an1Ja 	putrfe1V 	 MFF IAVLL#1 	o;FDTEl 	1 
VthrAo 	Choiarae MFK. VAVIL23 -FJD--..Et 	19 
C.131orobium 	repidum 19 
Ceoborer 	juifjrrciuo.ns 	 MKFI2VVLE1 	D­ E: 	15 
KN4-- I 	1p6a hunt o'$D';i'E: 	60 
K13P-1bta hum 11 
MLs 	Iu$cU2LS MAJRVLVAP-LALL41Si'$h AQ?A-A?'3MVAI.VL93 	"0-7E 
hu_retisa ----------------- --------'.--- 	 V' FVL2;-3 D-TE: 	£4 
E1S1_Dajio 	rari 5LA4ALLAFQAJAMLV9Q4A 'LbtHHl'-- --G--DWN - *314 14IAVVPSS u 
ECO1I EAVLDLLA1S55GAQAV.PAP0 Q,2.DVIHL11EATENV1IEAAI11-4E 	74 
S.typhl EAVLrLLI?PE1AA1 'kD 	5'ADV!N:1.T1E,'M5 - Et' 14'[.TE.tA 	I -- 	74 
K.0reu5c43iae D 	t:  DV 	1q : 	E1, 	II 	:r. -A 	D 72 
S.çestls EsvL114jtD'-.AEA- :. 	D '. ItV IT'AE:: 	EE 	II 	E1 	-i 1 4 
P aeruglr sa El 	 9 	E '2 F 	F 	j 	V5 	I 	SE I' 	E E S 	-13 
S.putratScierS :.:: 	-.A,,çjrç 	Y!'D.u'2M::v'-'N- FT 	E-014-I 	II 	Es:- 	-ID - 
V.ohC1rae ES 	_'- 	--:5 	QIASW 5 11'2'2II 	v143,rIEE --IP - ET 	£I::E1-. 	- 	-:. 	 -- 1 4 
C. tepldua E 	.T-:.:-.0 	'2A 	A' 	?D- 	ivN,tT'AE.SEI4ET 	ti-. 	EII' 	- 	- 	'- 74 
eobaoter - E. 	:-Dt1CAE'- 	NIE 	Ey-P3iT 	5'-'7' 	U.',: E.' -S 	 -- 	 73 
MP- 1ahuir 5--:' 	s.:i.1- 	E.'Dç.N 	A'ID-T'ALME'7EF 	i .11  El 	-s 116 
KNP-ib E.'::,S:AE 	,.'' 	'D 	"2'-!';:DT 	T2 	:.:ss. 	U- 	TE, -s 	-- 	116 
MuSJT E 	1. 	 '.. 	S ID 	&.jH 	D T 	.3EF'.5 5 	1 E 	 114 
EASEl LVL 	EV'2.P.kpD''2Ms-'.'IDS.l' 	IQFSE 	14L.TE3.". 	1A 	- 70 
ESI_Danlo. r EAAY'PMYUL9PIS'3A5 	1jt PA14'2%H VMD4I SDNTM1SESA IJ1(14Q 	113 
E. coli 1' PLAQAD!AED. 	VES 3 	IWL9SI,7SE- TAOS-SI: S- - - - -- s-s 	c2,'L'2YM 	334 
S.typhi PLS0EEsD.-- ----'l 77 AAA 	UL.S'SS 	5D1ID'- 	.:.=,s: 	95 	rI'2VI 	£34 
K.pxleumoDlae ::.PL'2; 	-E'r__DS 	P-:A 	mt-or' -.:E , I:SE 	DPOS. 1"-1 	PL 43I14 	132 
Y pest Is 1P 	DIE 	D £. 	rAh-, 	14 	DI' 	-"E 	Z.-,EPIDi.Y 	 q 	P i 	ttd 	134 
P. aerug1rc.sa  D. 	5- 	ED '0 	f' 	3AA 	[5D'A14'7 "2 QV9PDVI.M_4 ArAEAO FV3L,1 	333 
S.putrefaciens 'TIE- DA 	I'D::: ,C'3A) 	Fl:. 	I 	STWAAE- E'' 	P:,-r 	gV'strF;"3I1 I 	139 
V_ chtzl 	 rae 0 	II 	5 	0 	F -ul- 	II 	"OF 	u 	'2 	lIFt) r 	C,CJ 	I ,I15j 	134 
C. te1dun, ] 	N:. 	0.01"' 	D-- 	- 	1-1,-A;?, 	It: -DY,'1'G8 	E 	D 	 - 	1- 	'L'3rL 	134 
Seobacter - 	S.-' 	X';S;ED iI-3.1v.,,:,-TI'1SE'C;.;STSNi'E S 	- 	A 	11-20,1 	133 
ENP-la_hum S)'DL4,A'-.-I' 	0,':.. F1--3'AF.AJ 	-III 	TF:'DC 	0 	11 	5 	E E' 	3?,S. tI-Il. 	176 
IGIP-lI 1TD...SH 	7-U 	0'- 	FF5. 	,5'I'FA':DC 	0 	N 	4 	4 E 176 
Musm '1 	iS 	II 	0: "I'3X-- F1L5'l'"':'D. 	0 'S 	S 	S E' 	30,s- 	Pt-IL.- 	174 
hum-retina -I'D. 	. ,:AAu 	DA?. 	'[-'FI-SAA  14 	STAiD-A 	0 'S 	S 	S ES 	AQIrlSlL' 	130 
ES1_Darlio.r MUD.:' 	0 	IJS!D 	- F-A-A --1:.- 	11015146 	D'S 	0 	I ''SD 	S D: AI'1I1.5 	173 
E.ColI •- IAI"tiIP 	D - - FP 	''r:° -I'DSD --- ---------- .-E 	SE 	' S 	L' 	1:00,, 	lO 
S. typhi - 	lAPAMLPI'D - -EPL-:'I:-TD:D ---- 	------- T?.E 	SE 	- S P 	'-DO 
K. pnamoniae l)AMLP-'I VA - -741 	i'TDLD----  -- --- '400? 	EE 'A:  E 	F 	OD 	£79 
Y.peOtis TSPVHLPILL-i'l"DD --- 	-- ------- -TID?SE , F--3 E F-DO'S 	190 
P.aeruginosa ,SiA?:IY-AS'."2T."ND'D- -- - ------- '10,0015 QM'A'E 	0 	F 05:75 	174 
s.putrefacierIs IAPU 	L011--cl?. 	-A'r:- 1- UDSD --- 	-------- —AAFNLNC'-': I'D' 	13 
V. 	olerac - 	IA PT I 	PM I7 - EP,,0,L..Ir..AUD ----- -- --------'1AAFIJ9L1As2 	0 	F 	E 190 
C.tepldum IAI'VIAA! 1.ES,'ET,'-"DE.- ------- --------'DAADIAAN57- - 	1 EE 	.92 
eOtacter :AP-Al.IXATL.I,0Y;P 	TI-lTD,'. ---- -------'4t,AAL'I'ETCIIE 	-I 	5' 191 
KNP-la _huu, - IAPVLOAISVL:---C-:E''-I' -' 	Ec'EE' 	'' WPYA1I1AEAL 	1.o 	- - 	5- 	5 	.rSO 
SNP-lb IAPVLAAVL?'2VE',T,'5 	E'2EE'A ----, 	WP 0,L-A5 	-- 	S 5 :so 
IAP'iLAASV1X' 	Er - - - -- --------- --------- -------------- - -- -43 
hum _retina SIXP'UQ 	--- FsL, 'AX 	 'i' 	----- A'13: WQXAI,L.- ---- -- ------ 161 
ES1_Danio. 1001:.:.;- :-JLP-- 	LEOTMOE DESS'-Wtis W 	1TNMVAVKS),GA:t4T E I'll Eo(v 	230 
S. coil 05014 	:'-I'T PAI'ML 	IAEOASOS 1 0- LJSAVLVLAE 	217 
S.th1 DEDTi'-'F1AYMLA9DIAAAS'4'D- I.'f5'-V1,VLAE 	217 
K.pOeuSOr.1 05014 	AT 	AYl4I..9lIAE1,JI4'SE 	-S. -- "LVI. 213 
Y.ç.SStls 0 	EU 	.''FMLA-I4 	1550). 	'7-0 ..D1,TE 	217 
-r'rF'.114L04j9 -- 10500,0-I 	N..D'-EL'JD 	214 
S.patrefsi.sir.o 05:1- 	,:5TPASMLA-Fl -- 1AEA.S0A 	E  
DE ,51'PAFWL),Et - 14QAA5 54E:  LVESL1'A 	214 
C.tepiduJu OVD 	"1"rPA?1IL.Sl21SDIA,7tDsLVAJVLELA-" 	215 
Geobactar B 	EN 	:.-'T'V1AYML.-1--- - --------------------- 	147 
SNP- La_hum ms 11 	'; - ,'T-rl-ArM 'ETALIIS IDl1SANVt.1'VLEL43i' 	265 
514K-lb Dv- 1OSVVTTK# 	W'ETAL. 	SSDIGOMVVL.El,'I"31 	265 
HuS_lfl 
hu_retit)4 
5S1_DaniO.r DE 41. ','!4TKT$ETD4.,7'-1IVD-'3ICt4NVI1I'J1sM'4AK 	279 
Fig. 4.1. ClustalW alignment of known ScrP analogues, bacterial (from unfinished 
genome projects), and eukaryotic (KNP- laipha and KNP- ibeta, different splicing forms of 
human KNP; ES1 - protein from zebrafish eye; ES'!' tag from human retina of an adult 
[Hillier et al., 1995]). Colour coding: L':\'-J (aliphatic/ hydrophobic) I'WY (aromatic); 




Recently submitted sequences of regions of human chromosomes 
7, 14 and 16 contain more ORFs which can potentially encode 
polypeptides similar to parts of ScrP [GenBank Accession Numbers 
AC009 196, and AC009034, EMB Accession Number AC0080151. This 
is consistent with the earlier suggestion [Nagamine et al., 1996] 
that more than one protein similar to ScrP may be produced in 
vertebrates, with different tissue or developmental specialisation. 
However, too high degree of similarity of these potential 
polypeptides to ScrP of E. coli (nearly 100% for polypeptides of 100-
120 aa long) may also indicate of cloning error. 
In any case, proteins similar to ScrP are present in many member 
species of the gamma subdivision of Proteo bacteria and in at least 
one Green Sulphur bacterium (Fig.4. 1), but absent from many other 
classes of bacteria and even from Haemophilus influenzae, which 
belongs to the Pasteurellaceae family of the gamma subdivision of 
Proteo bacteria. The conservation among ScrP analogues from 
different species is strikingly high. Among bacteria, 73-94% amino 
acids in ScrP analogues are similar, and 57-88% are identical to 
ScrP. In eukaryotic proteins there is 46% (KNP-lalpha) and 32% 
(ES1) of identity to ScrP, and 64% and 59% of similarity, 
respectively. This similarity continues throughout the whole length 
of the proteins, with the exception of N-termini, which are 
presumably signal peptides. As it was suggested [Scott et at., 19971, 
such a high degree of conservation may indicate that ScrP and its 
analogues are involved in a basic molecular mechanism common to 
bacteria and higher organisms. Unexpectedly, proteins with any 
degree of similarity to ScrP are absent from Saccharomyces 
cerevisiae, but present in higher eukaryotes including fish and 
mammals. These findings suggest that the physiological functions 
of proteins related to ScrP are important, but cast no light on their 
actual functions. 
Interestingly, in the Enterobacteriaceae the genes potentially coding 
for ScrPs are present in the same environment as that of scrP on 
the E. coli chromosome, i.e. the downstream ends of scrP in E. coli, 
Salmonella typhi, S. typhimurium, S. paratyphi A, Klebsiella 
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pneumoniae and Yersinia pestis all overlap 1-4 bp with the upstream 
ends of genes similar to mtgA, and a gene similar to arcB is present 
about 230 bp upstream from the start codon of each scrP. This 
could either be due to merely their evolutionary proximity, or the 
arrangement might be conserved because the functions of ArcB, 
ScrP and MtgA are connected. However, in the other bacterial 
genomes possessing a gene similar to scrP but belonging to 
different taxonomic groups in the gamma subdivision of 
Proteobacteria (Vibrio cholerae, Pseudo monas aeruginosa, Shewanella 
putrefaciens) or to Chiorobium tepidum (Green Sulphur Bacteria group) 
(Fig. 4. 1), the scrP analogue is not accompanied by genes similar to 
mtgA or arcB, thus undermining the proposal that their proximity in 
the Enterobacteriaceae implies related functions. 
Searches for a signal peptide in ScrP using the computer 
programmes SignalP and PSORT (see chapter 2.7) produce 
contradictory results. One SignaiP prediction, based on the Hidden 
Markov model, suggests that ScrP is unlikely to contain a cleavable 
signal peptide and thus is not a secreted protein. However, the 
other SignalP prediction, based on the Neutral Networks model, 
suggests that ScrP might be cleaved between amino acids 36 and 
37. 
PSORT analysis also predicts that ScrP is a secreted protein, with a 
possible signal peptide cleaved between amino acids 34 and 35. 
Moreover, it predicts that ScrP should be localised in the 
periplasmic space, with a probability of 0.92. 
The human ScrP-like protein KNP- 1 has similarly been found to 
have a potential signal peptide for targeting it into mitochondria, 
while ES1, expressed specifically in adult zebrafish eye 
photoreceptor cells, has been shown to be neither a nuclear nor a 
membrane-associated protein. PSORT2 and SignalP analyses of 
KNP- 1 show a 65% likelihood that it is a mitochondrial polypeptide. 
As for ES 1, the predictions for localisation are: cytoplasmic 40%, 
nuclear 30%, mitochondrial 17%. As already mentioned above and 
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in chapter 1, ES 1 is not in fact a nuclear protein, but it could be a 
cytoplasmic protein. 
Similar analyses were carried out for MtgA. All the computer 
programmes used predict the presence of one transmembrane 
region in MtgA, between amino acids 15-21 and 36-39. Furthermore, 
according to TMHMM, TMpred, PHDhtm, and HMMTOP (see chapter 
2.7), the N-terminus of MtgA should be oriented into the cytoplasm, 
and its C-terminus into the periplasm. 
4.2. In vivo expression of the plasmid-borne genes of the arcB 
operon. 
4.2.1. Expression of serF and mtgA in mini- and maxicells. 
D. Smillie and F. Townsley conducted an analysis of the proteins 
encoded by the Hind Ill-EcoR I insert of pFMT1 in minicells [Smillie, 
19941. They were able to identify polypeptides of estimated 
molecular size -14 kDa and -28 kDa on SDS-PAGE, and the 28 kDa 
polypeptide was thought to be ScrP. However, the Hind Ill-EcoR I 
insert in pFMT1 has the potential to encode at least three 
polypeptides - ArcB, ScrP and the hypothetical MtgA, with 
calculated sizes of 88 kDa, 23 kDa and 27 kDa respectively. The 
28 kDa band migrates between the precursor and mature forms of 
plasmid encoded 13-lactamase, which makes it difficult to judge to 
which of the proteins - ScrP or MtgA - it actually corresponds. The 
presence of the second of these proteins could have been masked 
by the -lactamase bands. Moreover, in their experiments only a 
faint protein band possibly corresponding to ArcB can be seen. At 
the time it seemed possible that pFMT1 might generate a 5'-
truncated arcB mRNA, leading to possible internally-started 
translation. We now know that pFMT1 has a full-length arcB gene 
with the ribosome-binding site changed by EcoR I cleavage. The 14 
kDa polypeptide also remained unexplained. 
133 
scrP studies 
To further investigate proteins encoded by the Hind Ill-EcoR I 
region, several other plasmids with disrupted scrP and mtgA genes 
were constructed and analysed, before and during the present work. 
D. Smillie inserted a KanR cassette into the Nsi I site of scrP in 
pFMT1, to produce pDSA28 [Smillie, 1994]. The orientation of the 
KanR cassette is opposite to that of the scrP gene, which was 
confirmed by restriction digests with Hind III, Nru I, and Xho I (Fig. 
4.2). 
pFMT1 has the ?522 clone of the Kohara E. coli library [Kohara et 
al., 1987] (see Fig 1.2.1) as its source of genomic DNA. In this 
clone, the beginning of arcB is situated very near the end of the 
chromosomal insert, and it was thought possible that arcB might be 
incomplete Accordingly A. Elding in this laboratory constructed a 
new plasmid, pACE1, using the 5.34 kb BamH 1-EcoR I fragment 
from the ?523 clone of the Kohara library [Elding, 19951. arcB is 
situated in the middle of the X523 DNA. However, the EcoR I 
recognition sequence lies in the ribosome-binding site of the gene, 
so that even though pACE1 (and probably pFMT1) carry a full-length 
arcB coding sequence, the original ribosome-binding site is 
damaged (Fig. 4.2). 
pACE 1 carries a large amount of DNA downstream of the Hind III 
site (which conveniently overlaps the stop codon of mtgA). In order 
to remove it the Hind III-BamH I chromosomal fragment from pACE 1 
was replaced with a synthetic Hind III - Not I - Bgl II linker 
(primers TK1 and TK2), thus destroying the BamH I and introducing 
a Not I site together with stop codons in all three frames in the 
direction of arcB, scrP and mtgA translation: 
Hind III 	Not 	a7111 
(TA) AGCTTGTGAGCGGCCGCTGA 
ACACTCGCCGGCGAC TCTAG 
The resulting plasmid was called pTAK1, and its structure was 




The minicell-producing strain P678.54 was separately transformed 
with the plasmids - pJJW 11, pACE 1, pFMT 1, pTAK 1, pDSA28 and 
pBluescript::Kan. Minicells were prepared and plasmid-encoded 
proteins labelled with [35S]Met as described in sections 2.3.7, 2.3.8. 
The labelled proteins in the crude minicell extracts were separated 
by 10% SDS-PAGE and visualised by autoradiography (Fig. 4.3). 
It can be seen that pTAK1 produces essentially the same pattern of 
expressed proteins as pFMT1. Both plasmids, as well as pACE1, 
encode a protein of -29 kDa, which appears on SDS-PAGE as a 
band between the two 13-lactamase bands; on the other hand, cells 
carrying pDSA28, in which scrP is disrupted with the KanR  cassette, 
do not produce this protein. This suggests that the protein 
corresponding to this band is either ScrP or MtgA. The absence of 
the latter from pDSA28 track could be either due to interruption of 
mtgA transcription by the insert in scrP, or due to obligatory coupled 
translation of mtgA with scrP. However, the results obtained with 
maxicells (discussed later) indicate that the MtgA runs as -25 kiJa 
protein in my gels. Accordingly the 29 kDa band in Fig. 4.3 is very 
likely to correspond to ScrP. 
The presence of the -14 kDa product is also evident in several 
tracks. This will be discussed later. 
In order to learn more about the identities of these proteins and 
about the transcription of the region, new disruptions were made 
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Figure 4.2. Scheme of the construction of plasmids pFMT 1 [Townsley, 19911, 
pDSA28 [Smillie, 1994), pACE1 [Elding, 19951, and pTAK1 (this work). The genes, 
relevant restriction sites and known promoters are shown. galK is promoterless. P 












M 	- Q_ ci o ci 














..-II i 4 I 	a
II 
 
Figure 4.3. Plasmid-encoded proteins expressed in minicells. M - molecular size 
marker, kDa; P678.54 cells carrying various plasmids; control experiment, 
P678.54 cells with no plasmid. Bands corresponding to GaIK, precursor and mature 
13-lactamase, GalE, 14 kDa protein and, presumably, ScrP, are shown on the right. 
The difference in Ga1K, ScrP and 14 kDa protein relative band intensities in pACE 1, 
pFMT1, and pTAK1 are presumably an artefact due to different amount of loaded 
material in the tracks. pBluescript::Kan was used as a control for 3-lactamase and 
KanR. 
pTAK1 was partially digested with BstB I and ligated with a 1.25 kb 
Acc I fragment from pUC4K carrying a KanR cassette. DNA 
restriction with these enzymes produces compatible cohesive ends. 
Several ligation products were produced: the insertion of the KanR 
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cassette into the BstB I site in mtgA in either orientation, resulting 
in pTAK2 and pTAK3; the replacement of the BstB I fragment of 
pTAK1 with the KanR cassette in either orientations, yielding in 
pTAK4 and pTAK5; and the insertion of the KanR cassette into the 
BstB I site in galK in the same orientation as the galK gene, 
resulting in pTAK6 (Fig. 4.4.). The structures of these plasmids 
were determined by restriction analysis with Nru I, EcoR I, BstB I, 
Nsi I. 
E Nr Ns BHNNrB E 
pTAK1 arcB Hscr' H mtiA 1L.I galK 	Am 	I' 
pTAK2 —1 I 	I_ga/K I I_Am}- arcB H_scrP Hm'IKanl_ _ 
pTAK3 H I 	_ I_ga/K I 	I_Ami— _arcB H scrP flmIKanI_ _ 
pTAK4H Am I— _arcB H scrP _ 
pTAK5H Am F- arcB HscrP I[m'IKanIgI—i 
pTAK6 H H mtgA g' Ikani F—I Am 	H arcB H scrP  
Figure 4.4. Plasmids constructed for studying expression of arcB-scrP region. 
Orientation of genes and relevant restriction sites are shown. m' - mtgA', g' - 'galK, 
E - EcoR I, Nr - Nru I, Ns - Nsi I, B - .BstB I, H - Hind III, N - Not I. xxx - translation 
stop codons in all three frames in the direction from mtgA to galK. Nru I, EcoR I, 
BstB I, NsiI 
Table 4.1. Orientation and calculated sizes of the products of some chimaeric 
genes presented on plasmids used in the maxicell experiment. 
Plasmid Chimaeric genes 
constructed 
Orientation of KanR 
relative to scrP (-3) 
Calculated 
product sizes 
pDSA28 scrP' + tail  16 kDa 
pTAK3,4 mtgA'+ tail  16.2kDa 
pTAK2, 5 mtgA' + tail -3 18.7 kDa 
The E. coli strain CSR603, designed for producing maxicells, was 
transformed with all of the above plasmids. Maxicells were then 
MIV 
prepared according to the protocol described in sections 2.3.9. The 
proteins synthesised were labelled with [ 35 S]Met. The crude 
maxicell extracts were separated by 12% SDS-PAGE and the 
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Figure 4.5. Plasmid-encoded proteins expressed in maxicells. 
M - molecular size marker, kDa; CSR603 cells carrvng various plasmids; -' control 
experiment, CSR603 cells with no plasmid. Bands corresponding to ArcB, GalK, 
lactamase, GalE', 14 kDa protein and, presumably, MtgA, are shown on the left. 
pUC4K was used as a control for -lactamase and KanR. 
In this experiment a faint band of -70 kDa appeared in the tracks 
corresponding to pFMT1, pDSA28, and pTAK1 - pTAK6, but not in 
the tracks containing the control pUC4K or pJJW 11. From earlier 
work [luchi et al., 1990; luchi and Lin, 1992a] it is known that ArcB 
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migrates between 72 and 82 kDa on SDS-PAGE, so this band 
presumably corresponds to ArcB. As seen from the figure, cells 
carrying pFMT1 as well as pTAK1 produce this protein. This is 
consistent with our expectation that pFMT1 has a full-length arcB 
gene, contrary to the uncertainty on this point which led to the 
construction of ArcB. 
The apparent presence of the comparable level of ArcB protein in 
pDSA28 suggests that arcB transcription has not been significantly 
affected by the insertion of an oppositely oriented KanR  cassette 
within scrP (Fig. 4.5). This suggests that the cassette - or the DNA 
between Nsi I site of scrP and the end of arcB - contains a 
terminator strong enough to prevent much convergent transcription 
into arcB. 
It is noteworthy that the 14 kDa protein band is seen in all tracks 
except the controls (pJJW1 1 and pUC4K) and at much the same 
level, irrespective of KanR disruptions of scrP, mtgA, or galK. This 
supports the hypothesis (discussed later) that this in fact is an 
internal, out-of-frame translation product of arcB mRNA. 
The band of -29 kDa, characteristic of one of the proteins encoded 
by the Hind Ill-EcoR I inserts in pFMT1, pTAK1 and pACE1 and 
observed in the minicells experiments, was not detected in the 
maxicell experiment, presumably because it was not resolved from 
the strong and apparently superimposed -lactamase and KanR 
(calculated molecular size 30.7 kDa) bands. However, a new faint 
band of apparent molecular size -25 kDa was produced by the cells 
carrying pFMT1, pTAK1 and pTAK6, where both the scrP and mtgA 
genes are intact. This band was absent from pTAK2 - pTAK5, 
pDSA28, and the control pUC4K and pJJW1 1 tracks. 
Both pTAK2 and pTAK5 have scrP intact and mtgA disrupted at 
BstB I by the KanR cassette, with the KanR gene being in the same 
orientation as mtgA. They should produce a truncated MtgA' with a 
chimaeric tail, of total size 18.7 kDa. pTAK4 and pTAK3 have scrP 
intact and mtgA disrupted by the KanR cassette in the orientation 
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opposite to mtgA, and should produce a chimaeric MtgK of 
16.2 kDa. There are several faint bands in this size range, but 
these are common to all the samples. Perhaps the chimaeric 
proteins are produced but unstable, or their are masked by the 
other common bands. 
Although pDSA28 has scrP disrupted by the KanR  cassette, mtgA is 
intact. However, the absence of the MtgA (--25 kDa) band from 
pDSA28 track is understandable if mtgA is not transcribed in this 
plasmid (because transcription from arcB and scrP' is blocked when 
it enters the KanR cassette) and/or if translation of mtgA is 
obligatorily coupled to that of scrP. Accordingly it seems reasonable 
to conclude that the -25 kDa band seen only in the pFMT1, pTAK1 
and pTAK6 tracks is formed by MtgA protein. 
In maxicells carrying plasmids pFMT1, pTAK1, pTAK2, pTAK3 and 
pDSA28 the full-length Ga1K polypeptide of calculated molecular 
size 41.3 kDa is synthesised, and the intensity of the 
corresponding band has been measured by densitometry. In 
pJJW1 1 the galK gene is known to be transcribed from its natural 
promoter, Pgai  [Wright and Hayward, 19871. This is absent from 
pFMT1 and pTAK1, so galK transcription becomes dependent on the 
plasmid promoter P, [Wright and Hayward, 19871, just upstream 
from the EcoR I site (see Fig. 4.2), and any promoters present in the 
DNA insert in pJJW 11. These plasmids generate about 4-fold less 
Ga1K than pJJW 11. 
pTAK2 produces a surprisingly similar amount of Ga1K, considering 
that KanR cassette is inserted within mtgA. This can be due to 
possible termination which balances out the transcription from 
KanR and Px  promoters by the terminator whose likely presence in 
the KanR cassette has been mentioned. 
pTAK3 and pDSA28 generate -7 fold less galactokinase than 
pJJW1 1, and in these cases galK mRNA synthesis is due to 
transcription coming either from P x hindered by transcription from 
the KanR promoter in the opposite direction, or from the 
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promoter(s) lying within the portion of mtgA downstream of its 
BstB I site or in the KanR cassette oriented in the direction 
opposite to the KanR  gene. 
In pTAK4 - pTAK6, the galK gene is either disrupted or 5'-truncated, 
so the failure to produce Ga1K is expected. 
4.2.2. Overexpression of scrP and mtgA using a T7 RNA 
polymerase -driven promoter. 
scrP and mtgA were cloned into pT7-7 [Tabor and Richardson, 19851 
under the control of its T7 RNA polymerase-driven promoter, so 
that upon T7 RNA polymerase induction the ScrP and MtgA 
polypeptides should be overproduced. Plasmids were constructed in 
which scrP together with mtgA, or mtgA alone, can be transcribed 
from the 17 010 promoter. 
The Mfe I-Hind III fragment of pTAK1 was cloned into the pT7-7 
vector digested with EcoR I and Hind III, to produce pTAK9. 
Similarly Vsp I-Hind III and Bfa I-Hind III fragments of pTAK1 were 
cloned into pT7-7 digested with Nde I and Hind III, to produce 
pTAK10 and pTAK11 respectively. Thus three different plasmids 
were obtained in which scrP and mtgA are fused to the T7 010 
promoter. 
To clone rntgA without intact scrP, the Nsi I-Hind III fragment of 
pTAK1 was cloned into pT7-7 digested with Pst I and Hind III, 
yielding pTAK8. Similarly the Xmn I-Hind III fragment of pTAK1 was 
cloned into pT7-7 digested with Sma I and Hind III to produce 
pTAK7. 
The structures of all the plasmids shown in Fig. 4.6 were verified by 
restriction analysis with Hind III and Cia I. 
Subtle differences exist between the forms of ScrP and of MtgA 
expected to be produced by these plasmids. 
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Vsp I Me I Nsi I CIa J,.Xmn I 
Bfa 	 1 II 
	
Hind III 
arcB 	 scrP 663 bpl 	mtgA 729 bp 
	
PTf
Sma t/Xmnl 	 Hind III C/al . 	
i I 	pTAK7 
Pstl/Nsil 	 Hind Ill C/al 
I go 	 j I pTAK8 
P -T7 	EcoRl/Mfe I 	 Hind IIIC/al 
1I I 1W 1I 	pTAK9 
P-T 	Nde l/Vsp i 	 Hind Ill C/a I 
pTAK1O 
P-T7 	Nde I/Bfa I 
	 I C/al 
pTAK11 
Figure 4.6. Cloning of mtgA and scrP into pT7-7. Relevant restriction sites are 
shown. 
In the case of pTAK9 (see below) ribosomes initiating at the 
T7 gene 10 ribosome-binding site, would start at AUG codon in the 
NcLe I site producing a heptapeptide terminated by the UGA stop-
codon in the ribosome-binding site of scrP. They are then likely to 
reinitiate either at the AUG codon of scrP, or at an AUG codon 
within the scrP ribosome-binding site. In the latter case the ScrP 
polypeptide produced will have three extra amino acid residues 
(MIT) at the N-terminus: 
pTAK9 
gene 10 rbs 	Nde I 	Eco PJ/Mfe I 	scrP rbs 
Pøio. .AGGAGAT ATACAT ATG GCT AGA ATT GCG AAA GGATGATC 
M A R I A K G * 
MI 
ScrP start 
ACA ATG AAG AAA... 
T 	M 	K 	K... 
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In the case of pTAK 10 and pTAK 11, the Nde I site and the start 
codon of the T7 gene 10 are destroyed. Thus in the case of pTAK1 1 
translation is likely to start at the natural scrP start codon, with 
ribosomes binding at the scrP ribosome binding site. 
For pTAK10, however, there are two possibilities illustrated below. 
One is that ribosomes would start translation at the AUG codon 
immediately after the destroyed Nde 1/ Vsp I site, leading to the 
production of a 25 amino acid polypeptide, and would then be likely 
to reinitiate in another frame, producing another 10 amino acid 
polypeptide. This process would interfere with the translation of 
ScrP. Another possibility is that the ribosomes would initiate at a 
GUG codon 2 nucleotides downstream of the above AUG, and the 
resulting octapeptide would terminate at the scrP ribosome-binding 
site at the UGA codon described for pTAK9. These ribosomes would 
then reinitiate either at the natural ribosome-binding site of scrP 
or three codons further upstream. 
pTAK1O 
gene 10 rbs Nde I/Vsp I 	 scrP rbs 
Pi 0. . AGGAGAT ATACA TAA2GTGTTTCAGTCAATTGCGAAAGGATGATCACA 
MC F SQL R K D D H N 




E EN W RN SE R MR R L * 
M... 
M K K I G VI L S G C G V Y D... 
pTAK11 
gene 10 rbs Nde I/Bfa I 
P010. . AGGAGAT ATACA TAGACCGGGGTGCGCGAATAC... 
scrP rbs 	ScrP start 
• . . ATTA1TGTGTTTCAGTCAATTGCGAAAGGATGATCACAATAAGAAAATTGGCG 
M K K I G V 
TAATTCTGAGCGGATGCGGCGTCTATGAC... 
I L S G C G V Y D... 
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In the case of pTAK7, one would expect production of a protein P7-
'ScrP carrying the first seven amino acids encoded by the polylinker 
of pT7-7 (MARIRAL) fused to amino acids 145 - 217 of ScrP (total 
calculated molecular size 8.7 kDa), together with MtgA. pTAK8 is 
similar to pTAK7 except that the fusion protein P8-'ScrP encoded by 
the polylinker of pT7-7 and a part of ScrP should have a molecular 
size 11.6 kDa (that is, MARIRARGSSRVDL fused to amino acids 125 
- 217 of ScrP). MtgA in pTAK7 and pTAK8 is either translationally 
coupled to ScrP, or independently translated from its own weak 
ribosome-binding site, or both - just as with mtgA encoded by the 
bacterial chromosome. However, the expression of mtgA relative to 
that of scrP from T7 RNA polymerase promoter can be lower than 
when it is expressed from E. coli RNA polymerase promoter, due to 
the effect known for "T7-overproduction systems' when two 
successive independently translated genes are expressed [lost and 
Dreyfus, 1995]. mRNA between fast moving T7 RNA polymerase and 
the lagging behind front ribosome is likely to be subjected to attack 
by nucleases. 
The above plasmids were transformed into the E. coli B strain 
BL2 1 (ADE3)plysS, and protein overexpression and labelling were 
carried out as described in section 2.5.3. The crude cell extracts 
were separated on 12% SDS-PAGE, and the labelled proteins were 
then visualised by autoradiography (Fig. 4.7). 
ScrP and MtgA contain 7 methionines each. Assuming that they 
both retain or lose their initial methionine, this allows estimation 
of the relative amounts of these proteins being synthesised simply 
by measuring the intensities of the corresponding bands on the 
auto radiograph. 
The autoradiograph of the gel (Fig. 4.7) reveals two bands of -27 and 
-27.5 kDa, present in all induced cells carrying plasmids with full 
length scrP and mtgA genes; these products are absent from the 
cells carrying plasmids encoding MtgA and a chimaeric truncated 
ScrP. These strong doublet bands are presumably ScrP. The doublet 
appearance will be discussed later. The third ScrP band, below the 
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-27 kDa band, is faint and obvious in pTAK1 1 track. The identity of 
-26 kDa band in the pTAK10 track is not clear. 
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Figure 4.7. Autoradiograph of the gel of the cells overexpressing ScrP and MtgA 
from pT7-7 derivatives. + or - IPTG - with or without T7-RNA polymerase 
induction. M- molecular size marker. Bands sizes and identities are shown on the 
left. The two bands of -27 and -27.5 kDa appearing in the induced cells carrying 
pTAK9, pTAK1O and pTAK1 1 should correspond to ScrP. 
On the other hand, all five IPTG-induced extracts from cells 
carrying pTAK7—pTAK1 1, show a band of -25 kDa, which 
presumably corresponds to MtgA. This band is fainter in the case of 
the plasmids encoding full-length scrP upstream of mtgA. This is 
what one would expect if translation of mtgA is obligatorily 
dependant on ribosomes reinitiating after termination of scrP, i.e. 
on translational coupling. In the cases of pTAK7 and pTAK8 the 
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ribosomes reaching the end of scrP will have initiated at the strong 
T7 gene 10 ribosome-binding site, whereas for pTAK9-1 1 they will 
have used the weaker site of scrP itself. 
As expected, the IPTG-induced cells carrying pTAK8 produce a 
strong band of 12 kDa, its intensity being about 5-7 times that of 
MtgA. The predicted peptide should contain 5 methionines, 
assuming that the N-terminal one is not cleaved off. This suggests 
that about one MtgA molecule is synthesised per 7-10 P8-'ScrP 
molecules. Similar calculations for pTAK9, pTAK10 and pTAK1 1, 
counting both bands of the doublet and the minor band as ScrP, 
give ratio of ScrP to MtgA produced 30, 16 and 44, correspondingly, 
with the error of the measurement about 20%. Because of the 
unexplained band, which can be a truncated form of ScrP, present 
in pTAK10 track, the ScrP/MtgA ratio is the lowest for this plasmid. 
Considering pTAK9 and pTAK1 1 results, one MtgA molecule is 
synthesised per every 30-50 molecules of ScrP in this experiment, 
which is even less than in case of pTAK8 which carries a truncated 
P8-'ScrP. This can be, apart from the big error of measurement, due 
to the mentioned above preference of "T7 overproduction' system 
for the upstream gene. According to this view, mtgA should be 
expressed better in pTAK7 than in pTAK8, and in pTAK8 better than 
in pTAK9— 11, because the distance between ribosome-binding site 
and the start of mtgA is the shortest in case of pTAK7, longer in 
case of pTAK8, and therefore mtgA has the better chance to get 
expressed than in cases of pTAK9-1 1. 
Consideration of these results suggests quite strongly that mtgA 
translation is rarely initiated independently. Instead it is 
dependant on reinitiation by ribosomes which have already 
translated scrP, with an efficiency of some 2-10%, at least under 
the conditions of this in vivo experiment. 
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4.2.3. Cell fractionation. 
BL2 1 (XDE3)plysS cells carrying pTAK8 and pTAK1 1 which had 
produced the most interpretable results above, were chosen for 
investigation of intracellular localisation of ScrP and MtgA. 
Cells induced and labelled with [35S]Met as above were subjected to 
fractionation as described in Section 2.5.3. Periplasmic, total 
membrane, outer membrane and cytoplasmic fractions were 
prepared. Their proteins were then fractionated on 10% tricine 
SDS—PAGE and examined by reverse staining (Fig. 4.8) and by 
autoradiography (Fig. 4.9). 
In the case of pTAK8, the overproduced MtgA is evident in the total 
cell extract, but does not appear in any of the cell fractions (Fig. 
4.9). This suggests that the protein has been lost during cell 
fractionation procedures used. However, as mentioned in chapter 1, 
overproduced MtgA was identified in a precipitate (at 200 000 x g) 
fraction of W3110 cells by Di Berardino et al. [Di Berardino et al., 
19961, which should correspond to total membrane fraction in Fig. 
4.8. Di Berardino et al. used 30 p.g of the precipitate fraction per 
track on a gel to be able to visualise the MtgA band with Coomassie 
staining. In Fig. 4.8, an amount of protein loaded per every track 
corresponds to about 12 pg of total cell protein, of which the 
precipitate fraction constitutes only a very small fraction. The 
faster-moving band which presumably corresponds to the P8-'ScrP 
chimaeric protein is found in the cytoplasmic fraction only. 
In the case of pTAK1 1, the three overproduced bands present in 
total cell extract are also found in cytoplasmic and periplasmic 
fractions, but are absent from the total membrane fraction (Fig. 
4.9). This confirms the theoretical prediction that ScrP should be 
transported into the periplasm. The presence of all the three bands 
in the c and p tracks suggests that none of them are MtgA (cf. 
pTAK8 results), and careful mobility comparisons support this view. 
Presumably MtgA is present in the total cell extract of the pTAK1 1, 
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Figure 4.8. 10% tricine-SDS- PAGE of proteins from cells overexpressing ScrP and 
MtgA (from pTAK1 1) or MtgA and P8-ScrP (from pTAK8), reverse-stained. M, 
molecular size marker; t(-I), total cell extract, culture not induced with IPTG. Cells 
induced with IPTG: t, total cell extract; c, cytoplasmic fraction; p, periplasmic 
fraction; tm, total membrane fraction; om, outer membrane fraction. 
The band patterns seen for ScrP overproduced by pTAK1 1 vary in 
mobility and intensity between two different gels (Fig. 4.7 and 4.9) 
as well as in intensity between total cell extract and periplasmic 
and cytoplasmic fractions (Fig. 4.9). The two different gel systems 
used might be partially responsible for the different band patterns, 
but could not explain their complexity. To investigate the 
possibility that the bands represent different stages of processing 
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Figure 4.9. Autoradiograph of the gel shown in Fig. 4.8. The marker track is 
Coomassie-stained. 
IPTG 	- 	+ 	+ 	+ 	+ 	+ 	+ 
fraction t t t p p 	p 	p 
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Figure 4.10. Fractionation of pulse-chase labelled proteins overproduced from 
pTAK1 1 (ScrP + MtgA) on 10% Glycine-SDS-PAGE gel. Cells were labelled according 
to a protocol described in Section 2.5.3 for 5 minutes, then cold methionine was 
added and culture incubation was continued for various times, as shown. IPTG+/-, 
with or without induction with IPTG; t, total cells; p, periplasmic fraction. 
150 
scrP studies 
As seen in Fig. 4. 10, the relative intensity of the ScrP bands did not 
change detectably during the chase of up to 20 minutes. This 
suggests that the bands are not forms of ScrP at different stages of 
processing. While it is possible that a different labelling protocol 
could produce a less negative result, the fact that the band 
patterns in the cytoplasmic and periplasmic fractions of pTAK1 1-
containing cells are identical (Fig. 4.9) also argues against the idea 
that the different bands are due to cleavage of ScrP during transfer 
to the periplasm. The appearance of the minor bands may be an 
artefact of the overproduction of ScrP, and a consequent inability of 
the cells to cope with its incorrect folding, leading in turn to some 
instability. 
4.3. Analysis of expression of the genes in the arcB operon. 
To investigate the expression of the scrP and mtgA genes in vivo, 
whether it is dependent on that of arcB, and how scrP and mtgA are 
expressed under various growth conditions, it was decided to 
construct translational fusions of arcB, scrP and mtgA to lacZ, and 
then transfer these onto the E. coli chromosome, replacing the 
natural arcB, scrP or mtgA genes. This approach avoids artefacts 
due to abnormal localisation of the fusions, as well as ensuring a 
normal gene copy number. 
4.3.1. Cloning of the EcoR I-BamH I fragment of pACE1 into 
pUC18. 
The chosen method of chromosomal gene replacement requires that 
the desired insertion, together with flanking homologous DNA, is 
present on a high copy number pUC-based plasmid. The EcoR I-
BamH I fragment of pACE1 was therefore cloned into pUC18 
digested with the same enzymes. The structure of the resulting 
plasmid, pBRU12, was confirmed by restriction mapping with 
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Figure 4.11. Scheme of construction of pALC3, pSLC3. pMLC3. Relevant 
restriction sites are shown. Xba I-alacZ--Ehe I is present only in pBRU12, pALC1, 
pSLC1, and pMLC1. 
4.3.2. lacZ fusion construction 
Each fusion was constructed in such a way that all the E. coil DNA 
downstream from the point of fusion in arcB, scrP, or mtgA, and 
extending as far as the first E. coli Bgl II site beyond the end of 
mtgA was removed, and replaced with the full-length iacZ gene, 
followed by a CAT cassette encoding chioramphenicol resistance 
gene (including its own promoter) (Fig. 4.12). 
The resulting ArcB'-'LacZ fusion protein would include the first 379 
amino acids of ArcB ending in the middle of the H 1 domain (amino 
acids 269-515) and thus containing His-292, but lacking the G-rich 
and N-domains necessary for autophosphorylation (see chapter 1). 
Similarly the ScrP-'LacZ and MtgA'-'LacZ fusion proteins would 
have about half of ScrP or MtgA respectively, fused to LacZ. 
First the lacZ-CAT cassette was amplified by PCR. A DNA template 
carrying the full length lacZ followed by CAT cassette, and primer 
3'Cml corresponding to the downstream end of the iacZ-CAT 
cassette, were kindly provided by Nicola Holden. Primers for 
creating suitable restriction sites at the beginning of the iacZ were 
designed for each fusion: ASCI-LACZ to allow ArcB'-LacZ fusion, 
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Bscrp for ScrP'-LacZ, and Bmtga for MtgA'-LacZ fusions (listed in 
chapter 2.1). 
PCR was conducted as described in Section 2.4.13, using Vent DNA 
polymerase in order to minimise PCR generated mutations, with 
annealing temperature of 55°C and extension time of 3 mm, 
appropriate for the length of the amplified DNA. The 4.0 kb of PCR 
products were gel-purified, then digested with Asc I and Bgl II (for 
the arcB fusion construction), or BstB I and Bgl II (for the scrP and 
mtgA fusion constructions). Asc I and Mlu I produce compatible 
cohesive ends, as do Cia I and BstB I. The fragments were 
accordingly ligated to pBRU 12 digested with Mitt I and Bgl II (for the 
arcB fusion construction), Cia I and .Bgl II (for the scrP fusion 
construction) or BstB I and Bgl II (for the mtgA fusion 
construction), respectively. However, attempts to clone these PCR 
products directly into pBRU 12 failed, and the whole PCR products 
were first subcloned into pBR322 digested with EcoR I (for the arcB 
fusion construction), or Nru I (for the scrP and mtgA fusion 
constructions). They were digested with the enzymes as above 
(Bgi II with Asc I or BstB I), 4.0 kb fragments were purified and 
then cloned into pBRU12. 
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Figure 4.12. The scheme of chromosomal lacZ fusions constructions. 
Relevant genes and restriction sites are shown. The crossover between 
homologous sequences of the chromosomes of TS9 and DA26 is about 520 bp. 
The orientation of genes in Tn5 is not known. 
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After transformation into the E. coil strain DH5a, CmR  and Amp' 
colonies growing at 37°C and turning blue on LB-plates containing 
X-gal were chosen for analysis. 
The plasmids were named pALC1, pSLC1, and pMLC1 - for QrcB, 
crP and rntgA fusions to acZ-.AT, respectively. Their structures 
were confirmed by restriction analysis with Bgi II, EcoR I (Fig. 4.11). 
pUC18 contains the sequence coding for the cx-peptide of 
3-galactosidase. To ensure stability of the fusion constructions in 
recA+ cells it was necessary to remove this sequence. To achieve 
this, pALC1, pSLC1 and pMLC1 were digested with Ehe I and Xba I 
(Fig. 4.1 1). The recessed 3' termini were then filled in by treatment 
with Sequenase® Version 2.0 T7 DNA polymerase, and re-ligated. 
After ligation the mixture was digested with Sal I endonuclease, to 
reduce recovery of the parental plasmid. The products were then 
transformed into DH5a and the transformants were plated at 30°C. 
The plasmid products were checked for the absence of Xba I, Ehe I 
and Sal I sites and the second Hind III site. The resulting plasmids 
were 186 bp shorter than their parents and were named pALC2, 
pSLC2, and pMLC2. 
4.3.3. Replacement of the chromosomal copies of arcB, scrP 
and mtgA with their lacZ fusions. 
The arcB region on the chromosome of E. coli strain TP8503 was 
partially replaced with the above iacZ fusion constructions 
according to the protocol described in section 2.3.6. TP8503 cells 
were transformed with pALC2, pSLC2 and pMLC2 and subjected to 
AmpR and  CmR selection at 30°C. The purified transformants were 
then grown in L-broth in the presence of chioramphenicol only, and 
P1 lysates were prepared on them. These lysates were used to 
transduce MM20 cells, which are polA and therefore cannot 
replicate ColE 1 derived plasmids, to CmR. The resulting CmR AmpS 
colonies were purified and used to produce second P1 lysates, 
which in turn were used to transduce TP8503 cells to CmR. 
However, none of the resulting CmR AmpS colonies turned blue on 
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LB-plates containing X-gal, even though DH5ct cells transformed 
with the corresponding plasmids had developed a blue phenotype. 
In principle this might be due to a copy number effect. On the other 
hand, the chromosome of DH5a cells contains the downstream 
portion of lacZ and produces the 0)-peptide of 3-ga1actosidase, 
whereas TP8503 is a lacZ-null strain. Therefore, it is possible that 
the PCR-generated lacZ-w portions in pALC2, pSLC2 and pMLC2 
contained errors producing a Lac phenotype, although their lacZ-a 
portions must be Lack because the DH5a cells transformed with 
these plasmids had been screened for the blue colour on LB-plates 
containing X-gal. 
To correct the lacZ sequence of pSLC2, its Aoc I-Nde I portion of 
lacZ was replaced with that from pMLHM::lacZ, a plasmid with the 
wild-type lacZ sequence from pTAC3953 [Tove Altung, pers. comm. to 
R. Hayward]. The sequence of the downstream end of lacZ beyond 
the Nde I restriction site in pSLC2 had been confirmed beforehand 
by sequence analysis of pSLC2 using primer 839F, which is directed 
upstream from within the beginning of the CAT gene. DH5ct was 
transformed to CmR with the pSLC2/lacZ ligation products. 
Transformants which turned blue on LB-plates containing X-gal 
were grown at 30°C, and had plasmid DNAs were isolated. TP8503 
cells were then transformed with these plasmids and grown at 
30°C. Blue TP8503 transformants carried pSLC3, the pSLC2 
analogue with the wild-type lacZ sequence. 
Next, pSLC3 was digested with Aoc I and BamH I, and its large 
fragment was purified and ligated with the small Aoc I-BamH I 
fragments of pALC1 and pMLC1. The ligation mixtures were 
enriched for the desired products by digestion with Sal I. Both the 
resulting plasmids should carry wild-type lacZ. They were named 
pALC3 and pMLC3, respectively (Fig. 4.11). 
pALC3, pSLC3 and pMLC3 were transformed into E. coli TP8503 
cells, and blue colonies were selected on LB-plates containing X- 
gal, Cm and Amp at 30°C. These were purified and grown in L-broth 
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at 30°C in the presence of chioramphenicol only, and used for the 
preparation of P1 lysates. 
MM20 cells were transduced with the resulting lysates, plated on 
L-agar containing chioramphenicol only, and grown at 37°C. 
Colonies sensitive to ampicillin were then purified (TA5, TS5, and 
TM5) and used to produce fresh P1 lysates, which were used to 
transduce TP8503 cells. Transductant colonies which had a CmR 
Amps phenotype were selected at 37°C. The resulting strains were 
named TA6 (with the arcB-lacZ fusion), TS6 (scrP-lacZ fusion), and 
TM6 (mtgA-lacZ fusion) (Fig. 4.12). 
In the presence of X-gal at 37°C, TA6 and TS6 colonies turn blue in 
their centres by the second day, whereas TM6 colonies do not give 
any noticeable blue colour. 
4.3.4. Confirmation of the structure of TA6, TS6 and TM6. 
The correct insertion of the lacZ fusion - CAT cassettes into the 
chromosome of TP8503 was confirmed by PCR analysis and by 













Figure 4.13. CAT is present on TA6, TS6 and TM6 chromosomes in the expected 
position. PCR analysis of single colonies of each of the strains using primers IntP 
and ExtP (Fig. 4.11). TP8503 (parental strain, CAT) is a negative control. 
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Figure 4.14. Southern blot analysis of chromosomal DNA of strains TP8503. TA6 
and TS6 digested with indicated enzymes. The probe was [32 P1-.labelled mixture of 
3.96 kb EcoR I-Hind III fragment of pTAK1 (100 ng) and X DNA (10 ng) (Boehringer 
Mannheim) (see section 2.4.9). pMLC1 digested with Hind III presented as a positive 
control. The markers are Ml - Gibco High Molecular Weight Marker, M2 - MBI 
Fermentass 1 kb ladder. Fragment sizes are given in kb. Expected fragment sizes are 
shown at the bottom. 
The PCR was performed on resuspended colonies of TA6, TS6 and 
TM6 cells, using primers IntP and ExtP to amplify a fragment of 
1.45 kb, between the downstream end of the CAT gene and the 
segment of chromosomal DNA lying beyond the BamH I site of the 
EcoR I-BamH I fragment used to construct pBRU12 (Fig. 4.12). The 
expected product of this reaction can only be amplified if the CAT 
gene is inserted in the correct location on the chromosome, 
because the IntP primer is complementary to the plasmid borne 
CAT gene (not present on the TP8503 chromosome), and the ExtP 
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primer is complementary to a piece of chromosomal DNA not 
present on the plasmids (Fig. 4.11). All three fusion strands (TA6, 
TS6 and TM6) yielded this PCR product, whereas TP8503 did not 
(Fig. 4.13). 
The analysis by Southern hybridisation was performed using 
chromosomal DNA purified according to the protocol described in 
section 2.4.10. The DNA was digested with the Sac II or Nde I 
restriction endonucleases, fractionated on a 0.7% agarose gel, 
Southern-blotted and probed with the gel-purified 3.96 kb EcoR I-
Hind III fragment of pTAK1 which includes the arcB, scrP and mtgA 
genes, [32P]-labelled as described in chapter 2 (2.4.9, 2.4.12). 
The expected size of the fragment hybridising to the probe in the 
case of the Sac II digests is 9.4 kb for TP8503, 10.6 kb for TA6, and 
12.5 kb for TS6 (Fig. 1.2.1). In the case of the Nde I digests, the 
expected size is 13.5 kb for TP8503, 6.8 kb for TA6, and 8.7 kb for 
TS6. 
The sizes of the fragments responding to the probe in the 
hybridisation experiment clearly correspond to those expected, 
thus confirming that the insertions of the lacZ-CAT cassettes have 
occurred in the correct loci (Fig. 4.14). 
4.3.5. Sensitivity to dyes. 
One phenotype produced by arcA and arcB mutations is sensitivity 
to certain redox dyes, such as toluidine blue and methylene blue. 
The mutants give tiny or no colonies on plates containing these 
dyes [Ishige et al., 1994]. TA6 should be ArcB due to insertion of 
the lacZ cassette in arcB, whereas TS6 and TM6 should be ArcB. 
These predictions were tested as follows. 
MM20 and DA26 are strains which carry arcB mutations [Smillie, 
1994; Ishige et al., 1994]. TA6, as well as MM20 and DA26, proved 
sensitive to toluidine blue and methylene blue when grown on T-
agar in the presence of dye. Moreover, when MM20 (arcB) was 
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transduced with P1 lysates grown on TS6 or TM6 strains and 
selected for CmR, all of the resulting transductants proved 
resistant to toluidine blue and methylene blue. These results 
provide further evidence for the correct insertion of the lacZ-CAT 
cassette into the TA6, TS6 and TM6 chromosomes. 
4.3.6. Complementation tests. 
Mutations in arcB can be complemented by providing arcB on a 
plasmid [Elding, 1995]. Tests of this sort were therefore carried out, 
as summarised in Table 4.2. 
Table 4.2. Colony size of strains on dye agars (toluidine blue and methylene blue) 
at 37°C. TP8503 is arcB+ control strain and, and pJJW1 1 is the arcB-null control 
(vector) plasmid. -: not tested. 
Strain TP8503 TS6 DA26 TA6 
Plasmid 
- normal normal tiny tiny 
pJJW11 - - tiny tiny 
PACE 1 - - normal tiny 
pTAK1 - - normal tiny 
pFMT1 1 	- - normal I 	tiny 
It can be seen that DA26 cells (AarcB::CAT) carrying pTAK1, pACE 1 
or pFMT1 all grow well on toluidine blue and methylene blue at 
37°C. This indicates that /iarcB can be complemented in trans by all 
three arcB1 plasmids, including pFMT1. This further confirms that 
pFMT1 encodes a fully functional ArcB, in contrast to earlier 
concern (mentioned in chapter 1) that pFMT1 might carry a 
truncated arcB which could not produce a functional protein 
[Smillie, 19941. 
In contrast, TA6 cells (arcB'-'lacZ, CAT) transformed with either 
pJJW1 1, pTAK1, pACE 1 or pFMT1 produce tiny colonies on dye 
agars. This indicates that the arcB mutation in TA6 can not be 
complemented in trans. 
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TA6 cells grow more slowly even on dye-free agar than those of TS6 
and TM6, which carry scrP-lacZ and mtgA-lacZ fusions, or their 
parent TP8503. This suggests that the fusion protein ArcB-LacZ 
may be toxic to cells. To test if this is the case, strains were 
transformed with plasmids encoding arcB + scrP + mtgA, (pACE 1, 
pTAK1 and pBRU12), or plasmids carrying the arcB-lacZ or scrP-lacZ 
fusions together with the CAT gene (pALC3 and pSLC3) and grown 
on the dye (toluidine blue) agar at 30°C. The results are presented 
in Table 4.3. 
The reason for doing these dye-sensitivity tests at the lower 
temperature was the previously observed deleterious effect of the 
pUC18 derivatives pBRU12, pALC3, pSLC3 and pMLC3 on colony 
growth at 37°C, presumably due to the very high copy number of 
these plasmids and consequent overexpression of the membrane 
protein LacZ(8aa)-ArcB or its 'LacZ fusion (ArcB produced from 
pBRU12 and its derivatives has 8 extra amino acids at its 
N-terminus, due to fusion to the beginning of LacZ). Similar 
observations of the toxicity of ArcB and even of ArcB lacking its 
transmembrane domains, when overexpressed from very high copy 
number plasmids (derivatives of pBluescript), were reported earlier 
[luchi and Lin, 1992b; luchi and Lin, 1992a]. In contrast, all the 
plasmids shown in Table 4.3. were derived from pBR322, and their 
effect on growth rate of cells at 30 or 37°C is negligible. 
Table 4.3. Colony size of strains on dye agar (toluidine blue) at 30°C. pACE 1 and 
pTAK1 are derivatives of pBR322. pBRU12, pALC3 and pSLC3 are derivatives of 
pUC18. pACE1, pTAK1, pBRU12 and pSLC3 contain full-length arcB. TP8503 and 
DH5cx are arcB. -: not tested. 
Strain TP8503 TA6 DH5a 
Plasmid 
- normal tiny normal 
pACE 1 - tiny - 
pTAK1 - - normal 
pBRU12 - tiny tiny 
pALC3 tiny I - tiny 
pSLC3 I 	- - tiny 
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All the plasmids with very high copy numbers, including pBRU12 
itself, show toxicity in all the strains analysed. Therefore, it is 
impossible to test the LacZ'(8aa)-ArcB-'LacZ fusion protein itself 
for particular toxicity using the set of plasmids we currently 
possess. It might be useful to transfer the DNA encoding ArcB'-
'LacZ fusion to a plasmid with the copy number of pBR322 or even 
lower, but this has not yet been done. The reason for the failure of 
ArcB+ plasmids to complement the arcB'-'lacZ single copy fusion 
gene to DyeR in strain TA6 remains unknown. 
4.3.7. The expression levels of the arcB-lacZ, scrP-lacZ and 
mtgA-lacZ fusions under various growth conditions. 
-ga1actosidase activity measurements. 
ArcB, as part of a two-component regulatory system, is involved in 
the aerobic/ anaerobic regulation of a large number of genes. It 
therefore seemed interesting to study the expression of all three 
genes in the putative arcB operon at different stages of growth 
under aerobic and anaerobic conditions. The strains carrying the 
lacZ fusions were grown aerobically (with vigorous shaking) or 
anaerobically (under strict anaerobiosis, as described in section 
2.2.4) in L-broth supplemented with 40 mM glucose, in the 
presence of the appropriate antibiotics (section 2.2.4). Samples 
were taken at different times during growth, and the 
-ga1actosidase activity measured as described in section 2.5.11. 
Raw data for one strain and growth conditions are exemplified by 
Fig. 4.15, and the overall results are presented in Fig. 4.16. 
Under aerobic conditions, TA6 cells produce a 3-galactosidase 
activity of about 11 Miller units during exponential growth. Upon 
entry into stationary phase, under the same conditions, which 
rises about 2-fold soon after entry into stationary phase (Fig. 4.15, 
4.16 a, and Table 4.4). 
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TS6 cells, grown under the same conditions, produce a 
3-ga1actosidase activity of about 9 Miller units during exponential 
growth, which rises 1.55-fold soon after entry into the stationary 
phase (Fig. 4.16 a, table 4.4). 
As mentioned before, luchi and Lin [luchi and Lin, 1992a] reported 
that the expression of arcB does not differ significantly between 
aerobic and anaerobic conditions. Our data show that it is about 
1.4 times higher under anaerobic than under aerobic conditions in 
the exponential growth phase, but is practically the same in the 
stationary phase under the both conditions (Fig. 4.16 b). This might 
suggest that the latter increase under aerobic conditions could be, 
at least partly, due to oxygen starvation at high cell densities. 
Although these changes in activity are rather small, they appear to 
be statistically significant (Table 4.4). 
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Figure 4.15. Growth curve and specific 3-galactosidase activity of TA6 cells grown 
on glucose-enriched L-broth under aerobic conditions. A 600 (left axis, diamonds) 
and specific 3-ga1actosidase activity (right axis, squares) are plotted against time. 
Different types of square symbols represent the results of 7 separate experiments. 
The data of one of the experiments (whose results are close to the mean ) are 
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Figure 4.16. a) 3-ga1actosidase activity of TA6 and TS6, with or without pACE 1, 
grown under aerobic and anaerobic conditions, in Miller units. The results shown 
are the means and standard errors of the activities in exponential (:) and 
stationary ( RI  ) phases, each derived from 6-11 experiments. A result of a single 
experiment is a mean of J-galactosidase activities (MU) of samples taken at A 600 
between 0.1 and 0.4 (for exponential phase); and a J-galactosidase activity of a 
sample taken 10 — 12 hours (aerobic growth) or 16-20 hours (anaerobic growth) 
after start of incubation. 
b) Ratio of the -galactosidase activity (MU) under anaerobic conditions 




Table 4.4. Data for Fig. 4.16, 3-galactosidase activities (means and standard 
errors) of TA6 and TS6 under different conditions, in Miller units. The data are 
plotted in Fig. 4.16. Stationary/ exponential phase ratios of 3-galactosidase 





Exponential Stationary Stationary/ 
exponential 
ratio 
Aerobic TA6 11.2± 1.0 21.3± 1.7 1.99±0.11 
TA6pACE1 12.5 ± 0.9 25.4 ± 2.21 2.04 ± 0.17 
TS6 8.7 ± 0.4 13.2 ± 0.5 1.55 ± 0.04 
TS6pACE1 10.1 ± 0.4 15.7 ± 0.8 1.56 ± 0.08 
Anaerobic TA6 15.2± 1.4 19.5± 1.0 1.29±0.11 
TA6pACE1 16.7 ± 1.7 24.3 ± 1.8 1.49 ± 0.12 
TS6 18.2± 1.1 21.3± 1.0 1.19 ±0.08 
TS6pACE1 1 	16.7 ± 0.7 20.8 ± 1.2 1 	1.24 ± 0.06 
Anaerobic/ 
aerobic ratio TA6 1.4 ± 0.2 0.9 ± 0.1  
TA6pACE1 1.3±0.2 1.0±0.1  
TS6 1 	2.1 ± 0.2 1.6 ± 0.1  
TS6pACE1 1.7±0.1 1.3±0.1  
In stationary phase TA6 cells produce similar amount of 
3-galactosidase under both aerobic and anaerobic conditions, 
whereas TS6 cells give specific activity higher under anaerobic than 
aerobic conditions (Fig. 4.16 a, table 4.4). 
Under anaerobic condition (exponential growth) the expression of 
scrP-lacZ fusion is about 2.1 times higher than under aerobic 
conditions, against only 1.4 times increase for arcB-lacZ. 
These observation provide a very tentative evidence for the 
following hypothesis. If the effects are transcriptional (this is not 
clear, since the protein fusions could also be affected by post-
transcriptional regulation of arcB and scrP), then the arcB promoter 
is somewhat induced by oxygen starvation; scrP is cotranscribed 
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with arcB, but can also be served by its own independent promoter 
which is induced under anaerobic conditions. 
The TM6 strain, which carries the mtgA-lacZ translational fusion on 
the chromosome, does not exhibit any detectable 0-galactosidase 
activity. This could either be due to its very low expression, or to 
inactivation of -galactosidase as a result of an abortive attempt by 
the cell to transport the fusion protein through the inner 
membrane into the periplasm - the normal locale of the MtgA 
protein [Di Berardino et al., 19961. The former is possible because 
even the best estimates of MtgA synthesis from T7 RNA 
polymerase-driven overexpression experiments suggest that there 
can be 7-10 times less MtgA synthesised than ScrP. The measured 
3-ga1actosidase activity of ScrP-LacZ fusion protein is 7-15 Miller 
units, therefore MtgA-LacZ fusion protein, provided it is active, 
would not be expected to be expressed at a detectable level. 
Growth curves show that the doubling time for ArcB - strain TA6 is 
approximately 1.5 (1.49 ± 0.15) times higher than that for its 
isogenic ArcB counterpart, TS6, at least under aerobic conditions. 
However, when both strains carry complementing pACE 1 or pTAK1 
with the arcB-scrP-mtgA served by a plasmid promoter the ratio of 
their doubling time becomes similar (1.02 ± 0.18). Thus the ArcB 
phenotype of TA6 is complemented by these plasmids in terms of 
growth rate, making it all the more puzzling that its dye-sensitivity 
is not complemented (as mentioned in the previous section). Since 
the dye-sensitivity of strain DA26 is complemented, it seems likely 
that the nature of the ArcB-LacZ fusion protein produced in TA6 
that underlies its persistent sensitivity. Perhaps the latter 
phenotype is more sensitive to the presence of defectively folded 
chimaeric ArcB protein in the cell, or its inappropriate localisation 
within the cell membrane. This can be especially the case if ArcB 
acts as a dimer when it senses the signal (in its sensor part) and 
passes it down to kinase domains. 
The 3-galactosidase expression by TA6 is scarcely affected by the 
presence or absence of pACE1, and the expression by TS6 shows 
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little more effect (Fig. 4.16 b). This indicates that the expression of 
arcB and scrP is ArcS-independent, and the expression of scrP is 
largely, if not completely, ScrP-independent. 
Detection of fusion proteins measured by Western analysis. 
To confirm that the f3-galactosidase measurements truly reflect the 
level of transcription and translation of the fusion genes and are 
not affected by decay of their protein products, cell extracts were 
subjected to SD S-PAGE and Western analysis. 
TA6, TS6 and TM6 cultures were sampled during aerobic growth. 
Samples were concentrated by centrifugation, resuspended in SDS-
PAGE loading buffer, lysed and fractionated by 7% SDS-PAGE. The 
gel was then blotted onto a nitrocellulose membrane and probed 
with anti- 3-ga1actosidase antibodies, as described in section 2.5.2. 
The results are shown in Fig. 4.17 and 4.18. 
There is a relatively high background, presumably due to the low 
level of expression of the fusion proteins and not the very 
impressive specificity of the antibody. Nevertheless it is clear that 
no extensive accumulation of -galactosidase decay products has 
been detected in the TA6 or TS6 samples (Fig. 4.17). 
In the exponential phase samples, the band corresponding to the 
ScrP-LacZ fusion protein shown on Fig. 4.18 is at least 6-fold more 
intense than that of MtgA-LacZ, and ArcB-LacZ is about twice as 
intense as ScrP-LacZ (it is not possible to talk about amounts of 
protein expression here as there was no calibration for amounts 
3-galactosidase made in this experiment). These observations do 
not contradict to relative amounts of ScrP and MtgA produced in the 
T7 RNA polymerase-driven in vivo-overexpression system and with 
the 3-ga1actosidase activity measurements discussed in the 
previous section. The difference between the ArcB-LacZ and ScrP-
LacZ results could reflect partial termination of transcription 
between arcB and scrP, and/or a different efficiency of their 
ribosome-binding sites. 
167 
a 	 b 
Sample 	 TA6 
A60° 	0.4 0.15 0.20 0.26 0.45 0.81 1.91 3.08 3.61 3,89 377 4.08 
I'act 
Hours after 
inoculation 31 	3.1 3.4 3.8 	4.2 	5.1 	6.0 7.3 	8.6 9.3 10.3 24 
158 
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Figure 4.17. Western blots of SDS-PAGE fractionated extracts of cells sampled at 
different times and A600 from 37°C L-broth cultures of a) TA6 and b) TS6. The total 
protein inputs in each track were nearly equal. Molecular size markers and a 
TP8503 (LacZ-null) control track are shown on the left of each blot. A sample of 
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Figure 4.18. Western blot of SDS-PAGE-fractionated extracts of cells sampled in 
exponential (A 600=0.5) (exp) and stationary (A600=3.5) (stat) phase (10 hours after 
inoculation). The total protein inputs in each track were nearly equal. M, positions 
of molecular weight markers. (Only the relevant, upper part of the gel is shown; the 
rest is heavily developed and uninterpretable, the specificity of the detection system 
was much lower than in the previous figure). 
The ArcB-LacZ and MtgA-LacZ fusion proteins migrate on the SDS-
PAGE gel at rates lower than their predicted sizes (162 and 
132 kDa), but well above -ga1actosidase. However, ScrP-LacZ 
(predicted molecular size 132 kDa) migrates at the same rate as 
3-galactosidase (116 kDa) (Fig. 4.18). If this is not a result of 
anomalous mobility (ScrP itself migrates close to the predicted 
rate), it could reflect rapid proteolytic separation of the ScrP and 
LacZ moieties of the fusion protein. Taking into account that ScrP 
has a leader peptide directing it to the periplasmic space, such an 
instability of the fusion protein seems to be fortunate in terms of 
accuracy of measurement of its expression using 3-galactosidase 
activity assays, since partially transported hybrid protein might not 
have such activity. 
The total membrane fractions of the TA6 and TS6 cells were 
isolated according to the protocol described in Section 2.5.8, and 
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were loaded, along with total cell extracts, onto 8% SDS-PAGE gels 
(TA6, Fig. 4.17 a; data for TS6 are not shown). The ArcB-LacZ fusion 
protein (of expected size) appeared in the insoluble (membrane) 
fraction, thus suggesting that ArcB is associated with the 
membrane, through the residues within the N-terminal 379 amino 
acids present in the fusion. This should be the inner membrane, as 
the fusion protein displays -galactosidase activity. This is 
consistent with earlier data and the prediction of an N-terminal 
membrane anchor (chapter 1). The insoluble fraction of the TS6 
cells does not respond to the antibody, which is not unexpected, 
provided the assumption about the instability of the ScrP-LacZ 
fusion protein is true. 
4.3.8. scrP expression appears to be independent of rpoS. 
Because both the arcB-lacZ and scrP-lacZ fusion strains show 
higher specific 3-galactosidase activity in stationary phase, an 
attempt was made to check whether the expression of scrP was 
affected by as, a sigma factor active in stationary phase and 
encoded by rpoS. 
AF681 [Farewell et al., 1996] was used as a source of an rpoS::KanR 
insertion mutation, which was transduced into TS6. The resulting 
CmR and  KanR colonies were screened for kat (RpoS -) phenotype, 
as described in Section 2.5.12. 
Judged by the -galactosidase activity in exponential and stationary 
phases (Fig. 4.19) TS6 and TS6rpoS showed exactly the same 
pattern of ScrP-LacZ expression, suggesting that its expression is 
independent of the presence or absence of cyS.  TS6rpoS required 
longer incubation to achieve the same cell density as rpoS strains. 
This can be due to smaller initial cell density of rpoS::KanR cells 
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Figure 4.19. a) Growth curves and b) corresponding -galactosidase activity 
measurements of TS6 (squares) and TS6rpoS (circles) at various times alter dilution 
and growth in L-broth at 37°C under aerobic conditions. The results of two 
experiments are shown. 
4.3.9. arcB and scrP expression is independent of arcA. 
One study has suggested that arcA expression partly depends on 
the Arc system ([Compan and Touati, 19941, chapter 1). To test for 
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effects of Arc system on arcB and scrP expression, two arcA 
mutations were used. Strain ECL1601 was used as a source of the 
arcA2 mutation linked to TetR  (zjj::TnlO), and DS941 arcA::Tn5 2.3 
was used as the source of a Tn5 insertion within arcA. (Both 
strains were kindly provided by Dr. Sean Colloms). A P1 lysate 
grown on ECL1601 was used to transduce TP8503 to TetR. TetR dye-
sensitive (arcA2 zjj::Tn 10) and dye-resistant (zjj::Tn 10) 
transductants were then purified and transduced to CmR  with a P1 
lysate grown on strain TA5. The resulting, purified dye-sensitive 
strains, TA8 and TAb, have the genotypes TP8503 arcA2 zjj:.'rnlO 
arcB'-'lacZ CAT, and TP8503 zjj:.Tn 10 arcB'-'lacZ CAT, respectively. 
The P1 lysate grown on TP8 503 arcA2 zjj::Tn 10 cells was also used 
to transduce TS6, to produce the dye-sensitive strain TS12 (TP8503 
arcA2 zjj:.Tn10 scrP'-'lacZ CAT arcB) and dye-resistant TS 13 (TP8503 
arcAl zjj:Tn 10 scrP'-'lacZ CAT arcB). 
A P1 lysate grown on DS941 arcA::Tn5 2.3 was used to transduce 
TA6 and TS6 cells to KanR. The resulting strains, selected for KanR 
CmR and screened for dye-sensitivity, were purified and named TA9 
(TP8503 arcA::Tn5 2.3 arcB'-'lacZ CAT) and TS 14 (TP8503 arcA::Tn5 
2.3 scrP-'lacZ CAT), respectively. 
The expression of the arcB'-'lacZ fusion is essentially the same in 
arcAl arcB and arcA arcB backgrounds (Table 4.5 and Fig. 4.16), at 
least under studied aerobic conditions. TA6 (arcB-'lacZ arcA), TA6 
supplemented with arcBI expressed from a plasmid, TA8 (arcB'-'lacZ 
arcA2) and TA6 arcA::Tn5 2.3 all show very similar 3-galactosidase 
activities under aerobic conditions, in both the exponential and 
stationary phases. This indicates that arcB expression is 
independent of ArcA regulator. However, this interpretation is 
subject to a caveat, because the dye-sensitive phenotype of TA6 is 
not complemented by pACE 1 or pTAK1. This is indicative of some 
impairment of Arc function in this strain, even though normal 
growth rate is restored by addition of those plasmids. Therefore all 
measurements of the expression of the arcB'-'lacZ fusion in this 
work, including those in Table 4.5, have been carried out with the 
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Arc system inactive (in plasmid-free TA6 -ArcB), or impaired (in TA6 
carrying arcB plasmids). This might conceivably conceal any 
requirement for ArcA. 
Table 4.5. Results of 3-galactosidase activity measurements (Miller units) of 
strains grown in L-broth at 37°C under aerobic conditions unless otherwise 
indicated. Cells were sampled at A 600  of approximately 0.3 (exponential phase) or 
about 11 hours after inoculation (stationary phase). *: the mean and range of two 





TA6 (arcA) 11.2 ± 1.0* 21.3 ± 1.7* 
TA9 
(TA6 arcA::Tn5 2.3)  
10.0 ± 2.2* 16.8 ± 2.7* 
TA10 (TA6 zjj::TnlO) 14.4 18.0 
TA8 
(TA10 arcA2)  
13.3 17.2 
TS6 8.7 ± 0.4* 13.2 ± 0.5* 
TS 14 
(TS6 areA::Tn5 2. 3 ) 
6.8 ± 0.2* 9.9 ± 1.4* 
TS13 (TS6 zjj::TnlO) 7.0 14.9 
TS 12 
(TSI3 arcA2)  
9.0 17.0 
TS 10 (scrP'-'lacZ, KanR 
LlarcB::CAT)  
2.0 ± 1.0* 2.3 ± 0.2* 
anaerobic growth 3.2 1.5 
TS11 
(TS6 arcB:frn5 5.4)  
3.6 ± 0.6* 5.4 ± 0.3k 
anaerobic growth 1 	7.7 5.7 
No such caveat applies to the conclusion that scrP expression is 
clearly independent on ArcA. The expression of the scrP'-'lacZ 
fusion is independent of this regulator and, therefore, on Arc 
system, at least under aerobic conditions, because it is essentially 
the same in arcB arcAl and arcB arcA strains (compare TS6 with 
TS 14, and TS 13 with TS 12, in table 4.5). 
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4.3.10. Expression of the scrP'-'lacZ fusion in an arcB 
background. 
The strain DA26 which carries arcB::CAT has been used to make 
an arcB-null strain carrying a chromosomal scrP-'lacZ fusion. DA26 
has a complete deletion of arcB, including the likely arcB promoter, 
and of an undetermined amount of intergenic DNA upstream and 
downstream from arcB [Ishige et al., 1994]. Before constructing the 
required strain it was necessary to find out if the length of DNA 
surviving on DA26 chromosome, between the CAT insertion and the 
Cia I site in the scrP gene (the site of the lacZ fusion insertion in 
TS6), would be sufficient for chromosomal recombination. This was 
done by PCR analysis using of several sets of primers (Fig. 4.20, 
4.21). 
CATout2 is a primer complementary to the beginning, and IntP to 
the end, of the CAT gene. Both are directed away from the CAT 
gene. 083V is a primer which starts at bp 378 of the coding 
sequence of scrP, and is directed upstream from it. 
The results of the PCR reactions show that amplification of DA26 
(and not the control TS6) samples with the IntP/083V pair of 
primers gives a specific product of approximately 0.52 kb, while PCR 
with the CATout2/083V pair does not (Fig. 4.21 a). This indicates 
that the CAT gene on the DA26 chromosome is oriented in the 
same direction as arcB and scrP, and that the distance between the 
downstream end of the CAT gene and the Cia I site in scrP gene 
(which is 470 bp downstream from the start of scrP) is close to 
0.52 kb. This should include about 50, but no more than 100 bp of 
the DNA upstream of the scrP gene. 
As seen from Fig. 4.21 c, PCRs with primer 997M do not produce 
products when DA26 sample is used as a substrate, whereas use of 
primer 834T leads to products of the expected sizes. The control 
reactions with TP8503 all produce the expected products. Sufficient 
DNA to hybridise with primer 834T (nt 69 to 52 upstream from the 
first scrP codon) is therefore present on the DA26 chromosome, 
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whereas sufficient DNA to hybridise productively with primer 997M 
(202-184 nt 28 nt upstream from the first scrP codon) is not. The 
distance between the downstream end of the CAT insertion on the 
DA26 chromosome and the Cia I site in scrP is therefore between 
0.58 and 0.67 kb. It remains unclear whether the putative scrP 
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Figure 4.20. Scheme of PCR reactions with TP8503, DA26, TS6 and TS10 cell 
samples and various primers, as mentioned in the text. Coordinates are relative to 
translational start for scrP. The proposed -35 and -10 elements of a putative scrP 
promoter ISmillie, 19941 lie between -84 and -56 nt upstream from +1. 
pSLC3 was the source of the scrP'-'lacZ fusion for study in a iarcB 
background. However, DA26 is 4arcB::CAT, so the CAT gene in 
pSLC3 was unsuitable as a marker for fusion insertion. Accordingly, 
the CAT gene in pSLC3 was first replaced with the KanR  cassette by 
digesting the plasmid with Hind III and Bgl II and ligating the 
products with the Hind III-BamH I fragment (encoding KanR)  of 
pUC4K (Fig. 4.22). The ligation products were transformed into 
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DH5a and the transformants were plated on agar containing X-gal, 
ampicillin and kanamycin at 30°C. Blue AmpR KanR colonies were 
purified and the structures of the plasmids present were verified by 
restriction analysis with BamH I and Hind III. the required plasmid 
was named pSLK3. 
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Figure 4.2 1. PCR products of the reactions (see Fig. 4.20) fractionated on 1% 
agarose gel. M, DNA molecular size markers, molecular sizes given in kb. a) PCR of 
DA26 and TS6 (control) samples with the IntP/083V or CATout2/083V pairs of 
primers. The specific product of -P0.52 kb present in the DA26 IntP/083V track is 
marked by an arrow on the right. b) - Confirmation of the expected insertion site of 
lacZ on the chromosomes of TS6 and TS10 by PCR with the 877L/Univ.P pair of 
primers. The expected product of 446 bp was synthesised. TP8503 was used as a 
control. c) - Determination of the region of the CAT gene insertion in DA26 by PCR 
using primers 997M or 834T as shown in a. Expected product sizes for TP8503 are: 
997M/876L, 280 bp; 997M/287M, 477 bp; 834T/876L, 147 bp; 834T/287M, 344 bp. 
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Figure 4.22. Construction of pSLK3 by replacement the CAT cassette in pSLC3 
with the KanR  cassette from pUC4K. 
pSLK3 was next used to replace the chromosomal scrP with the 
scrP'-'lacZ fusion in MM20asn (according to the protocol described 
in section 2.3.5). TP8503 cells were transformed with pSLK3 at 
30°C, with AmpR  and KanR selection. A purified AmpR KanR 
transformant was then grown at 30°C in L-broth in the presence of 
kanamycin only, and a P1 lysate was prepared. This lysate was used 
to transduce MM20asri cells at 37°C, selecting for KanR. A purified 
transductant which was Amps KanR (as well as CmS) was named 
TS9. The structure of its scrP region is shown in Fig. 4.12. 
The strain TS9 was now transduced with a P1 lysate made on DA26 
(4arcB::CAT) cells and the transductants were plated on L-agar 
containing X-gal, chioramphenicol, and kanamycin. Despite the 
short region of homology (about 0.6 kb) available for recombination 
between the CAT gene and the scrP'-lacZ junction (Fig. 4.12), a few 
CmR KanR colonies were recovered. All were white, indicating that 
the level of scrP-lacZ expression was very low, in contrast to that in 
the KanR parent TS9, which gave blue colonies on X-gal plates. 
Note that whereas transcription of scrP in TS9 can come from both 
arcB (and possibly other upstream promoters) and the putative scrP 
promoter(s), in the recovered white colonies (they have ParcB 
deleted) only the putative scrP promoters may serve the gene. This 
suggests that the latter are either inherently very weak, or 
weakened or inactivated by the tarcB::CAT replacement. It is also 
evident that transcription from the CAT promoter is efficiently 
terminated upstream of scrP. 
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One of the white colonies was purified, and a P1 lysate was 
prepared on it. TP8503 cells were then transduced with this lysate, 
selecting for KanR and CmR. The resulting strain, named TS10, was 
purified, and its ArcB- phenotype was confirmed by its dye-
sensitivity. The structure of its scrP region is shown in Fig. 4.12 
and was confirmed by PCR analysis (Fig. 4.20 and 4.21 b). The 
results of the PCR reactions show that amplification with the 
877L/Univ.P pair of primers produces a predicted 446 bp product 
when TS6 and TS10, but not TP8503, samples are used in the 
reaction. 
Due to uncertainty regarding the possible deletion of a putative 
scrP promoter in strain DA26 and its derivatives TS9 and TS10, 
strain DS941 arcB::Tn5 5.4 was used as the source of an alternative 
arcB mutation. In this strain all the coding sequence for arc.B is 
present, but it is interrupted by the insertion of Tn5 at codon 473. 
P1 grown on this strain was used for transduction of TS6 (Fig. 4.12), 
with selection of CmR and KanR transductants. The presence of the 
arcB: :Tn5 5.4 insertion in the resulting purified strain, TS 11, was 
confirmed by dye-sensitivity test. 
TS10 and TS1 1 were assayed for -galactosidase activity under 
aerobic as well as under anaerobic conditions. The results are 
presented in Table 4.5. 
In exponential and stationary phases, the amount of 
-galactosidase activity in aerobically grown TS 10 cells is between 1 
and 3 Miller units. It was also detected at a comparable level in 
anaerobically grown cells. This residual level of ScrP-LacZ 
synthesis might be due either to slight leakage of transcription 
from the CAT gene, or due to transcription from the putative scrP 
promoter which may, as discussed above, have wholly or partially 
escaped deletion from the TS 10 chromosome (Fig. 4.12). 
TS1 1 cells, on the other hand, show approximately 3-4 Miller units 
of 3-ga1actosidase activity in exponential phase and about 5.4 
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Miller units in stationary phase under aerobic, and 7.7 and 5.7 MU, 
respectively, under anaerobic conditions. 
If we suppose that the scrP transcription in TS 11 is coming from 
the putative scrP promoter (and not from Tn5 readthrough), then it 
can be assumed that about half of scrP transcripts produced under 
aerobic and anaerobic conditions in the normal operon (represented 
by TS6) come from the independent scrP promoter. The lower level 
of expression in TS 10 would then imply that scrP promoter is wholly 
or partially inactivated by the deletion associated with 
chromosomal L%arcB::CAT replacement in DA26. 
This reasoning is based, however, on the results of one or two 
experiments which need to be repeated. They are also weakened by 
the fact that in some cases Tn5, when inserted into an operon at 
certain sites, causes low level constitutive expression of distal 
genes [Berg et al., 19801. This was assumed to be due to a promoter 
within ends of Tn5 which possibly overlaps Tn5 target sequence 
boundary. 
Discussion 
The analysis of expression of genes adjacent to scrP showed that 
they all are transcribed from the promoter upstream of arcB, 
however the study of the expression of arcB'-'lacZ and scrP'-'lacZ 
fusions on the chromosome suggested that there might be an 
independent scrP promoter induced under anaerobiosis. Recent 
work by T. Azam in this laboratory [Azam, 19991 indicated that there 
is a promoter in the arcB-scrP intergenic region, and an even 
stronger one in this region in the opposite direction whose role is 
unclear. If so, this promoter, or at least 5' part of it, can be within 
that part of the intergenic region which is not present in DA26, TS9 
and TS 10 strain, since these express very little of scrP'-'lacZ fusion. 
It should be noted that translational -galactosidase fusions is not 
the best the choice of study of activity of proteins which are 
transported through the inner membrane, such as ScrP (a 
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periplasmic protein, as has been shown in this work) and MtgA. 
Proteins fused to -galactosidase might stick in the inner 
membrane and jam the secretion machinery. 3-ga1actosidase might 
not fold correctly and consequently does not show activity [Murphy 
and Beckwith, 1996]. Fortunately for our purposes it was possible to 
measure the expression of ScrP-LacZ fusion by measuring the 
activity of the cleaved 3-galactosidase. 
The MtgA-LacZ fusion protein is more stable therefore it should 
have difficulties during transportation through the inner 
membrane, and due to this reason its -galactosidase activity might 
not be detected. However, from the overexpression studies it can 
be concluded that MtgA is expressed many fold lower than ScrP, 
and therefore MtgA-LacZ fusion expression should be indetectably 
low for conventional 3-galactosidase assays. 
The 3-galactosidase activity exhibited by ArcB-LacZ fusion protein 
in this study might have been less than the one produced by the 
same amount of LacZ protein, due to localisation of N-terminal of 
ArcB-LacZ in certain parts of inner membrane and therefore 
hindrance of LacZ portion of the fusion to form tetramers necessary 
for -galactosidase function. 
The EcoR I-Hind III DNA fragment present in pFMT1, pTAK1 and 
other plasmids described further has the potential to encode only 
the ORFs arcB, scrP and mtgA. The 14 kDa peptide observed by 
Smillie [Smillie, 1994] in minicell experiment with pFMT1, and in 
maxicell experiment described in this work, is unaccounted for. It 
is not seen in the cells overexpressing scrP and mtgA, therefore it 
should be assigned to the DNA upstream from mtgA. The analysis 
of the entire EcoR I-Hind III region reveals an ORF within arcB long 
enough to encode a polypeptide of 15 kDa. It starts at 972 and 
finishes at 1374 nt of the arcB coding frame. Whether this 
polypeptide is an artefact of plasmid expression system, or it has a 
biological significance and is expressed in cells under physiological 
conditions, remains unclear. Similarity searches for the "15 kDa" 
ORF retrieve several DNA sequences, all from ongoing bacterial 
180 
sequencing projects, and all belonging to y-subdivision of 
Proteo bacteria. Each of these retrieved sequences is a part of a gene 
corresponding to E. coli arcB, and none of them constitute an ORF, 
as they all contain 1-5 stop codons. Therefore it seems that such a 
long ORF within E. coli arcB is there by chance, and possibly it is 
not expressed from the chromosome. 
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Article Outline AE 
Proteins overproduced in Escherichia coil sometimes form Inclusion bodies, which can then be dissolved with the help of 
chaotropic reagents such as guanidine hydrochloride or urea. To recover proteins in aqueous buffers suitable for biochemical 
use, the concentrations of chaotropic reagents then must be reduced, usually by dialysis or rapid dilution (Ref. ., 2. 2.). 
Unwanted re-precipitation often happens at this stage. Here, we report that dialysis against buffers containing 75% glycerol 
prevents such re-precipitation, and that the solubility can be efficiently maintained through a subsequent rapid dilution of 
the glycerol. 
Protocol 
The solubilization procedure consisted of two steps: 
Solubilizatlon of Inclusion bodies In guanidine hydrochloride (GnHCI) solution and removal of GnHCI 
The inclusion bodies are conventionally prepared from E. co/i cell homogenates by centrifugation for 30 min at 
13&puncsp;000 rpm at 4°C, and suspended In TEM buffer (10 mM Trls-HCI (pH 7.5), 1 mM EDTA, 1 mM 2-mercaptoethanol) 
containing GnHCI. The final concentration of GnHCI should not be less than 6M. Any Insoluble materials are removed by 
centrifugation under the same conditions. The supernatant is then rapidly diluted with 10 volumes of a buffer containing no 
denaturants, and kept for more than 20 min at 4°C, after which the suspension is centrifuged again. The resulting 
precipitate should contain proteins that are difficult to solubilize by ordinary procedures. The solubilization, dilution and 
centrifugation cycle is repeated once more, completing a very efficient purification step for such proteins. 
The washed precipitates are again dissolved In TEM buffer containing 6M GnHCI In a graduated conical tube, at a 
concentration of 2&ndash;20 mg protein/ml, as judged by the BCA protein assay (Pierce, Rockford). The solution Is 
transferred into dialysis tubing and an equal volume of glycerol Is added to prevent gelation of proteins during dialysis. 
After sealing the tubing, the solution Is mixed by inversion. The total protein concentration at this stage should be less than 
10 mg/ml; preferably less than 2 mg/mt. If the tubing contains less than 5 ml, It is placed in a 50 ml conical tube 
containing 45 ml of a 3:1 (vfv) mixture of glycerol and TEM buffer. If the volume Is greater, a 300&ndash;1000 ml 
centrifuge bottle is used. The tube or bottle is then rotated at 10 rpm and 4°C for more than 10 h. The 75% glycerol buffer 
is changed twice each 2&ndash;4 h or once after 8 h. The dialyzed solution can then be stored In a freezer at &mlnus;20°C. 
Dilution in an aqueous buffer 
The 75% glycerol solution containing 1&ndash;10 mg protein/ml is rapidly diluted with 6.5&ndash;14 volumes of TEM buffer 
containing 0.1 M NaCl to give a final solution containing 10&ndash;5% glycerol. For large scale preparations, the glycerol 
solution Is added dropwise at the center of the diluent, which Is simultaneously subjected to vigorous magnetIc stirring. For 
small scale preparations, drops of the glycerol solution are placed on the wall or lid of an Eppendorf tube containing diluent, 
followed by Vortex mixing at full-speed for 10 sec. The diluted samples are placed on ice for more than 10 mm, then 
centrifuged at not less than 10&puncsp;000?g to remove possible precipitate. 
Results and discussion 
No precipitation was observed with any of the ten test proteins in the first step ( Table 1 ). The high glycerol concentration is 
essential. Significant precipitation was observed when it was decreased to 50%. In the second step, rapid dilution is required 
for a high yield. The second step could be further improved by selecting better buffer components and by use of 
ion-exchange resin during renaturatlon (Ref. 1, L 3), but we here used only TEM buffer for dilution. 
# 	Source P ro te l n/ modifl ca tlon a 	Vector/host 	 So l u blllzedb 	ACtI V ItYc 	imp rovemen td 
Eschenchia 	Sigma-70 with deletion pTrc99A9/C600 	 >°"° 	+ 	 10 
co/i 	 of aa 130 through 374 
and carrying an 
HMKtag e. Also 4 
derivatives 
> 95%9 Not 10 
determined 
2 	Drosophila 175 aa section of TFIIII pGEX4T2h/6L21(DE3)1  9% + 180 
melanogaster homologue fused with 
GST at N-terminus 
3 	Arabidopsis Chioroplast SigA with pET15b1/BL21(DE3, 60% Not 85 
thaliana signal peptide 	
pLysS)1 
determined 
ibid 	. without signal 	IbId 15% Not 11 
peptide determined 
4 	Tetrahymena A translational factor pTE31/BL21(DE3)' >95% Not 110 
thermophila (His) 6 at C-terminus determined 
5 	Hen egg AvldinJ with a saturating 
- >95% + 10 
modification by 
FITC H 
aprepared in this study (1, 5) or gifts from Dr Hiroyuki Kose in the National Institute of Genetics (2), or from Dr Kan 
Tanaka (3) and Dr Koichi Ito (4) of Tokyo University. 
bFractions  of proteins recovered in the supernatant of the final buffer containing 5% glycerol. 
CACtiv itl es  were measured by transcription initiation (1), binding to a glutathione column (2), and binding to blotln (5). 
dRa tios  of the yields by the new procedure and the control procedure. 
eSee  Ref. 
'Derivatives with single amino-acid substitutions. 
9The K502C mutant of the sigma-70 derivative (50 &mu;g) was refolded on 0.1 ml of DEAE Tovooearl S650 resin 
(Toyobo). 
hFrom  Amersham Pharmacia Biotech 
'From Novagen 
From Talyo Kagaku, Tokyo 
kAfter  modification with FTC (Molecular Probe), unreacted FITC was removed by adding acetone to 50%, with precipitation 
of the modified avidin. 
In the conventional method that we have used as a standard for comparison. 0.1&ndash;10 mg total protein/ml in 6M GnHCI solution was 
dialyzed directly against TEM buffer containing 0.1 M NaCI and 5% glycerol, and the dialyzed solution was centrifuged to remove insoluble 
proteins. The initial protein concentrations used in the new procedure were 15-fold more concentrated, to compensate for the 15-fold rapid 
dilution in the second step. The soluble fractions obtained by the two procedures were analyzed by SDS PAGE and the gels were 
reverse-stained (Ref. 4, ). Proteins were quantitated by reference to bands of various amounts of 6M GnHCI solutions or 75% glycerol 
,oiutions. The new procedure improved yields by 10 to 180 fold ( Ile—L). Two further procedures were tested, using one of 4 I proteins in 
Table  1. A stepwise dialysis procedure (3 M, 1.5 M, 0.75 M, 0.4 M, and 0 M GnHCI for 3 h each) gave the same yield as the conventional 
dialysis. By contrast, a resin-assisted version of the new procedure, which is more convenient for purification, gave an equally excellent result 
LthILL). An on-exchange resin was added in the tubing, and dialyzed against the 75% and then 5% glycerol buffers in place of rapid dilution. 
The resin was collected by centrifugation, and the protein was eluted with TEM buffer containing 0.5M KCI. 
The new procedure was applicable to inclusion bodies formed by proteins with intact primary structures (4 3), deletion derivatives (# I) or 
artificial structures (4 2. 4), as well as a chemically modified protein (# 5). Activities of some proteins were confirmed, indicating their 
renaturation. at least partially. The yield depends on the components of the diluent and the results shown in Table .J. could probably be 
improved further. The effect of the components is unpredictable; for example, use of Triton X-lO0 or other detergents generally increased the 
yields, but reduced that of protein 4 4. 
The resulting aqueous and 75% glycerol solutions are not always stable, and further precipitation can take place. In the case of proteins # 1, 
s..1utions as concentrated as 10 mg protein/ml could be obtained in the final dilution step. However, these slowly formed precipitates over the 
course of several days at 4°C, stabilizing only when the concentration reached 2 mg/ml. Inclusion of Triton XI 00 prevented this instability. 
Proteins 4 3 precipitated in the 75% glycerol solution after a storage of three months at &minus;20°C. 
The exact basis of the improvement obtained by this procedure is not known. We can speculate that the increase in viscosity might prevent 
aegregation and precipitation, and that the high H-bond forming character of glycerol might stabilize protein conformations. Indeed, proteins 
seem to interact with glycerol similarly to water, because lysozyme keeps its native conformation in glycerol (Ref. ). This procedure has been 
under patent application (Ref. 2). 
cknowledgements 	 00 
re work was supported by an International Collaboration Grant of Japanese Ministry of 
Eucatlon, Science and Culture to NS (09044238). 
eferences 	 00 
(1] Mukhopadhyay A. (1997) 
Adv. Biochem. Eng. Biotechnol. , 56:61-109. Cited by 
Rudolph R. and Lille H. (1996) 
FASEB J. , 10:49-56. Cited by 
Grisshammer, R. and Nagai, K. (1995) in DNA Cloning 2: Expression Systems: A Practical 
Approach (Glover, D.M. and Hames, B.D., eds), pp. 59&ndash;92, IRL Press 
Fernandez-Patron C., Castellanos-Serra L. and Rodriguez P. (1992) 
Biorechniques , 12:564-573. Cited by 
Ortiz M.L. et al. (1992) 
FEBS Lett. , 296:300-304. Cited by 
Rariy R.V. and Klibanov A.M. (1997) 
Proc. Nat!. Acad. Sc!. U. S. A. , 94:13520-13523. Full text Cited by 
japan. Pat. Int. Cat. BOl) 19/00 (#144758) 
(8) Nagai H. and Shimamoto N. (1998) 




protein assay from Blo-Rad 
DEAE Toyopearl S650 resin 
DEAF Tovopearl 5650 resin from Tovobo 
P11: S0168952598015765 
Copyright 
© 1998 Elsevier Science Limited. All rights reserved. 
Research 	Reviews 	Journal 	News & 	Books & 	Science BioIVedNet ..' 	 Beta Test 	Collection Comment Labware Jobs 
Information for Advertisers 
Web 
Links 	'---'.'•.-.' 
0 Elsevier Science Limited 2000 
